<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<base href="%20">
<title>GONAL-f, INN-follitropin alfa</title>
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Helvetica;
	panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
	{font-family:Courier;
	panose-1:2 7 4 9 2 2 5 2 4 4;}
@font-face
	{font-family:"Tms Rmn";
	panose-1:2 2 6 3 4 5 5 2 3 4;}
@font-face
	{font-family:Helv;
	panose-1:2 11 6 4 2 2 2 3 2 4;}
@font-face
	{font-family:"New York";
	panose-1:2 4 5 3 6 5 6 2 3 4;}
@font-face
	{font-family:System;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;}
@font-face
	{font-family:Batang;
	panose-1:2 3 6 0 0 1 1 1 1 1;}
@font-face
	{font-family:SimSun;
	panose-1:2 1 6 0 3 1 1 1 1 1;}
@font-face
	{font-family:PMingLiU;
	panose-1:2 1 6 1 0 1 1 1 1 1;}
@font-face
	{font-family:"MS Gothic";
	panose-1:2 11 6 9 7 2 5 8 2 4;}
@font-face
	{font-family:Dotum;
	panose-1:2 11 6 0 0 1 1 1 1 1;}
@font-face
	{font-family:SimHei;
	panose-1:2 1 6 0 3 1 1 1 1 1;}
@font-face
	{font-family:MingLiU;
	panose-1:2 1 6 9 0 1 1 1 1 1;}
@font-face
	{font-family:Mincho;
	panose-1:2 2 6 9 4 3 5 8 3 5;}
@font-face
	{font-family:Gulim;
	panose-1:2 11 6 0 0 1 1 1 1 1;}
@font-face
	{font-family:Century;
	panose-1:2 4 6 4 5 5 5 2 3 4;}
@font-face
	{font-family:"Angsana New";
	panose-1:2 2 6 3 5 4 5 2 3 4;}
@font-face
	{font-family:"Cordia New";
	panose-1:2 11 3 4 2 2 2 2 2 4;}
@font-face
	{font-family:Mangal;
	panose-1:0 0 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:Latha;
	panose-1:2 0 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:Sylfaen;
	panose-1:1 10 5 2 5 3 6 3 3 3;}
@font-face
	{font-family:Vrinda;
	panose-1:0 0 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:Raavi;
	panose-1:2 0 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:Shruti;
	panose-1:2 0 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:Sendnya;
	panose-1:0 0 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:Gautami;
	panose-1:2 0 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:Tunga;
	panose-1:0 0 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Estrangelo Edessa";
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:"Yu Gothic";
	panose-1:2 11 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:DengXian;
	panose-1:2 1 6 0 3 1 1 1 1 1;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
	{font-family:"Calibri Light";
	panose-1:2 15 3 2 2 2 4 3 2 4;}
@font-face
	{font-family:"Palatino Linotype";
	panose-1:2 4 5 2 5 5 5 3 3 4;}
@font-face
	{font-family:Verdana;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
	{font-family:"Segoe UI Emoji";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:Cambria;
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"\@SimSun";
	panose-1:2 1 6 0 3 1 1 1 1 1;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	text-align:justify;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
h1
	{mso-style-link:"Heading 1 Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:28.35pt;
	text-align:center;
	text-indent:-28.35pt;
	line-height:normal;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
h2
	{mso-style-link:"Heading 2 Char";
	margin-top:.25in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.7pt;
	text-align:left;
	text-indent:-56.7pt;
	line-height:18.0pt;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
h3
	{mso-style-link:"Heading 3 Char";
	margin-top:.25in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.7pt;
	text-align:left;
	text-indent:-56.7pt;
	line-height:18.0pt;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
h4
	{mso-style-name:"Heading 4\,D70AR4\,titel 4";
	mso-style-link:"Heading 4 Char\,D70AR4 Char\,titel 4 Char";
	margin-top:.25in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.7pt;
	text-align:left;
	text-indent:-56.7pt;
	line-height:18.0pt;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:normal;}
h5
	{mso-style-link:"Heading 5 Char";
	margin-top:.25in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.7pt;
	text-align:left;
	text-indent:-56.7pt;
	line-height:18.0pt;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:normal;}
h6
	{mso-style-link:"Heading 6 Char";
	margin-top:.25in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.7pt;
	text-align:left;
	line-height:18.0pt;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:normal;
	font-style:italic;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{mso-style-link:"Heading 7 Char";
	margin-top:.25in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:85.05pt;
	text-align:left;
	text-indent:-28.35pt;
	line-height:18.0pt;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{mso-style-link:"Heading 8 Char";
	margin-top:24.0pt;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:85.05pt;
	text-align:left;
	text-indent:-85.05pt;
	line-height:18.0pt;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{mso-style-link:"Heading 9 Char";
	margin-top:.25in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:85.05pt;
	text-align:left;
	text-indent:-85.05pt;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoIndex1, li.MsoIndex1, div.MsoIndex1
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:12.0pt;
	text-align:justify;
	text-indent:-12.0pt;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoIndex2, li.MsoIndex2, div.MsoIndex2
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:24.0pt;
	text-align:justify;
	text-indent:-12.0pt;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoIndex3, li.MsoIndex3, div.MsoIndex3
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	text-align:justify;
	text-indent:-12.0pt;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoIndex4, li.MsoIndex4, div.MsoIndex4
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:48.0pt;
	text-align:justify;
	text-indent:-12.0pt;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoIndex5, li.MsoIndex5, div.MsoIndex5
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:60.0pt;
	text-align:justify;
	text-indent:-12.0pt;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoIndex6, li.MsoIndex6, div.MsoIndex6
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	text-align:justify;
	text-indent:-12.0pt;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoIndex7, li.MsoIndex7, div.MsoIndex7
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:84.0pt;
	text-align:justify;
	text-indent:-12.0pt;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoIndex8, li.MsoIndex8, div.MsoIndex8
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:96.0pt;
	text-align:justify;
	text-indent:-12.0pt;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoIndex9, li.MsoIndex9, div.MsoIndex9
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.5in;
	text-align:justify;
	text-indent:-12.0pt;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoToc1, li.MsoToc1, div.MsoToc1
	{margin-top:.25in;
	margin-right:28.35pt;
	margin-bottom:0in;
	margin-left:56.7pt;
	text-align:left;
	text-indent:-56.7pt;
	line-height:18.0pt;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
p.MsoToc2, li.MsoToc2, div.MsoToc2
	{margin-top:0in;
	margin-right:28.35pt;
	margin-bottom:0in;
	margin-left:56.7pt;
	text-align:left;
	text-indent:-56.7pt;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;}
p.MsoToc3, li.MsoToc3, div.MsoToc3
	{margin-top:0in;
	margin-right:28.35pt;
	margin-bottom:0in;
	margin-left:56.7pt;
	text-align:left;
	text-indent:-56.7pt;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoToc4, li.MsoToc4, div.MsoToc4
	{margin-top:0in;
	margin-right:28.35pt;
	margin-bottom:0in;
	margin-left:56.7pt;
	text-align:left;
	text-indent:-56.7pt;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoToc5, li.MsoToc5, div.MsoToc5
	{margin-top:0in;
	margin-right:28.35pt;
	margin-bottom:0in;
	margin-left:56.7pt;
	text-align:left;
	text-indent:-56.7pt;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoToc6, li.MsoToc6, div.MsoToc6
	{margin-top:0in;
	margin-right:28.35pt;
	margin-bottom:0in;
	margin-left:56.7pt;
	text-align:left;
	text-indent:-56.7pt;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoToc7, li.MsoToc7, div.MsoToc7
	{margin-top:0in;
	margin-right:28.35pt;
	margin-bottom:0in;
	margin-left:56.7pt;
	text-align:left;
	text-indent:-56.7pt;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoToc8, li.MsoToc8, div.MsoToc8
	{margin-top:12.0pt;
	margin-right:28.35pt;
	margin-bottom:0in;
	margin-left:85.05pt;
	text-align:left;
	text-indent:-85.05pt;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoToc9, li.MsoToc9, div.MsoToc9
	{margin-top:12.0pt;
	margin-right:28.35pt;
	margin-bottom:0in;
	margin-left:85.05pt;
	text-align:left;
	text-indent:-85.05pt;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoNormalIndent, li.MsoNormalIndent, div.MsoNormalIndent
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.7pt;
	text-align:left;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoFootnoteText, li.MsoFootnoteText, div.MsoFootnoteText
	{mso-style-link:"Footnote Text Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:28.35pt;
	text-align:left;
	text-indent:-28.35pt;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoCommentText, li.MsoCommentText, div.MsoCommentText
	{mso-style-link:"Comment Text Char";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	text-align:justify;
	line-height:18.0pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{mso-style-link:"Header Char";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	text-align:left;
	line-height:18.0pt;
	border:none;
	padding:0in;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{mso-style-link:"Footer Char";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	text-align:left;
	line-height:18.0pt;
	border:none;
	padding:0in;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoIndexHeading, li.MsoIndexHeading, div.MsoIndexHeading
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	text-align:justify;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Arial",sans-serif;
	font-weight:bold;}
p.MsoCaption, li.MsoCaption, div.MsoCaption
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	text-align:justify;
	line-height:18.0pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoTof, li.MsoTof, div.MsoTof
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	text-align:justify;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoEnvelopeAddress, li.MsoEnvelopeAddress, div.MsoEnvelopeAddress
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.0in;
	text-align:justify;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Arial",sans-serif;}
p.MsoEnvelopeReturn, li.MsoEnvelopeReturn, div.MsoEnvelopeReturn
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	text-align:justify;
	line-height:18.0pt;
	font-size:10.0pt;
	font-family:"Arial",sans-serif;}
span.MsoFootnoteReference
	{font-family:"Times New Roman",serif;
	position:relative;
	top:0pt;
	font-style:italic;
	vertical-align:baseline;}
span.MsoCommentReference
	{font-family:"Times New Roman",serif;}
span.MsoPageNumber
	{font-family:"Times New Roman",serif;}
span.MsoEndnoteReference
	{font-family:"Times New Roman",serif;
	position:relative;
	top:0pt;
	font-style:italic;
	vertical-align:super;}
p.MsoEndnoteText, li.MsoEndnoteText, div.MsoEndnoteText
	{mso-style-link:"Endnote Text Char";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:28.35pt;
	text-align:left;
	text-indent:-28.35pt;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoToa, li.MsoToa, div.MsoToa
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:12.0pt;
	text-align:justify;
	text-indent:-12.0pt;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoMacroText, li.MsoMacroText, div.MsoMacroText
	{mso-style-link:"Macro Text Char";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	text-align:justify;
	line-height:18.0pt;
	font-size:10.0pt;
	font-family:"Courier New";}
p.MsoToaHeading, li.MsoToaHeading, div.MsoToaHeading
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	text-align:justify;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Arial",sans-serif;
	font-weight:bold;}
p.MsoList, li.MsoList, div.MsoList
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:14.15pt;
	text-align:justify;
	text-indent:-14.15pt;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBullet, li.MsoListBullet, div.MsoListBullet
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	text-align:justify;
	text-indent:-.25in;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumber, li.MsoListNumber, div.MsoListNumber
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	text-align:justify;
	text-indent:-.25in;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoList2, li.MsoList2, div.MsoList2
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:28.3pt;
	text-align:justify;
	text-indent:-14.15pt;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoList3, li.MsoList3, div.MsoList3
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:42.45pt;
	text-align:justify;
	text-indent:-14.15pt;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoList4, li.MsoList4, div.MsoList4
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.6pt;
	text-align:justify;
	text-indent:-14.15pt;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoList5, li.MsoList5, div.MsoList5
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:70.75pt;
	text-align:justify;
	text-indent:-14.15pt;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBullet2, li.MsoListBullet2, div.MsoListBullet2
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:32.15pt;
	text-align:justify;
	text-indent:-.25in;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBullet3, li.MsoListBullet3, div.MsoListBullet3
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:46.3pt;
	text-align:justify;
	text-indent:-.25in;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBullet4, li.MsoListBullet4, div.MsoListBullet4
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:60.45pt;
	text-align:justify;
	text-indent:-.25in;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBullet5, li.MsoListBullet5, div.MsoListBullet5
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:74.6pt;
	text-align:justify;
	text-indent:-.25in;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumber2, li.MsoListNumber2, div.MsoListNumber2
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:32.15pt;
	text-align:justify;
	text-indent:-.25in;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumber3, li.MsoListNumber3, div.MsoListNumber3
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:46.3pt;
	text-align:justify;
	text-indent:-.25in;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumber4, li.MsoListNumber4, div.MsoListNumber4
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:60.45pt;
	text-align:justify;
	text-indent:-.25in;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumber5, li.MsoListNumber5, div.MsoListNumber5
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:74.6pt;
	text-align:justify;
	text-indent:-.25in;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoTitle, li.MsoTitle, div.MsoTitle
	{mso-style-link:"Title Char";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	text-align:center;
	line-height:18.0pt;
	font-size:16.0pt;
	font-family:"Arial",sans-serif;
	font-weight:bold;}
p.MsoClosing, li.MsoClosing, div.MsoClosing
	{mso-style-link:"Closing Char";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:212.6pt;
	text-align:justify;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoSignature, li.MsoSignature, div.MsoSignature
	{mso-style-link:"Signature Char";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:212.6pt;
	text-align:justify;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{mso-style-link:"Body Text Char";
	margin:0in;
	text-align:justify;
	line-height:18.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoBodyTextIndent, li.MsoBodyTextIndent, div.MsoBodyTextIndent
	{mso-style-link:"Body Text Indent Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:21.25pt;
	text-align:justify;
	text-indent:-21.25pt;
	line-height:18.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinue, li.MsoListContinue, div.MsoListContinue
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:14.15pt;
	text-align:justify;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinue2, li.MsoListContinue2, div.MsoListContinue2
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:28.3pt;
	text-align:justify;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinue3, li.MsoListContinue3, div.MsoListContinue3
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:42.45pt;
	text-align:justify;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinue4, li.MsoListContinue4, div.MsoListContinue4
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:56.6pt;
	text-align:justify;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinue5, li.MsoListContinue5, div.MsoListContinue5
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:70.75pt;
	text-align:justify;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoMessageHeader, li.MsoMessageHeader, div.MsoMessageHeader
	{mso-style-link:"Message Header Char";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.7pt;
	text-align:justify;
	text-indent:-56.7pt;
	line-height:18.0pt;
	background:#CCCCCC;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Arial",sans-serif;}
p.MsoSubtitle, li.MsoSubtitle, div.MsoSubtitle
	{mso-style-link:"Subtitle Char";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	text-align:center;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Arial",sans-serif;}
p.MsoSalutation, li.MsoSalutation, div.MsoSalutation
	{mso-style-link:"Salutation Char";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	text-align:justify;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoDate, li.MsoDate, div.MsoDate
	{mso-style-link:"Date Char";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	text-align:justify;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoBodyTextFirstIndent, li.MsoBodyTextFirstIndent, div.MsoBodyTextFirstIndent
	{mso-style-link:"Body Text First Indent Char";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:justify;
	text-indent:10.5pt;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoBodyTextFirstIndent2, li.MsoBodyTextFirstIndent2, div.MsoBodyTextFirstIndent2
	{mso-style-link:"Body Text First Indent 2 Char";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:14.15pt;
	text-align:justify;
	text-indent:10.5pt;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoNoteHeading, li.MsoNoteHeading, div.MsoNoteHeading
	{mso-style-link:"Note Heading Char";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	text-align:justify;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2
	{mso-style-link:"Body Text 2 Char";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	text-align:left;
	line-height:18.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoBodyText3, li.MsoBodyText3, div.MsoBodyText3
	{mso-style-link:"Body Text 3 Char";
	margin:0in;
	text-align:left;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2
	{mso-style-link:"Body Text Indent 2 Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:28.35pt;
	text-align:justify;
	text-indent:-28.35pt;
	line-height:18.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoBodyTextIndent3, li.MsoBodyTextIndent3, div.MsoBodyTextIndent3
	{mso-style-link:"Body Text Indent 3 Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:28.35pt;
	text-align:left;
	line-height:18.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoBlockText, li.MsoBlockText, div.MsoBlockText
	{margin-top:0in;
	margin-right:14.1pt;
	margin-bottom:0in;
	margin-left:28.35pt;
	text-align:left;
	text-indent:-28.35pt;
	line-height:18.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
a:link, span.MsoHyperlink
	{font-family:"Times New Roman",serif;
	color:blue;
	text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
	{font-family:"Times New Roman",serif;
	color:purple;
	text-decoration:underline;}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{mso-style-link:"Document Map Char";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	text-align:justify;
	line-height:18.0pt;
	background:navy;
	font-size:10.0pt;
	font-family:"Tahoma",sans-serif;}
p.MsoPlainText, li.MsoPlainText, div.MsoPlainText
	{mso-style-link:"Plain Text Char";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	text-align:justify;
	line-height:18.0pt;
	font-size:10.0pt;
	font-family:"Courier New";}
p.MsoAutoSig, li.MsoAutoSig, div.MsoAutoSig
	{mso-style-link:"E-mail Signature Char";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	text-align:justify;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	text-align:justify;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
address
	{mso-style-link:"HTML Address Char";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-style:italic;}
pre
	{mso-style-link:"HTML Preformatted Char";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:18.0pt;
	font-size:10.0pt;
	font-family:"Courier New";}
p.MsoCommentSubject, li.MsoCommentSubject, div.MsoCommentSubject
	{mso-style-link:"Comment Subject Char";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	text-align:justify;
	line-height:18.0pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-link:"Balloon Text Char";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	text-align:justify;
	line-height:18.0pt;
	font-size:8.0pt;
	font-family:"Tahoma",sans-serif;}
p.MsoRMPane, li.MsoRMPane, div.MsoRMPane
	{margin:0in;
	text-align:left;
	line-height:normal;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	text-align:justify;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoTocHeading, li.MsoTocHeading, div.MsoTocHeading
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:0in;
	text-align:center;
	line-height:normal;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.Heading1Char
	{mso-style-name:"Heading 1 Char";
	mso-style-link:"Heading 1";
	font-weight:bold;}
span.Heading2Char
	{mso-style-name:"Heading 2 Char";
	mso-style-link:"Heading 2";
	font-family:"Cambria",serif;
	font-weight:bold;
	font-style:italic;}
span.Heading3Char
	{mso-style-name:"Heading 3 Char";
	mso-style-link:"Heading 3";
	font-family:"Cambria",serif;
	font-weight:bold;}
span.Heading4Char
	{mso-style-name:"Heading 4 Char\,D70AR4 Char\,titel 4 Char";
	mso-style-link:"Heading 4\,D70AR4\,titel 4";
	font-family:"Calibri",sans-serif;
	font-weight:bold;}
span.Heading5Char
	{mso-style-name:"Heading 5 Char";
	mso-style-link:"Heading 5";
	font-family:"Calibri",sans-serif;
	font-weight:bold;
	font-style:italic;}
span.Heading6Char
	{mso-style-name:"Heading 6 Char";
	mso-style-link:"Heading 6";
	font-family:"Calibri",sans-serif;
	font-weight:bold;}
span.Heading7Char
	{mso-style-name:"Heading 7 Char";
	mso-style-link:"Heading 7";
	font-family:"Calibri",sans-serif;}
span.Heading8Char
	{mso-style-name:"Heading 8 Char";
	mso-style-link:"Heading 8";
	font-family:"Calibri",sans-serif;
	font-style:italic;}
span.Heading9Char
	{mso-style-name:"Heading 9 Char";
	mso-style-link:"Heading 9";
	font-family:"Cambria",serif;}
span.HTMLAddressChar
	{mso-style-name:"HTML Address Char";
	mso-style-link:"HTML Address";
	font-style:italic;}
p.Indent, li.Indent, div.Indent
	{mso-style-name:Indent;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.7pt;
	text-align:left;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.HTMLPreformattedChar
	{mso-style-name:"HTML Preformatted Char";
	mso-style-link:"HTML Preformatted";
	font-family:"Courier New";}
span.FootnoteTextChar
	{mso-style-name:"Footnote Text Char";
	mso-style-link:"Footnote Text";}
span.CommentTextChar
	{mso-style-name:"Comment Text Char";
	mso-style-link:"Comment Text";}
span.HeaderChar
	{mso-style-name:"Header Char";
	mso-style-link:Header;}
span.FooterChar
	{mso-style-name:"Footer Char";
	mso-style-link:Footer;
	font-weight:bold;}
span.EndnoteTextChar
	{mso-style-name:"Endnote Text Char";
	mso-style-link:"Endnote Text";}
span.MacroTextChar
	{mso-style-name:"Macro Text Char";
	mso-style-link:"Macro Text";
	font-family:"Courier New";}
span.TitleChar
	{mso-style-name:"Title Char";
	mso-style-link:Title;
	font-family:"Cambria",serif;
	font-weight:bold;}
span.ClosingChar
	{mso-style-name:"Closing Char";
	mso-style-link:Closing;}
span.SignatureChar
	{mso-style-name:"Signature Char";
	mso-style-link:Signature;}
span.BodyTextChar
	{mso-style-name:"Body Text Char";
	mso-style-link:"Body Text";}
span.BodyTextIndentChar
	{mso-style-name:"Body Text Indent Char";
	mso-style-link:"Body Text Indent";}
span.MessageHeaderChar
	{mso-style-name:"Message Header Char";
	mso-style-link:"Message Header";
	font-family:"Cambria",serif;
	background:#CCCCCC;}
span.SubtitleChar
	{mso-style-name:"Subtitle Char";
	mso-style-link:Subtitle;
	font-family:"Cambria",serif;}
span.SalutationChar
	{mso-style-name:"Salutation Char";
	mso-style-link:Salutation;}
span.DateChar
	{mso-style-name:"Date Char";
	mso-style-link:Date;}
span.BodyTextFirstIndentChar
	{mso-style-name:"Body Text First Indent Char";
	mso-style-link:"Body Text First Indent";}
span.BodyTextFirstIndent2Char
	{mso-style-name:"Body Text First Indent 2 Char";
	mso-style-link:"Body Text First Indent 2";}
span.NoteHeadingChar
	{mso-style-name:"Note Heading Char";
	mso-style-link:"Note Heading";}
span.BodyText2Char
	{mso-style-name:"Body Text 2 Char";
	mso-style-link:"Body Text 2";}
span.BodyText3Char
	{mso-style-name:"Body Text 3 Char";
	mso-style-link:"Body Text 3";}
span.BodyTextIndent2Char
	{mso-style-name:"Body Text Indent 2 Char";
	mso-style-link:"Body Text Indent 2";}
span.BodyTextIndent3Char
	{mso-style-name:"Body Text Indent 3 Char";
	mso-style-link:"Body Text Indent 3";}
span.DocumentMapChar
	{mso-style-name:"Document Map Char";
	mso-style-link:"Document Map";
	font-family:"Tahoma",sans-serif;}
span.PlainTextChar
	{mso-style-name:"Plain Text Char";
	mso-style-link:"Plain Text";
	font-family:"Courier New";}
span.E-mailSignatureChar
	{mso-style-name:"E-mail Signature Char";
	mso-style-link:"E-mail Signature";}
span.CommentSubjectChar
	{mso-style-name:"Comment Subject Char";
	mso-style-link:"Comment Subject";
	font-weight:bold;}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-link:"Balloon Text";
	font-family:"Tahoma",sans-serif;}
p.TOC6, li.TOC6, div.TOC6
	{mso-style-name:TOC6;
	margin-top:0in;
	margin-right:28.35pt;
	margin-bottom:0in;
	margin-left:56.7pt;
	text-align:left;
	text-indent:-56.7pt;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.NormalIndent2, li.NormalIndent2, div.NormalIndent2
	{mso-style-name:"Normal Indent 2";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:85.05pt;
	text-align:left;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.Legend, li.Legend, div.Legend
	{mso-style-name:Legend;
	margin-top:3.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	text-align:left;
	line-height:18.0pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.NormalIndent3, li.NormalIndent3, div.NormalIndent3
	{mso-style-name:"Normal Indent 3";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:85.05pt;
	text-align:justify;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.Indent2, li.Indent2, div.Indent2
	{mso-style-name:"Indent 2";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.7pt;
	text-align:justify;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.Considrant, li.Considrant, div.Considrant
	{mso-style-name:Considérant;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:35.45pt;
	text-align:justify;
	text-indent:-35.45pt;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MC, li.MC, div.MC
	{mso-style-name:MC;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:left;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Arial",sans-serif;}
p.Sprechblasentext1, li.Sprechblasentext1, div.Sprechblasentext1
	{mso-style-name:Sprechblasentext1;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	text-align:justify;
	line-height:18.0pt;
	font-size:8.0pt;
	font-family:"Tahoma",sans-serif;}
p.Kommentarthema1, li.Kommentarthema1, div.Kommentarthema1
	{mso-style-name:Kommentarthema1;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	text-align:justify;
	line-height:18.0pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.Formatvorlage1, li.Formatvorlage1, div.Formatvorlage1
	{mso-style-name:Formatvorlage1;
	margin:0in;
	text-align:left;
	line-height:18.0pt;
	font-size:11.0pt;
	font-family:"Arial",sans-serif;}
p.Personnequisigne, li.Personnequisigne, div.Personnequisigne
	{mso-style-name:"Personne qui signe";
	margin:0in;
	text-align:left;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-style:italic;}
p.Institutionquisigne, li.Institutionquisigne, div.Institutionquisigne
	{mso-style-name:"Institution qui signe";
	margin-top:.5in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	text-align:justify;
	line-height:18.0pt;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-style:italic;}
p.Fait, li.Fait, div.Fait
	{mso-style-name:"Fait à";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	text-align:justify;
	line-height:18.0pt;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.Rfrenceinstitutionelle, li.Rfrenceinstitutionelle, div.Rfrenceinstitutionelle
	{mso-style-name:"Référence institutionelle";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:255.15pt;
	text-align:left;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.Emission, li.Emission, div.Emission
	{mso-style-name:Emission;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:255.15pt;
	text-align:left;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.Sous-titreobjet, li.Sous-titreobjet, div.Sous-titreobjet
	{mso-style-name:"Sous-titre objet";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	text-align:justify;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.Titreobjet, li.Titreobjet, div.Titreobjet
	{mso-style-name:"Titre objet";
	margin-top:.25in;
	margin-right:0in;
	margin-bottom:.25in;
	margin-left:0in;
	text-align:center;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.Datedadoption, li.Datedadoption, div.Datedadoption
	{mso-style-name:"Date d\0027adoption";
	margin-top:.25in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	text-align:center;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.Typedudocument, li.Typedudocument, div.Typedudocument
	{mso-style-name:"Type du document";
	margin-top:.25in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	text-align:center;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.Titrearticle, li.Titrearticle, div.Titrearticle
	{mso-style-name:"Titre article";
	margin-top:.25in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:center;
	line-height:18.0pt;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-style:italic;}
p.Formuledadoption, li.Formuledadoption, div.Formuledadoption
	{mso-style-name:"Formule d\0027adoption";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:justify;
	line-height:18.0pt;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.Institutionquiagit, li.Institutionquiagit, div.Institutionquiagit
	{mso-style-name:"Institution qui agit";
	margin-top:30.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:justify;
	line-height:18.0pt;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.Langue, li.Langue, div.Langue
	{mso-style-name:Langue;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:30.0pt;
	margin-left:0in;
	text-align:center;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
p.Nomdelinstitution, li.Nomdelinstitution, div.Nomdelinstitution
	{mso-style-name:"Nom de l\0027institution";
	margin:0in;
	text-align:left;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Arial",sans-serif;}
p.Langueoriginale, li.Langueoriginale, div.Langueoriginale
	{mso-style-name:"Langue originale";
	margin-top:.25in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:center;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;}
p.MemoHeaderStyle, li.MemoHeaderStyle, div.MemoHeaderStyle
	{mso-style-name:MemoHeaderStyle;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:70.9pt;
	text-align:justify;
	font-size:11.0pt;
	font-family:"Arial",sans-serif;
	font-variant:small-caps;
	font-weight:bold;}
p.normalafs1, li.normalafs1, div.normalafs1
	{mso-style-name:normalafs1;
	margin:0in;
	text-align:justify;
	line-height:18.0pt;
	layout-grid-mode:char;
	font-size:11.0pt;
	font-family:"Arial",sans-serif;}
p.TitleA, li.TitleA, div.TitleA
	{mso-style-name:"Title A";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	text-align:center;
	line-height:18.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.TitleB, li.TitleB, div.TitleB
	{mso-style-name:"Title B";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:28.35pt;
	text-align:left;
	text-indent:-28.35pt;
	line-height:18.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.Text, li.Text, div.Text
	{mso-style-name:Text;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:0in;
	text-align:left;
	line-height:15.6pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.Titlefortables, li.Titlefortables, div.Titlefortables
	{mso-style-name:"Title for tables";
	margin-top:24.0pt;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:85.05pt;
	text-align:left;
	text-indent:-85.05pt;
	line-height:18.0pt;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.Default, li.Default, div.Default
	{mso-style-name:Default;
	margin:0in;
	text-align:justify;
	line-height:18.0pt;
	text-autospace:none;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	color:black;}
p.spctablefootnote, li.spctablefootnote, div.spctablefootnote
	{mso-style-name:spctablefootnote;
	margin:0in;
	text-align:left;
	line-height:18.0pt;
	font-size:9.0pt;
	font-family:"Times New Roman",serif;}
p.spctabletitleleft, li.spctabletitleleft, div.spctabletitleleft
	{mso-style-name:spctabletitleleft;
	margin:0in;
	text-align:left;
	line-height:18.0pt;
	font-size:9.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.LUTOlist-bullets, li.LUTOlist-bullets, div.LUTOlist-bullets
	{mso-style-name:"LUTO list - bullets";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	text-align:justify;
	text-indent:-.25in;
	line-height:18.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.Gonal-fTitle1, li.Gonal-fTitle1, div.Gonal-fTitle1
	{mso-style-name:"Gonal-f Title 1";
	margin-top:20.0pt;
	margin-right:0in;
	margin-bottom:20.0pt;
	margin-left:0in;
	text-align:left;
	line-height:18.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	color:#9B243E;
	font-weight:bold;}
p.Gonal-fTitle2, li.Gonal-fTitle2, div.Gonal-fTitle2
	{mso-style-name:"Gonal-f Title 2";
	margin-top:20.0pt;
	margin-right:0in;
	margin-bottom:10.0pt;
	margin-left:0in;
	text-align:left;
	line-height:18.0pt;
	border:none;
	padding:0in;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	color:#9B243E;
	font-weight:bold;}
p.Gonal-fPlainText1, li.Gonal-fPlainText1, div.Gonal-fPlainText1
	{mso-style-name:"Gonal-f Plain Text 1";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:left;
	line-height:18.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.Gonal-fWarning, li.Gonal-fWarning, div.Gonal-fWarning
	{mso-style-name:"Gonal-f Warning";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:left;
	line-height:18.0pt;
	background:#FFE7E7;
	border:none;
	padding:0in;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	font-style:italic;}
p.Gonal-fWarningTitle, li.Gonal-fWarningTitle, div.Gonal-fWarningTitle
	{mso-style-name:"Gonal-f Warning Title";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:left;
	line-height:18.0pt;
	background:#FFE7E7;
	border:none;
	padding:0in;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;
	text-decoration:underline;}
span.CharChar
	{mso-style-name:"Char Char";
	font-family:"Times New Roman",serif;}
span.CharChar1
	{mso-style-name:"Char Char1";
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
p.BodytextAgency, li.BodytextAgency, div.BodytextAgency
	{mso-style-name:"Body text \(Agency\)";
	mso-style-link:"Body text \(Agency\) Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:7.0pt;
	margin-left:0in;
	text-align:left;
	line-height:14.0pt;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;}
span.BodytextAgencyChar
	{mso-style-name:"Body text \(Agency\) Char";
	mso-style-link:"Body text \(Agency\)";
	font-family:"Verdana",sans-serif;}
p.ii-47otoa, li.ii-47otoa, div.ii-47otoa
	{mso-style-name:ii-47otoa;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:11.0pt;
	text-align:left;
	text-indent:-11.0pt;
	line-height:normal;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.ii-47onormal, li.ii-47onormal, div.ii-47onormal
	{mso-style-name:ii-47onormal;
	margin:0in;
	text-align:left;
	line-height:normal;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.Label, li.Label, div.Label
	{mso-style-name:Label;
	margin:0in;
	text-align:left;
	line-height:normal;
	border:none;
	padding:0in;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
p.Heading1left, li.Heading1left, div.Heading1left
	{mso-style-name:"Heading 1 left";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:28.35pt;
	text-align:left;
	text-indent:-28.35pt;
	line-height:normal;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.UnresolvedMention1
	{mso-style-name:"Unresolved Mention1";
	color:#605E5C;
	background:#E1DFDD;}
span.msoIns
	{mso-style-name:"";
	text-decoration:underline;
	color:teal;}
span.msoDel
	{mso-style-name:"";
	text-decoration:line-through;
	color:red;}
.MsoChpDefault
	{font-size:10.0pt;}
 /* Page Definitions */
 @page WordSection1
	{size:595.35pt 842.0pt;
	margin:56.7pt 70.9pt 56.7pt 70.9pt;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 ol
	{margin-bottom:0in;}
ul
	{margin-bottom:0in;}
-->
</style>

</head>

<body lang=EN-US link=blue vlink=purple style='word-wrap:break-word'>

<div class=WordSection1>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>ANNEX I</span></b></p>

<p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<h1><span lang=EN-GB>SUMMARY OF PRODUCT CHARACTERISTICS</span></h1>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>1.       NAME
OF THE MEDICINAL PRODUCT</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#F3F3F3'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 75&nbsp;IU&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#F3F3F3'><span
lang=EN-GB style='font-size:11.0pt;color:black'>GONAL-f 75&nbsp;IU powder and
solvent for solution for injection</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E6E6E6'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 1050&nbsp;IU&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E6E6E6'><span
lang=EN-GB style='font-size:11.0pt;color:black'>GONAL-f 1050&nbsp;IU/1.75&nbsp;mL
powder and solvent for solution for injection</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#CCCCCC'><i><span lang=EN-GB
style='font-size:11.0pt;color:black'>&lt;GONAL-f 450&nbsp;IU&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#CCCCCC'><span lang=EN-GB
style='font-size:11.0pt;color:black'>GONAL-f 450&nbsp;IU/0.75&nbsp;mL powder
and solvent for solution for injection</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>2.       QUALITATIVE
AND QUANTITATIVE COMPOSITION</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#F3F3F3'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 75&nbsp;IU&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F3F3F3'><span lang=EN-GB style='font-size:11.0pt;color:black'>Each
vial contains 5.5&nbsp;micrograms of follitropin alfa* equivalent to
75&nbsp;IU. Each mL of the reconstituted solution contains 75&nbsp;IU.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E6E6E6'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 1050&nbsp;IU&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#E6E6E6'><span lang=EN-GB style='font-size:11.0pt;color:black'>Each
multidose vial contains 87&nbsp;micrograms of follitropin alfa* (equivalent to
1200&nbsp;IU), in order to deliver 77&nbsp;micrograms (equivalent to
1050&nbsp;IU) in 1.75&nbsp;mL. Each mL of the reconstituted solution contains
600&nbsp;IU.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#CCCCCC'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 450 IU&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#CCCCCC'><span lang=EN-GB style='font-size:11.0pt;color:black'>Each
multidose vial contains 44&nbsp;micrograms of follitropin alfa* (equivalent to
600&nbsp;IU), in order to deliver 33&nbsp;micrograms (equivalent to
450&nbsp;IU) in 0.75&nbsp;mL. Each mL of the reconstituted solution contains
600&nbsp;IU.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>* recombinant human follicle
stimulating hormone (r&#8209;hFSH) produced in Chinese Hamster Ovary (CHO)
cells by recombinant DNA technology</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E6E6E6'><i><span
lang=EN-GB style='font-size:11.0pt;color:black;background:#D9D9D9'>Additionally
&lt;GONAL-f 1050&nbsp;IU&gt; </span></i><i><span lang=EN-GB style='font-size:
11.0pt;color:black'>+ <span style='background:#BFBFBF'>&lt;GONAL-f 450 IU&gt;</span></span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#D9D9D9'><u><span
lang=EN-GB style='font-size:11.0pt;color:black'>Excipient with known effect:</span></u><span
lang=EN-GB style='font-size:11.0pt;color:black'> The reconstituted solution
contains 9.45&nbsp;mg benzyl alcohol per mL.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>For the full list of excipients, see section&nbsp;6.1.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>3.       PHARMACEUTICAL
FORM</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>Powder and solvent for solution for injection.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>Appearance of the powder: white lyophilised pellet.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>Appearance of the solvent: clear colourless solution.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>The pH of the reconstituted solution is 6.5&#8209;7.5.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>4.       CLINICAL
PARTICULARS</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<h2 style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:28.35pt;
margin-bottom:.0001pt;text-indent:-28.35pt;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;text-transform:none'>4.1     Therapeutic
indications</span></h2>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB style='font-size:11.0pt'>In adult women</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Anovulation (including
polycystic ovarian syndrome) in women who have been unresponsive to treatment
with clomiphene citrate.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Stimulation of
multifollicular development in women undergoing superovulation for assisted
reproductive technologies (ART) such as <i>in&nbsp;vitro</i> fertilisation
(IVF), gamete intra-fallopian transfer and zygote intra-fallopian transfer.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>GONAL-f in association
with a luteinising hormone (LH) preparation is recommended for the stimulation
of follicular development in women with severe LH and FSH deficiency. In
clinical trials these patients were defined by an endogenous serum LH level
&lt;&nbsp;1.2&nbsp;IU/L.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><i><u><span lang=EN-GB
style='font-size:11.0pt'><span style='text-decoration:none'>&nbsp;</span></span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB style='font-size:11.0pt'>In adult men</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'><span style='text-decoration:none'>&nbsp;</span></span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>GONAL-f is indicated
for the stimulation of spermatogenesis in men who have congenital or acquired
hypogonadotrophic hypogonadism with concomitant human Chorionic Gonadotropin
(hCG) therapy.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<h2 style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:28.35pt;
margin-bottom:.0001pt;text-indent:-28.35pt;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;text-transform:none'>4.2     Posology and
method of administration</span></h2>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Treatment with GONAL-f should
be initiated under the supervision of a physician experienced in the treatment
of fertility disorders.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB style='font-size:11.0pt'>Posology</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>The dose recommendations given for GONAL-f are those in use for
urinary FSH. Clinical assessment of GONAL&#8209;f indicates that its daily
doses, regimens of administration, and treatment monitoring procedures should
not be different from those currently used for urinary FSH-containing medicinal
products. It is advised to adhere to the recommended starting doses indicated
below.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Comparative clinical studies
have shown that on average patients require a lower cumulative dose and shorter
treatment duration with GONAL&#8209;f compared with urinary FSH. Therefore, it
is considered appropriate to give a lower total dose of GONAL&#8209;f than
generally used for urinary FSH, not only in order to optimise follicular
development but also to minimise the risk of unwanted ovarian hyperstimulation.
See section&nbsp;5.1.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E6E6E6'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>Additional <span
style='background:#D9D9D9'>&lt;GONAL-f 1050&nbsp;IU&gt;</span> + <span
style='background:#BFBFBF'>&lt;GONAL-f 450 IU&gt;</span> </span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#E6E6E6'><span lang=EN-GB style='font-size:11.0pt;color:black'>Bioequivalence
has been demonstrated between equivalent doses of the monodose presentation and
the multidose presentation of GONAL-f.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E6E6E6'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E6E6E6'><span
lang=EN-GB style='font-size:11.0pt;color:black'>The following table states the
volume to be administered to deliver the prescribed dose:</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E6E6E6'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div align=center>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr style='page-break-inside:avoid'>
  <td width=189 valign=top style='width:141.75pt;border:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormalIndent style='margin-top:0in;margin-right:0in;margin-bottom:
  0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;
  line-height:normal;background:#E6E6E6'><b><span lang=EN-GB style='font-size:
  11.0pt;color:black'>Dose (IU)</span></b></p>
  </td>
  <td width=189 valign=top style='width:141.75pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormalIndent style='margin-top:0in;margin-right:0in;margin-bottom:
  0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;
  line-height:normal;background:#E6E6E6'><b><span lang=EN-GB style='font-size:
  11.0pt;color:black'>Volume to be injected (mL)</span></b></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width=189 valign=top style='width:141.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormalIndent style='margin-top:0in;margin-right:0in;margin-bottom:
  0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;
  line-height:normal;background:#E6E6E6'><span lang=EN-GB style='font-size:
  11.0pt;color:black'>75</span></p>
  </td>
  <td width=189 valign=top style='width:141.75pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormalIndent style='margin-top:0in;margin-right:0in;margin-bottom:
  0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;
  line-height:normal;background:#E6E6E6'><span lang=EN-GB style='font-size:
  11.0pt;color:black'>0.13</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width=189 valign=top style='width:141.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormalIndent style='margin-top:0in;margin-right:0in;margin-bottom:
  0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;
  line-height:normal;background:#E6E6E6'><span lang=EN-GB style='font-size:
  11.0pt;color:black'>150</span></p>
  </td>
  <td width=189 valign=top style='width:141.75pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormalIndent style='margin-top:0in;margin-right:0in;margin-bottom:
  0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;
  line-height:normal;background:#E6E6E6'><span lang=EN-GB style='font-size:
  11.0pt;color:black'>0.25</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width=189 valign=top style='width:141.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormalIndent style='margin-top:0in;margin-right:0in;margin-bottom:
  0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;
  line-height:normal;background:#E6E6E6'><span lang=EN-GB style='font-size:
  11.0pt;color:black'>225</span></p>
  </td>
  <td width=189 valign=top style='width:141.75pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormalIndent style='margin-top:0in;margin-right:0in;margin-bottom:
  0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;
  line-height:normal;background:#E6E6E6'><span lang=EN-GB style='font-size:
  11.0pt;color:black'>0.38</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width=189 valign=top style='width:141.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormalIndent style='margin-top:0in;margin-right:0in;margin-bottom:
  0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;
  line-height:normal;background:#E6E6E6'><span lang=EN-GB style='font-size:
  11.0pt;color:black'>300</span></p>
  </td>
  <td width=189 valign=top style='width:141.75pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormalIndent style='margin-top:0in;margin-right:0in;margin-bottom:
  0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;
  line-height:normal;background:#E6E6E6'><span lang=EN-GB style='font-size:
  11.0pt;color:black'>0.50</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width=189 valign=top style='width:141.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormalIndent style='margin-top:0in;margin-right:0in;margin-bottom:
  0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;
  line-height:normal;background:#E6E6E6'><span lang=EN-GB style='font-size:
  11.0pt;color:black'>375</span></p>
  </td>
  <td width=189 valign=top style='width:141.75pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormalIndent style='margin-top:0in;margin-right:0in;margin-bottom:
  0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;
  line-height:normal;background:#E6E6E6'><span lang=EN-GB style='font-size:
  11.0pt;color:black'>0.63</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width=189 valign=top style='width:141.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormalIndent style='margin-top:0in;margin-right:0in;margin-bottom:
  0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;
  line-height:normal;background:#E6E6E6'><span lang=EN-GB style='font-size:
  11.0pt;color:black'>450</span></p>
  </td>
  <td width=189 valign=top style='width:141.75pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormalIndent style='margin-top:0in;margin-right:0in;margin-bottom:
  0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;
  line-height:normal;background:#E6E6E6'><span lang=EN-GB style='font-size:
  11.0pt;color:black'>0.75</span></p>
  </td>
 </tr>
</table>

</div>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>Women with anovulation (including polycystic
ovarian syndrome)</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>GONAL&#8209;f may be given as
a course of daily injections. In menstruating women treatment should commence
within the first 7&nbsp;days of the menstrual cycle.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>A commonly used regimen
commences at 75&#8209;150&nbsp;IU FSH daily and is increased preferably by 37.5
or 75&nbsp;IU at 7 or preferably 14&nbsp;day intervals if necessary, to obtain
an adequate, but not excessive, response. Treatment should be tailored to the
individual patients response as assessed by measuring follicle size by
ultrasound and/or oestrogen secretion. The maximal daily dose is usually not
higher than 225&nbsp;IU FSH. If a patient fails to respond adequately after
4&nbsp;weeks of treatment, that cycle should be abandoned and the patient
should undergo further evaluation after which she may recommence treatment at a
higher starting dose than in the abandoned cycle.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>When an optimal response is
obtained, a single injection of 250&nbsp;micrograms recombinant human
choriogonadotropin alfa (r&#8209;hCG) or 5,000&nbsp;IU, up to 10,000&nbsp;IU
hCG should be administered 24&#8209;48&nbsp;hours after the last GONAL-f
injection. The patient is recommended to have coitus on the day of, and the day
following, hCG administration. Alternatively, intrauterine insemination (IUI)
may be performed.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>If an excessive response is
obtained, treatment should be stopped and hCG withheld (see section&nbsp;4.4).
Treatment should recommence in the next cycle at a dose lower than that of the
previous cycle.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><u><span lang=EN-GB style='font-size:11.0pt'><span style='text-decoration:
 none'>&nbsp;</span></span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><i><u><span lang=EN-GB style='font-size:11.0pt'>Women
undergoing ovarian stimulation for multiple follicular development prior to in&nbsp;vitro
fertilisation or other assisted reproductive technologies</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>A
commonly used regimen for superovulation involves the administration of 150&#8209;225&nbsp;IU
of GONAL&#8209;f daily, commencing on days&nbsp;2 or 3 of the cycle. Treatment
is continued until adequate follicular development has been achieved (as
assessed by monitoring of serum oestrogen concentrations and/or ultrasound
examination), with the dose adjusted according to the patients response, to
usually not higher than 450&nbsp;IU daily. In general, adequate follicular
development is achieved on average by the tenth day of treatment (range 5 to
20&nbsp;days).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>A single injection of
250&nbsp;micrograms r&#8209;hCG or 5,000&nbsp;IU up to 10,000&nbsp;IU hCG is
administered 24&#8209;48&nbsp;hours after the last GONAL-f injection to induce
final follicular maturation.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Down-regulation with a
gonadotropin-releasing hormone (GnRH) agonist or antagonist is now commonly
used in order to suppress the endogenous LH surge and to control tonic levels
of LH. In a commonly used protocol, GONAL&#8209;f is started approximately
2&nbsp;weeks after the start of agonist treatment, both being continued until
adequate follicular development is achieved. For example, following two weeks
of treatment with an agonist, 150&#8209;225&nbsp;IU GONAL-f are administered
for the first 7&nbsp;days. The dose is then adjusted according to the ovarian
response.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Overall experience with IVF
indicates that in general the treatment success rate remains stable during the
first four attempts and gradually declines thereafter.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>Women with anovulation resulting from
severe LH and FSH deficiency</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>In LH and FSH deficient women
(hypogonadotrophic hypogonadism), the objective of GONAL&#8209;f therapy in
association with lutropin alfa is to develop a single mature Graafian follicle
from which the oocyte will be liberated after the administration of human
chorionic gonadotropin (hCG). GONAL&#8209;f should be given as a course of
daily injections simultaneously with lutropin alfa. Since these patients are
amenorrhoeic and have low endogenous oestrogen secretion, treatment can
commence at any time.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>A recommended regimen
commences at 75&nbsp;IU of lutropin alfa daily with 75&#8209;150&nbsp;IU FSH.
Treatment should be tailored to the individual patients response as assessed
by measuring follicle size by ultrasound and oestrogen response.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>If an FSH dose increase is
deemed appropriate, dose adaptation should preferably be after 7&#8209;14&nbsp;day
intervals and preferably by 37.5&#8209;75&nbsp;IU increments. It may be
acceptable to extend the duration of stimulation in any one cycle to up to
5&nbsp;weeks.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>When an optimal response is
obtained, a single injection of 250&nbsp;micrograms r-hCG or 5,000&nbsp;IU up
to 10,000&nbsp;IU hCG should be administered 24&#8209;48&nbsp;hours after the
last GONAL&#8209;f and lutropin alfa injections. The patient is recommended to
have coitus on the day of, and on the day following, hCG administration. Alternatively,
IUI may be performed.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Luteal phase support may be
considered since lack of substances with luteotrophic activity (LH/hCG) after
ovulation may lead to premature failure of the corpus luteum.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>If an excessive response is
obtained, treatment should be stopped and hCG withheld. Treatment should
recommence in the next cycle at a dose of FSH lower than that of the previous
cycle.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>Men with hypogonadotrophic hypogonadism</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>GONAL&#8209;f should be given
at a dose of 150&nbsp;IU three times a week, concomitantly with hCG, for a
minimum of 4&nbsp;months. If after this period, the patient has not responded,
the combination treatment may be continued; current clinical experience
indicates that treatment for at least 18&nbsp;months may be necessary to
achieve spermatogenesis.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><u><span lang=EN-GB style='font-size:11.0pt'><span style='text-decoration:
 none'>&nbsp;</span></span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB style='font-size:11.0pt'>Special populations</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'><span style='text-decoration:none'>&nbsp;</span></span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>Elderly</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>There is no relevant use of
GONAL&#8209;f in the elderly population. Safety and effectiveness of GONAL&#8209;f
in elderly patients have not been established.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>Renal or hepatic impairment</span></u></i></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>Safety, efficacy and pharmacokinetics of GONAL&#8209;f in patients
with renal or hepatic impairment have not been established.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><i><u><span lang=EN-GB>Paediatric population</span></u></i></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>There is no relevant use of GONAL-f in the paediatric population.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB style='font-size:11.0pt'>Method of administration</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>GONAL&#8209;f is intended for
subcutaneous use. The injection should be given at the same time each day.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>The first injection of GONAL&#8209;f
should be performed under direct medical supervision. Self-administration of
GONAL&#8209;f should only be performed by patients who are well motivated,
adequately trained and have access to expert advice.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#F3F3F3'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 75&nbsp;IU&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F3F3F3'><span lang=EN-GB style='font-size:11.0pt;color:black'>The
injection site should be alternated daily.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><i><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E6E6E6'><i><span
lang=EN-GB style='font-size:11.0pt;color:black;background:#D9D9D9'>&lt;GONAL-f
1050&nbsp;IU&gt;</span></i><i><span lang=EN-GB style='font-size:11.0pt;
color:black'> + <span style='background:#BFBFBF'>&lt;GONAL-f 450 IU&gt;</span> </span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#E6E6E6'><span lang=EN-GB style='font-size:11.0pt;color:black'>As
GONAL-f multidose is intended for several injections, clear instructions should
be provided to the patients to avoid misuse of the multidose presentation.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#E6E6E6'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#E6E6E6'><span lang=EN-GB style='font-size:11.0pt;color:black'>Due
to a local reactivity to benzyl alcohol, the same site of injection should not
be used on consecutive days.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#E6E6E6'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#E6E6E6'><span lang=EN-GB style='font-size:11.0pt;color:black'>Individual
reconstituted vials should be for single patient use only.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>For instructions on the
reconstitution and administration of GONAL&#8209;f powder and solvent for
solution for injection see section&nbsp;6.6 and the package leaflet.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<h2 style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:28.35pt;
margin-bottom:.0001pt;text-indent:-28.35pt;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;text-transform:none'>4.3     Contraindications</span></h2>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>hypersensitivity to the
active substance or to any of the excipients listed in section&nbsp;6.1</span></p>

<p class=MsoNormal align=left style='margin:0in;margin-bottom:.0001pt;
text-align:left;text-indent:0in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>tumours of the
hypothalamus or pituitary gland</span></p>

<p class=MsoNormal align=left style='margin:0in;margin-bottom:.0001pt;
text-align:left;text-indent:0in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>ovarian enlargement or
ovarian cyst not due to polycystic ovarian syndrome</span></p>

<p class=MsoNormal align=left style='margin:0in;margin-bottom:.0001pt;
text-align:left;text-indent:0in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>gynaecological
haemorrhages of unknown aetiology</span></p>

<p class=MsoNormal align=left style='margin:0in;margin-bottom:.0001pt;
text-align:left;text-indent:0in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>ovarian, uterine or
mammary carcinoma</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>GONAL-f must not be used when an effective
response cannot be obtained, such as:</span></p>

<p class=MsoNormal align=left style='margin:0in;margin-bottom:.0001pt;
text-align:left;text-indent:0in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>primary ovarian failure</span></p>

<p class=MsoNormal align=left style='margin:0in;margin-bottom:.0001pt;
text-align:left;text-indent:0in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>malformations of sexual
organs incompatible with pregnancy</span></p>

<p class=MsoNormal align=left style='margin:0in;margin-bottom:.0001pt;
text-align:left;text-indent:0in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>fibroid tumours of the
uterus incompatible with pregnancy</span></p>

<p class=MsoNormal align=left style='margin:0in;margin-bottom:.0001pt;
text-align:left;text-indent:0in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>primary testicular
insufficiency</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<h2 style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:28.35pt;
margin-bottom:.0001pt;text-indent:-28.35pt;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;text-transform:none'>4.4     Special
warnings and precautions for use</span></h2>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal;page-break-after:
avoid'><u><span lang=EN-GB style='font-size:11.0pt'>Traceability</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>In order to improve the
traceability of biological medicinal products, the name and the batch number of
the administered product should be clearly recorded.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><u><span lang=EN-GB style='font-size:11.0pt'>General recommendations</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>GONAL&#8209;f is a potent
gonadotrophic substance capable of causing mild to severe adverse reactions and
should only be used by physicians who are thoroughly familiar with infertility
problems and their management.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Gonadotropin therapy requires
a certain time commitment by physicians and supportive health professionals, as
well as the availability of appropriate monitoring facilities. In women, safe
and effective use of GONAL&#8209;f calls for monitoring of ovarian response
with ultrasound, alone or preferably in combination with measurement of serum
oestradiol levels, on a regular basis. There may be a degree of inter&#8209;patient
variability in response to FSH administration, with a poor response to FSH in
some patients and exaggerated response in others. The lowest effective dose in
relation to the treatment objective should be used in both men and women.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB style='font-size:11.0pt'>Porphyria</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'><span style='text-decoration:none'>&nbsp;</span></span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Patients with porphyria or a
family history of porphyria should be closely monitored during treatment with
GONAL&#8209;f. Deterioration or a first appearance of this condition may
require cessation of treatment.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB style='font-size:11.0pt'>Treatment in women</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Before starting treatment, the
couples infertility should be assessed as appropriate and putative
contraindications for pregnancy evaluated. In particular, patients should be
evaluated for hypothyroidism, adrenocortical deficiency, hyperprolactinemia and
appropriate specific treatment given.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Patients undergoing
stimulation of follicular growth, whether as treatment for anovulatory
infertility or ART procedures, may experience ovarian enlargement or develop
hyperstimulation. Adherence to recommended GONAL&#8209;f dose and regimen of
administration and careful monitoring of therapy will minimise the incidence of
such events. For accurate interpretation of the indices of follicle development
and maturation, the physician should be experienced in the interpretation of
the relevant tests.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>In clinical trials, an
increase of the ovarian sensitivity to GONAL&#8209;f was shown when
administered with lutropin alfa. If an FSH dose increase is deemed appropriate,
dose adaptation should preferably be at 7&#8209;14&nbsp;day intervals and
preferably with 37.5-75&nbsp;IU increments.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>No direct comparison of GONAL&#8209;f/LH
versus human menopausal gonadotropin (hMG) has been performed. Comparison with
historical data suggests that the ovulation rate obtained with GONAL&#8209;f/LH
is similar to that obtained with hMG.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<h3 style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:28.35pt;
margin-bottom:.0001pt;text-indent:-28.35pt;line-height:normal'><i><u><span
lang=EN-GB style='font-size:11.0pt;font-weight:normal'>Ovarian Hyperstimulation
Syndrome (OHSS)</span></u></i></h3>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>A certain degree of ovarian
enlargement is an expected effect of controlled ovarian stimulation. It is more
commonly seen in women with polycystic ovarian syndrome and usually regresses
without treatment.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>In distinction to uncomplicated ovarian enlargement, OHSS is a
condition that can manifest itself with increasing degrees of severity. It
comprises marked ovarian enlargement, high serum sex steroids, and an increase
in vascular permeability which can result in an accumulation of fluid in the
peritoneal, pleural and, rarely, in the pericardial cavities.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>The following symptomatology
may be observed in severe cases of OHSS: abdominal pain, abdominal distension,
severe ovarian enlargement, weight gain, dyspnoea, oliguria and gastrointestinal
symptoms including nausea, vomiting and diarrhoea. Clinical evaluation may
reveal hypovolaemia, haemoconcentration, electrolyte imbalances, ascites,
haemoperitoneum, pleural effusions, hydrothorax, or acute pulmonary distress.
Very rarely, severe OHSS may be complicated by ovarian torsion or
thromboembolic events such as pulmonary embolism, ischaemic stroke or
myocardial infarction.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Independent risk factors for
developing OHSS include polycystic ovarian syndrome high absolute or rapidly rising
serum oestradiol levels (e.g. &gt;&nbsp;900&nbsp;pg/mL or
&gt;&nbsp;3,300&nbsp;pmol/L in anovulation; &gt;&nbsp;3,000&nbsp;pg/mL or
&gt;&nbsp;11,000&nbsp;pmol/L in ART) and large number of developing ovarian
follicles (e.g. &gt;&nbsp;3&nbsp;follicles of &#8805;&nbsp;14&nbsp;mm in
diameter in anovulation; &#8805;&nbsp;20 follicles of &#8805;&nbsp;12&nbsp;mm in
diameter in ART).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Adherence to recommended
GONAL&#8209;f dose and regimen of administration can minimise the risk of
ovarian hyperstimulation (see sections&nbsp;4.2 and 4.8). Monitoring of
stimulation cycles by ultrasound scans as well as oestradiol measurements are
recommended to early identify risk factors.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>There is evidence to suggest that hCG plays a key role in triggering
OHSS and that the syndrome may be more severe and more protracted if pregnancy
occurs. Therefore, if signs of ovarian hyperstimulation occur such as serum
oestradiol level &gt;&nbsp;5,500&nbsp;pg/mL or &gt;&nbsp;20,200&nbsp;pmol/L
and/or &#8805;&nbsp;40&nbsp;follicles in total, it is recommended that hCG be
withheld and the patient be advised to refrain from coitus or to use barrier
contraceptive methods for at least 4&nbsp;days. OHSS may progress rapidly
(within 24&nbsp;hours) or over several days to become a serious medical event.
It most often occurs after hormonal treatment has been discontinued and reaches
its maximum at about seven to ten days following treatment. Therefore, patients
should be followed for at least two weeks after hCG administration.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><a
name="OLEII-109_Company_Response_to_LoQLINK4"></a><a
name="OLEII-109_Company_Response_to_LoQLINK5"></a><span lang=EN-GB>In ART,
aspiration of all follicles prior to ovulation may reduce the occurrence of
hyperstimulation.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Mild or moderate OHSS usually
resolves spontaneously. If severe OHSS occurs, it is recommended that
gonadotropin treatment be stopped if still ongoing, and that the patient be
hospitalised and appropriate therapy be started.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>Multiple pregnancy</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>In patients undergoing
ovulation induction, the incidence of multiple pregnancy is increased compared
with natural conception. The majority of multiple conceptions are twins.
Multiple pregnancy, especially of high order, carries an increased risk of
adverse maternal and perinatal outcomes.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>To minimise the risk of
multiple pregnancy, careful monitoring of ovarian response is recommended.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>In patients undergoing ART
procedures the risk of multiple pregnancy is related mainly to the number of
embryos replaced, their quality and the patient age.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>The patients should be
advised of the potential risk of multiple births before starting treatment.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>Pregnancy loss</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>The incidence of pregnancy loss
by miscarriage or abortion is higher in patients undergoing stimulation of
follicular growth for ovulation induction or ART than following natural
conception.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>Ectopic pregnancy</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Women with a history of tubal
disease are at risk of ectopic pregnancy, whether the pregnancy is obtained by
spontaneous conception or with fertility treatments. The prevalence of ectopic
pregnancy after ART, was reported to be higher than in the general population.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>Reproductive system neoplasms</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>There have been reports of
ovarian and other reproductive system neoplasms, both benign and malignant, in
women who have undergone multiple treatment regimens for infertility treatment.
It is not yet established whether or not treatment with gonadotropins increases
the risk of these tumours in infertile women.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>Congenital malformation</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>The prevalence of congenital
malformations after ART may be slightly higher than after spontaneous
conceptions. This is thought to be due to differences in parental
characteristics (e.g. maternal age, sperm characteristics) and multiple
pregnancies.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>Thromboembolic events</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>In women with recent or
ongoing thromboembolic disease or women with generally recognised risk factors
for thromboembolic events, such as personal or family history, treatment with
gonadotropins may further increase the risk for aggravation or occurrence of
such events. In these women, the benefits of gonadotropin administration need
to be weighed against the risks. It should be noted however that pregnancy
itself as well as OHSS also carry an increased risk of thromboembolic events.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB style='font-size:11.0pt'>Treatment in men</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Elevated endogenous FSH
levels are indicative of primary testicular failure. Such patients are unresponsive
to GONAL&#8209;f/hCG therapy. GONAL-f should not be used when an effective
response cannot be obtained.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Semen analysis is recommended
4 to 6&nbsp;months after the beginning of treatment as part of the assessment
of the response.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB style='font-size:11.0pt'>Sodium content</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>GONAL&#8209;f contains less
than 1&nbsp;mmol sodium (23&nbsp;mg) per dose, i.e. it is essentially sodium&#8209;free.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E6E6E6'><i><span
lang=EN-GB style='font-size:11.0pt;color:black;background:#D9D9D9'>Additionally
&lt;GONAL-f 1050&nbsp;IU&gt; </span></i><i><span lang=EN-GB style='font-size:
11.0pt;color:black'>+ <span style='background:#BFBFBF'>&lt;GONAL-f 450 IU&gt;</span>
</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#D9D9D9'><u><span lang=EN-GB
style='font-size:11.0pt;color:black'>Solvent containing benzyl alcohol</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#D9D9D9'><u><span lang=EN-GB
style='font-size:11.0pt'><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#D9D9D9'><span lang=EN-GB style='font-size:11.0pt;color:black'>Following
reconstitution with the solvent provided, this medicinal product contains
1.23&nbsp;mg benzyl alcohol in each 75&nbsp;IU dose which is equivalent to
9.45&nbsp;mg/mL. Benzyl alcohol may cause allergic reactions.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<h2 style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:28.35pt;
margin-bottom:.0001pt;text-indent:-28.35pt;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;text-transform:none'>4.5     Interaction
with other medicinal products and other forms of interaction</span></h2>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Concomitant use of GONAL-f
with other medicinal products used to stimulate ovulation (e.g. hCG, clomiphene
citrate) may potentiate the follicular response, whereas concurrent use of a
GnRH agonist or antagonist to induce pituitary desensitisation may increase the
dose of GONAL-f needed to elicit an adequate ovarian response. No other
clinically significant medicinal product interaction has been reported during
GONAL-f therapy.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<h2 style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:28.35pt;
margin-bottom:.0001pt;text-indent:-28.35pt;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;text-transform:none'>4.6     Fertility,
pregnancy and lactation</span></h2>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB style='font-size:11.0pt'>Pregnancy</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB style='font-size:11.0pt'><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>There is no indication for
use of GONAL-f during pregnancy. Data on a limited number of exposed
pregnancies (less than 300&nbsp;pregnancy outcomes) indicate no malformative or
feto/neonatal toxicity of follitropin alfa.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>No teratogenic effect has
been observed in animal studies (see section&nbsp;5.3).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>In case of exposure during
pregnancy, clinical data are not sufficient to exclude a teratogenic effect of
GONAL&#8209;f.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB style='font-size:11.0pt'>Breast&#8209;feeding</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB style='font-size:11.0pt'><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>GONAL&#8209;f is not
indicated during breast&#8209;feeding.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB style='font-size:11.0pt'>Fertility</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB style='font-size:11.0pt'><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoPlainText align=left style='margin-top:0in;text-align:left;
line-height:normal'><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>GONAL&#8209;f
is indicated for use in infertility (see section&nbsp;4.1).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<h2 style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:28.35pt;
margin-bottom:.0001pt;text-indent:-28.35pt;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;text-transform:none'>4.7     Effects on ability
to drive and use machines</span></h2>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>GONAL&#8209;f is expected to
have no or negligible influence on the ability to drive and use machines.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<h2 style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:28.35pt;
margin-bottom:.0001pt;text-indent:-28.35pt;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;text-transform:none'>4.8     Undesirable
effects</span></h2>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal;page-break-after:
avoid'><u><span lang=EN-GB style='font-size:11.0pt'>Summary of the safety
profile</span></u></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal;page-break-after:
avoid'><u><span lang=EN-GB style='font-size:11.0pt'><span style='text-decoration:
 none'>&nbsp;</span></span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>The most commonly reported
adverse reactions are headache, ovarian cysts and local injection site
reactions (e.g. pain, erythema, haematoma, swelling and/or irritation at the
site of injection).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Mild or moderate ovarian
hyperstimulation syndrome (OHSS) has been commonly reported and should be
considered as an intrinsic risk of the stimulation procedure. Severe OHSS is
uncommon (see section&nbsp;4.4).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Thromboembolism may occur
very rarely (see section&nbsp;4.4).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal;page-break-after:
avoid'><u><span lang=EN-GB style='font-size:11.0pt'>List of adverse reactions</span></u></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal;page-break-after:
avoid'><u><span lang=EN-GB style='font-size:11.0pt'><span style='text-decoration:
 none'>&nbsp;</span></span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>The following definitions
apply to the frequency terminology used hereafter: very common (&#8805;&nbsp;1/10),
common (&#8805;&nbsp;1/100 to &lt;&nbsp;1/10), uncommon (&#8805;&nbsp;1/1,000
to &lt;&nbsp;1/100), rare (&#8805;&nbsp;1/10,000 to &lt;&nbsp;1/1,000), very
rare (&lt;&nbsp;1/10,000).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB style='font-size:11.0pt'>Treatment in women</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>Immune system disorders</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:92.15pt;margin-bottom:.0001pt;text-align:left;
text-indent:-92.15pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>Very rare:                Mild to severe
hypersensitivity reactions including anaphylactic reactions and shock</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:92.15pt;margin-bottom:.0001pt;text-align:left;
text-indent:-92.15pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:92.15pt;margin-bottom:.0001pt;text-align:left;
text-indent:-92.15pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>Nervous system disorders</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:92.15pt;margin-bottom:.0001pt;text-align:left;
text-indent:-92.15pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>Very common:         Headache</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:92.15pt;margin-bottom:.0001pt;text-align:left;
text-indent:-92.15pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:92.15pt;margin-bottom:.0001pt;text-align:left;
text-indent:-92.15pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>Vascular disorders</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:92.15pt;margin-bottom:.0001pt;text-align:left;
text-indent:-92.15pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>Very rare:                Thromboembolism (both in association with and
separate from OHSS)</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:92.15pt;margin-bottom:.0001pt;text-align:left;
text-indent:-92.15pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:92.15pt;margin-bottom:.0001pt;text-align:left;
text-indent:-92.15pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>Respiratory, thoracic and mediastinal
disorders</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:92.15pt;margin-bottom:.0001pt;text-align:left;
text-indent:-92.15pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>Very rare:                Exacerbation or aggravation of asthma</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:92.15pt;margin-bottom:.0001pt;text-align:left;
text-indent:-92.15pt;line-height:normal'><u><span lang=EN-GB style='font-size:
11.0pt'><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:92.15pt;margin-bottom:.0001pt;text-align:left;
text-indent:-92.15pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>Gastrointestinal disorders</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:92.15pt;margin-bottom:.0001pt;text-align:left;
text-indent:-92.15pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>Common:                Abdominal pain, abdominal distension, abdominal
discomfort, nausea, vomiting, diarrhoea</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:92.15pt;margin-bottom:.0001pt;text-align:left;
text-indent:-92.15pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:92.15pt;margin-bottom:.0001pt;text-align:left;
text-indent:-92.15pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>Reproductive system and breast disorders</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:92.15pt;margin-bottom:.0001pt;text-align:left;
text-indent:-92.15pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>Very common:         Ovarian cysts</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:92.15pt;margin-bottom:.0001pt;text-align:left;
text-indent:-92.15pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>Common:                Mild or moderate OHSS (including associated
symptomatology)</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:92.15pt;margin-bottom:.0001pt;text-align:left;
text-indent:-92.15pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>Uncommon:            Severe OHSS (including associated symptomatology)
(see section&nbsp;4.4)</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:92.15pt;margin-bottom:.0001pt;text-align:left;
text-indent:-92.15pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>Rare:                       Complication of severe OHSS</span></p>

<p class=Formatvorlage1 style='margin-left:92.15pt;text-indent:-92.15pt;
line-height:normal'><span lang=EN-GB style='font-family:"Times New Roman",serif'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:92.15pt;margin-bottom:.0001pt;text-align:left;
text-indent:-92.15pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>General disorders and administration site
conditions</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:92.15pt;margin-bottom:.0001pt;text-align:left;
text-indent:-92.15pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>Very common:         Injection site reactions (e.g. pain, erythema,
haematoma, swelling and/or irritation at the site of injection)</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><i><u><span lang=EN-GB style='font-size:11.0pt'><span style='text-decoration:
 none'>&nbsp;</span></span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'>Treatment
in men</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>Immune system disorders</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:92.15pt;margin-bottom:.0001pt;text-align:left;
text-indent:-92.15pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>Very rare:                Mild to severe hypersensitivity reactions
including anaphylactic reactions and shock</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:92.15pt;margin-bottom:.0001pt;text-align:left;
text-indent:-92.15pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:92.15pt;margin-bottom:.0001pt;text-align:left;
text-indent:-92.15pt;line-height:normal'><i><u><span lang=EN-GB
style='font-size:11.0pt'>Respiratory, thoracic and mediastinal disorders</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:92.15pt;margin-bottom:.0001pt;text-align:left;
text-indent:-92.15pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>Very rare:                Exacerbation or aggravation of asthma</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:92.15pt;margin-bottom:.0001pt;text-align:left;
text-indent:-92.15pt;line-height:normal'><u><span lang=EN-GB style='font-size:
11.0pt'><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:92.15pt;margin-bottom:.0001pt;text-align:left;
text-indent:-92.15pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>Skin and subcutaneous tissue disorders</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:92.15pt;margin-bottom:.0001pt;text-align:left;
text-indent:-92.15pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>Common:                Acne</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:92.15pt;margin-bottom:.0001pt;text-align:left;
text-indent:-92.15pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:92.15pt;margin-bottom:.0001pt;text-align:left;
text-indent:-92.15pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>Reproductive system and breast disorders</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:92.15pt;margin-bottom:.0001pt;text-align:left;
text-indent:-92.15pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>Common:                Gynaecomastia, varicocele</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:92.15pt;margin-bottom:.0001pt;text-align:left;
text-indent:-92.15pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:92.15pt;margin-bottom:.0001pt;text-align:left;
text-indent:-92.15pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>General disorders and administration site conditions</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:92.15pt;margin-bottom:.0001pt;text-align:left;
text-indent:-92.15pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>Very common:         Injection site reactions (e.g. pain, erythema,
haematoma, swelling and/or irritation at the site of injection)</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><i><u><span lang=EN-GB style='font-size:11.0pt'><span style='text-decoration:
 none'>&nbsp;</span></span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>Investigations</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>Common:                Weight gain</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;text-autospace:none'><u><span lang=EN-GB
style='font-size:11.0pt'>Reporting of suspected adverse reactions</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;text-autospace:none'><span lang=EN-GB style='font-size:11.0pt'>Reporting
suspected adverse reactions after authorisation of the medicinal product is
important. It allows continued monitoring of the benefit/risk balance of the
medicinal product. Healthcare professionals are asked to report any suspected
adverse reactions via the <span style='color:black;background:#D9D9D9'>national
reporting system listed in </span></span><span lang=EN-GB><a
href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc"><span
style='font-size:11.0pt;background:#D9D9D9'>Appendix&nbsp;V</span></a></span><span
lang=EN-GB style='font-size:11.0pt'>.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<h2 style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:28.35pt;
margin-bottom:.0001pt;text-indent:-28.35pt;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;text-transform:none'>4.9     Overdose</span></h2>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>The effects of an overdose of
GONAL-f are unknown, nevertheless, there is a possibility that OHSS may occur
(see section&nbsp;4.4).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>5.       PHARMACOLOGICAL
PROPERTIES</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<h2 style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:28.35pt;
margin-bottom:.0001pt;text-indent:-28.35pt;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;text-transform:none'>5.1     Pharmacodynamic
properties</span></h2>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Pharmacotherapeutic group:
Sex hormones and modulators of the genital systems, gonadotropins, ATC code:
G03GA05.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;text-autospace:none'><span lang=EN-GB style='font-size:11.0pt'>In women,
the most important effect resulting from parenteral administration of FSH is
the development of mature Graafian follicles.</span><i><span lang=EN-GB
style='font-size:11.0pt'> </span></i><a
name="OLEII-109_Company_Response_to_LoQLINK16"></a><span lang=EN-GB
style='font-size:11.0pt'>In women with anovulation, the object of GONAL-f
therapy is to develop a single mature Graafian follicle from which the ovum
will be liberated after the administration of hCG.</span><a
name="OLEII-109_Company_Response_to_LoQLINK17"></a></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB style='font-size:11.0pt'>Clinical efficacy and safety in women</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB style='font-size:11.0pt'><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>In clinical trials, patients
with severe FSH and LH deficiency were defined by an endogenous serum LH level
&lt;&nbsp;1.2&nbsp;IU/L as measured in a central laboratory. However, it should
be taken into account that there are variations between LH measurements
performed in different laboratories.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>In clinical studies comparing
r&#8209;hFSH (follitropin alfa) and urinary FSH in ART (see table below) and in
ovulation induction, GONAL&#8209;f was more potent than urinary FSH in terms of
a lower total dose and a shorter treatment period needed to trigger follicular
maturation.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>In ART, GONAL-f at a lower
total dose and shorter treatment period than urinary FSH, resulted in a higher
number of oocytes retrieved when compared to urinary FSH.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>Table:
Results of study GF&nbsp;8407 (randomised parallel group study comparing
efficacy and safety of GONAL&#8209;f with urinary FSH in assisted reproduction
technologies)</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='margin-left:19.6pt;border-collapse:collapse;border:none'>
 <tr style='page-break-inside:avoid'>
  <td width=243 valign=top style='width:182.6pt;border:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=Titlefortables style='margin:0in;text-indent:0in;line-height:normal'><span
  lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=142 valign=top style='width:106.3pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=Titlefortables style='margin:0in;text-indent:0in;line-height:normal'><span
  lang=EN-GB style='font-size:11.0pt'>GONAL-f<br>
  (n = 130)</span></p>
  </td>
  <td width=142 valign=top style='width:106.35pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=Titlefortables style='margin:0in;text-indent:0in;line-height:normal'><span
  lang=EN-GB style='font-size:11.0pt'>urinary FSH</span><span lang=EN-GB
  style='font-size:11.0pt'> <br>
  (n = 116)</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width=243 valign=top style='width:182.6pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=left style='margin-top:0in;text-align:left;
  line-height:normal;page-break-after:avoid'><span lang=EN-GB style='font-size:
  11.0pt'>Number of oocytes retrieved</span></p>
  </td>
  <td width=142 valign=top style='width:106.3pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=left style='margin-top:0in;text-align:left;
  line-height:normal;page-break-after:avoid'><span lang=EN-GB style='font-size:
  11.0pt'>11.0 ± 5.9</span></p>
  </td>
  <td width=142 valign=top style='width:106.35pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=left style='margin-top:0in;text-align:left;
  line-height:normal;page-break-after:avoid'><span lang=EN-GB style='font-size:
  11.0pt'>8.8 ± 4.8</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width=243 valign=top style='width:182.6pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=left style='margin-top:0in;text-align:left;
  line-height:normal;page-break-after:avoid'><span lang=EN-GB style='font-size:
  11.0pt'>Days of FSH stimulation required</span></p>
  </td>
  <td width=142 valign=top style='width:106.3pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=left style='margin-top:0in;text-align:left;
  line-height:normal;page-break-after:avoid'><span lang=EN-GB style='font-size:
  11.0pt'>11.7 ± 1.9</span></p>
  </td>
  <td width=142 valign=top style='width:106.35pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=left style='margin-top:0in;text-align:left;
  line-height:normal;page-break-after:avoid'><span lang=EN-GB style='font-size:
  11.0pt'>14.5 ± 3.3</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width=243 valign=top style='width:182.6pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=left style='margin-top:0in;text-align:left;
  line-height:normal;page-break-after:avoid'><span lang=EN-GB style='font-size:
  11.0pt'>Total dose of FSH required (number of FSH 75&nbsp;IU ampoules) </span></p>
  </td>
  <td width=142 valign=top style='width:106.3pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=left style='margin-top:0in;text-align:left;
  line-height:normal;page-break-after:avoid'><span lang=EN-GB style='font-size:
  11.0pt'>27.6 ± 10.2</span></p>
  </td>
  <td width=142 valign=top style='width:106.35pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=left style='margin-top:0in;text-align:left;
  line-height:normal;page-break-after:avoid'><span lang=EN-GB style='font-size:
  11.0pt'>40.7 ± 13.6</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width=243 valign=top style='width:182.6pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=left style='margin-top:0in;text-align:left;
  line-height:normal'><span lang=EN-GB style='font-size:11.0pt'>Need to
  increase the dose (%)</span></p>
  </td>
  <td width=142 valign=top style='width:106.3pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=left style='margin-top:0in;text-align:left;
  line-height:normal'><span lang=EN-GB style='font-size:11.0pt'>56.2</span></p>
  </td>
  <td width=142 valign=top style='width:106.35pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=left style='margin-top:0in;text-align:left;
  line-height:normal'><span lang=EN-GB style='font-size:11.0pt'>85.3</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Differences between the 2&nbsp;groups
were statistically significant (p&lt;&nbsp;0.05) for all criteria listed.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><i><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'>Clinical
efficacy and safety in men</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><i><u><span lang=EN-GB style='font-size:11.0pt'><span
 style='text-decoration:none'>&nbsp;</span></span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>In men deficient in FSH,
GONAL&#8209;f administered concomitantly with hCG for at least 4&nbsp;months
induces spermatogenesis.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<h2 style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:28.35pt;
margin-bottom:.0001pt;text-indent:-28.35pt;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;text-transform:none'>5.2     Pharmacokinetic
properties</span></h2>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>Following
intravenous administration, follitropin alfa is distributed to the
extracellular fluid space with an initial half-life of around 2&nbsp;hours and
eliminated from the body with a terminal half-life of about one day. The steady
state volume of distribution and total clearance are 10&nbsp;L and
0.6&nbsp;L/h, respectively. One&#8209;eighth of the follitropin alfa dose is
excreted in the urine.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Following subcutaneous
administration, the absolute bioavailability is about 70%. Following repeated
administration, follitropin alfa accumulates 3&#8209;fold achieving a steady&#8209;state
within 3&#8209;4&nbsp;days. In women whose endogenous gonadotropin secretion is
suppressed, follitropin alfa has nevertheless been shown to effectively
stimulate follicular development and steroidogenesis, despite unmeasurable LH
levels.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<h2 style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:28.35pt;
margin-bottom:.0001pt;text-indent:-28.35pt;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;text-transform:none'>5.3     Preclinical
safety data</span></h2>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Non-clinical data reveal no
special hazard for humans based on conventional studies of single and repeated
dose toxicity and genotoxicity additional to that already stated in other
sections of this SmPC.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E6E6E6'><span
lang=EN-GB style='font-size:11.0pt;color:black'>A<i>dditional in &lt;GONAL-f
1050&nbsp;IU&gt; + <span style='background:#BFBFBF'>&lt;GONAL-f 450 IU&gt;</span>
</i></span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#E6E6E6'><span lang=EN-GB style='font-size:11.0pt;color:black'>In
rabbits, the formulation reconstituted with 0.9% benzyl alcohol and 0.9% benzyl
alcohol alone, both resulted in a slight haemorrhage and subacute inflammation
after single subcutaneous injection or mild inflammatory and degenerative
changes after single intramuscular injection respectively.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Impaired fertility has been
reported in rats exposed to pharmacological doses of follitropin alfa
(&#8805;&nbsp;40&nbsp;IU/kg/day) for extended periods, through reduced
fecundity.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Given in high doses
(&#8805;&nbsp;5&nbsp;IU/kg/day) follitropin alfa caused a decrease in the
number of viable foetuses without being a teratogen, and dystocia similar to
that observed with urinary Menopausal Gonadotropin (hMG). However, since
GONAL-f is not indicated in pregnancy, these data are of limited clinical
relevance.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=Formatvorlage1 style='line-height:normal'><span lang=EN-GB
style='font-family:"Times New Roman",serif'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>6.       PHARMACEUTICAL
PARTICULARS</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<h2 style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:28.35pt;
margin-bottom:.0001pt;text-indent:-28.35pt;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;text-transform:none'>6.1     List of
excipients</span></h2>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#F3F3F3'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 75&nbsp;IU&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#F3F3F3'><u><span
lang=EN-GB style='font-size:11.0pt;color:black'>Powder</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#F3F3F3'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#F3F3F3'><span
lang=EN-GB style='font-size:11.0pt;color:black'>Sucrose</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#F3F3F3'><span
lang=EN-GB style='font-size:11.0pt;color:black'>Sodium dihydrogen phosphate
monohydrate</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#F3F3F3'><span
lang=EN-GB style='font-size:11.0pt;color:black'>Disodium phosphate dihydrate</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F3F3F3'><span lang=EN-GB style='font-size:11.0pt;color:black'>Methionine</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F3F3F3'><span lang=EN-GB style='font-size:11.0pt;color:black'>Polysorbate
20</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F3F3F3'><span lang=EN-GB style='font-size:11.0pt;color:black'>Phosphoric
acid, concentrated</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F3F3F3'><span lang=EN-GB style='font-size:11.0pt;color:black'>Sodium
hydroxide</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F3F3F3'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#F3F3F3'><u><span
lang=EN-GB style='font-size:11.0pt;color:black'>Solvent</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#F3F3F3'><u><span
lang=EN-GB style='font-size:11.0pt'><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F3F3F3'><span lang=EN-GB style='font-size:11.0pt;color:black'>Water
for injections</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E6E6E6'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 1050&nbsp;IU&gt; + <span
style='background:#BFBFBF'>&lt;GONAL-f 450 IU&gt;</span> </span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E6E6E6'><u><span
lang=EN-GB style='font-size:11.0pt;color:black'>Powder</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E6E6E6'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E6E6E6'><span
lang=EN-GB style='font-size:11.0pt;color:black'>Sucrose</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E6E6E6'><span
lang=EN-GB style='font-size:11.0pt;color:black'>Sodium dihydrogen phosphate
monohydrate</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E6E6E6'><span
lang=EN-GB style='font-size:11.0pt;color:black'>Disodium phosphate dihydrate</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#E6E6E6'><span lang=EN-GB style='font-size:11.0pt;color:black'>Phosphoric
acid, concentrated</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#E6E6E6'><span lang=EN-GB style='font-size:11.0pt;color:black'>Sodium
hydroxide</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#E6E6E6'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E6E6E6'><u><span
lang=EN-GB style='font-size:11.0pt;color:black'>Solvent</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E6E6E6'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#E6E6E6'><span lang=EN-GB style='font-size:11.0pt;color:black'>Water
for injections</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#E6E6E6'><span lang=EN-GB style='font-size:11.0pt;color:black'>Benzyl
alcohol</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<h2 style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:28.35pt;
margin-bottom:.0001pt;text-indent:-28.35pt;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;text-transform:none'>6.2     Incompatibilities</span></h2>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#F3F3F3'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 75&nbsp;IU</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F3F3F3'><span lang=EN-GB style='font-size:11.0pt;color:black'>This
medicinal product must not be mixed with other medicinal products except those
mentioned in section&nbsp;6.6.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E6E6E6'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 1050&nbsp;IU&gt; + <span
style='background:#BFBFBF'>&lt;GONAL-f 450 IU&gt;</span> <span
style='background:#A6A6A6'>&gt;</span></span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#E6E6E6'><span lang=EN-GB style='font-size:11.0pt;color:black'>In
the absence of compatibility studies, this medicinal product must not be mixed
with other medicinal products.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<h2 style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:28.35pt;
margin-bottom:.0001pt;text-indent:-28.35pt;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;text-transform:none'>6.3     Shelf life</span></h2>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#F3F3F3'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 75&nbsp;IU&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F2F2F2'><span lang=EN-GB style='font-size:11.0pt;color:black'>3&nbsp;years.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F3F3F3'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F3F3F3'><span lang=EN-GB style='font-size:11.0pt;color:black'>For
immediate and single use following first opening and reconstitution.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E6E6E6'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 1050&nbsp;IU&gt; + <span
style='background:#BFBFBF'>&lt;GONAL-f 450 IU&gt;</span> </span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E6E6E6'><span
lang=EN-GB style='font-size:11.0pt;color:black'>2&nbsp;years.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#E6E6E6'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#E6E6E6'><span lang=EN-GB style='font-size:11.0pt;color:black'>The
reconstituted solution is stable for 28&nbsp;days at or below 25°C.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<h2 style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:28.35pt;
margin-bottom:.0001pt;text-indent:-28.35pt;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;text-transform:none'>6.4     Special
precautions for storage</span></h2>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#F3F3F3'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 75&nbsp;IU&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F3F3F3'><span lang=EN-GB style='font-size:11.0pt;color:black'>Do
not store above 25°C.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F3F3F3'><span lang=EN-GB style='font-size:11.0pt;color:black'>Store
in the original package, in order to protect from light.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E6E6E6'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 1050&nbsp;IU&gt; + <span
style='background:#BFBFBF'>&lt;GONAL-f 450 IU&gt;</span> </span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#E6E6E6'><span lang=EN-GB style='font-size:11.0pt;color:black'>Prior
to reconstitution, do not store above 25°C. Store in the original package, in
order to protect from light.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#E6E6E6'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#E6E6E6'><span lang=EN-GB style='font-size:11.0pt;color:black'>After
reconstitution, do not store above 25°C. Do not freeze. Store in the original
container, in order to protect from light.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<h2 style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:28.35pt;
margin-bottom:.0001pt;text-indent:-28.35pt;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;text-transform:none'>6.5     Nature and
contents of container</span></h2>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#F3F3F3'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 75&nbsp;IU&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F2F2F2'><span lang=EN-GB style='font-size:11.0pt;color:black'>GONAL&#8209;f
is presented as a powder and solvent for injection. The powder is presented in
3&nbsp;mL vials (Type&nbsp;I glass), with rubber stopper (bromobutyl rubber)
and aluminium flip&#8209;off cap. The 1&nbsp;mL solvent for reconstitution is
presented in 1&nbsp;mL pre&#8209;filled syringes (Type&nbsp;I glass) with a
rubber stopper.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F2F2F2'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoCommentText align=left style='margin-top:0in;text-align:left;
line-height:normal;background:#F2F2F2'><span lang=EN-GB style='font-size:11.0pt;
color:black'>The medicinal product is supplied in packs of 1, 5, or
10&nbsp;vials with 1, 5 or 10 of solvent pre-filled syringes.</span></p>

<p class=MsoCommentText align=left style='margin-top:0in;text-align:left;
line-height:normal;background:#F2F2F2'><span lang=EN-GB style='font-size:11.0pt;
color:black'>Not all pack sizes may be marketed.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E6E6E6'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 1050&nbsp;IU&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#E6E6E6'><span lang=EN-GB style='font-size:11.0pt;color:black'>GONAL&nbsp;f
is presented as a powder and solvent for injection. The powder is presented in
3&nbsp;mL vials (Type&nbsp;I glass), with rubber stopper (bromobutyl rubber)
and aluminium flip&#8209;off cap. The solvent for reconstitution is presented
in 2&nbsp;mL pre&#8209;filled syringes (Type&nbsp;I glass) with a rubber
stopper. The administration syringes made of polypropylene with a stainless
steel pre-fixed needle are also provided.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#E6E6E6'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#E6E6E6'><span lang=EN-GB style='font-size:11.0pt;color:black'>The
medicinal product is supplied as a pack of 1&nbsp;vial of powder with 1 pre&#8209;filled
syringe of solvent for reconstitution and 15&nbsp;disposable syringes for
administration graduated in FSH units.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><i><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#CCCCCC'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 450 IU&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#CCCCCC'><span lang=EN-GB style='font-size:11.0pt;color:black'>GONAL&nbsp;f
is presented as a powder and solvent for injection. The powder is presented in
3&nbsp;mL vials (Type&nbsp;I glass), with rubber stopper (bromobutyl rubber)
and aluminium flip&#8209;off cap. The solvent for reconstitution is presented
in 1&nbsp;mL pre&#8209;filled syringes (Type&nbsp;I glass) with a rubber
stopper. The administration syringes made of polypropylene with a stainless
steel pre-fixed needle are also provided.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#CCCCCC'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#CCCCCC'><span lang=EN-GB style='font-size:11.0pt;color:black'>The
medicinal product is supplied as a pack of 1&nbsp;vial of powder with 1 pre&#8209;filled
syringe of solvent for reconstitution and 6&nbsp;disposable syringes for
administration graduated in FSH units.</span></p>

<h2 style='margin:0in;margin-bottom:.0001pt;text-indent:0in;line-height:normal;
page-break-after:auto'><span lang=EN-GB style='font-size:11.0pt;text-transform:
none'>&nbsp;</span></h2>

<h2 style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:28.35pt;
margin-bottom:.0001pt;text-indent:-28.35pt;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;text-transform:none'>6.6     Special
precautions for disposal and other handling</span></h2>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#F3F3F3'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 75&nbsp;IU&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F3F3F3'><span lang=EN-GB style='font-size:11.0pt;color:black'>For
single use only.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F3F3F3'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F3F3F3'><span lang=EN-GB style='font-size:11.0pt;color:black'>GONAL-f
must be reconstituted with the solvent before use (see section How to prepare
and use the GONAL-f powder and solvent in the package leaflet).</span></p>

<p class=Formatvorlage1 style='line-height:normal;background:#F3F3F3'><span
lang=EN-GB style='font-family:"Times New Roman",serif'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F3F3F3'><span lang=EN-GB style='font-size:11.0pt;color:black'>GONAL-f
may be co-reconstituted with lutropin alfa and co-administered as a single
injection. In this case lutropin alfa should be reconstituted first and then
used to reconstitute GONAL-f powder.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F3F3F3'><span lang=EN-GB style='font-size:11.0pt;color:black'>Studies
have shown that co-administration with lutropin alfa, does not significantly
alter the activity, stability, pharmacokinetic nor pharmacodynamic properties
of the active substances.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E6E6E6'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 1050&nbsp;IU&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#E6E6E6'><span lang=EN-GB style='font-size:11.0pt;color:black'>GONAL-f
1050&nbsp;IU/1.75&nbsp;mL powder must be reconstituted with the 2&nbsp;mL
solvent provided before use.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#E6E6E6'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#E6E6E6'><span lang=EN-GB style='font-size:11.0pt;color:black'>GONAL-f
1050&nbsp;IU/1.75&nbsp;mL powder must not be reconstituted with any other
GONAL-f containers.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#E6E6E6'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#E6E6E6'><span lang=EN-GB style='font-size:11.0pt;color:black'>The
solvent pre-filled syringe provided should be used for reconstitution only and
then disposed of in accordance with local requirements. A set of administration
syringes graduated in FSH units is supplied in the GONAL-f multidose box.
Alternatively, a 1&nbsp;mL syringe, graduated in mL, with pre&#8209;fixed
needle for subcutaneous administration could be used (see section How to
prepare and use the GONAL&#8209;f powder and solvent in the package leaflet).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#CCCCCC'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 450 IU&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#CCCCCC'><span lang=EN-GB style='font-size:11.0pt;color:black'>GONAL-f
450&nbsp;IU/0.75&nbsp;mL powder be reconstituted with the 1&nbsp;mL solvent
provided before use.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#CCCCCC'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#CCCCCC'><span lang=EN-GB style='font-size:11.0pt;color:black'>GONAL-f
450&nbsp;IU/0.75&nbsp;mL powder must not be reconstituted with any other
GONAL-f containers.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#CCCCCC'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#CCCCCC'><span lang=EN-GB style='font-size:11.0pt;color:black'>The
solvent pre-filled syringe provided should be used for reconstitution only and
then disposed of in accordance with local requirements. A set of administration
syringes graduated in FSH units is supplied in the GONAL-f multidose box.
Alternatively, a 1&nbsp;mL syringe, graduated in mL, with pre&#8209;fixed
needle for subcutaneous administration could be used (see section How to
prepare and use the GONAL&#8209;f powder and solvent in the package leaflet).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>The reconstituted solution
should not be administered if it contains particles or is not clear.</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Any unused medicinal product
or waste material should be disposed of in accordance with local requirements.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>7.       MARKETING
AUTHORISATION HOLDER</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoListParagraph style='margin:0in;margin-bottom:.0001pt;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>Merck
Europe B.V.</span></p>

<p class=MsoListParagraph style='margin:0in;margin-bottom:.0001pt;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>Gustav
Mahlerplein&nbsp;102</span></p>

<p class=MsoListParagraph style='margin:0in;margin-bottom:.0001pt;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>1082
MA Amsterdam</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>The Netherlands</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#F3F3F3'><b><span
lang=EN-GB style='font-size:11.0pt;color:black;text-transform:uppercase'>8.       MARKETING
AUTHORISATION NUMBERS</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#F3F3F3'><i><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#F3F3F3'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 75&nbsp;IU&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F3F3F3'><span lang=FR style='font-size:11.0pt;color:black'>EU/1/95/001/025</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F3F3F3'><span lang=FR style='font-size:11.0pt;color:black'>EU/1/95/001/026</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F3F3F3'><span lang=FR style='font-size:11.0pt;color:black'>EU/1/95/001/027</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=FR style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=FR style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#D9D9D9'><b><span lang=FR
style='font-size:11.0pt;color:black'>8.       MARKETING AUTHORISATION NUMBER</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#D9D9D9'><span
lang=FR style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E6E6E6'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 1050&nbsp;IU&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#E6E6E6'><span lang=EN-GB style='font-size:11.0pt;color:black'>EU/1/95/001/021</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#CCCCCC'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 450 IU&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#CCCCCC'><span lang=EN-GB style='font-size:11.0pt;color:black'>EU/1/95/001/031</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>9.       DATE
OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Date of first authorisation:
20&nbsp;October 1995.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Date of latest renewal: 20&nbsp;October
2010.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>10.     DATE
OF REVISION OF THE TEXT</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Detailed information on this
medicinal product is available on the website of the European Medicines Agency </span><span
lang=EN-GB><a href="http://www.ema.europa.eu/"><span style='font-size:11.0pt'>http://www.ema.europa.eu</span></a></span><span
lang=EN-GB style='font-size:11.0pt'>.</span></p>

<b><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span></b>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>1.       NAME OF THE
MEDICINAL PRODUCT</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#D5DCE4'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f <span
style='background:yellow'>150</span> IU PEN&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#D5DCE4'><span lang=EN-GB
style='font-size:11.0pt;color:black'>GONAL-f <span style='background:yellow'>150&nbsp;IU/0.25</span>&nbsp;mL
solution for injection in pre-filled pen</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#CCFFFF'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 300 IU PEN&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#CCFFFF'><span
lang=EN-GB style='font-size:11.0pt;color:black'>GONAL-f 300&nbsp;IU/0.5&nbsp;mL
solution for injection in pre-filled pen</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#CCECFF'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 450 IU PEN&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#CCECFF'><span
lang=EN-GB style='font-size:11.0pt;color:black'>GONAL-f
450&nbsp;IU/0.75&nbsp;mL solution for injection in pre-filled pen</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#99CCFF'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 900 IU PEN&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#99CCFF'><span
lang=EN-GB style='font-size:11.0pt;color:black'>GONAL-f 900&nbsp;IU/1.5&nbsp;mL
solution for injection in pre-filled pen</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>2.       QUALITATIVE
AND QUANTITATIVE COMPOSITION</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>Each mL of the solution contains 600&nbsp;IU of follitropin alfa*
(equivalent to 44&nbsp;micrograms).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#D5DCE4'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f <span
style='background:yellow'>150</span> IU PEN&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#D5DCE4'><span
lang=EN-GB style='font-size:11.0pt;color:black'>Each pre-filled multidose pen
delivers <span style='background:yellow'>150</span>&nbsp;IU (equivalent to <span
style='background:yellow'>11</span>&nbsp;micrograms) in <span style='background:
yellow'>0.25</span>&nbsp;mL.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#CCFFFF'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 300 IU PEN&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#CCFFFF'><span lang=EN-GB
style='font-size:11.0pt;color:black'>Each pre-filled multidose pen delivers
300&nbsp;IU (equivalent to 22&nbsp;micrograms) in 0.5&nbsp;mL.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#CCECFF'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 450 IU PEN&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#CCECFF'><span lang=EN-GB
style='font-size:11.0pt;color:black'>Each pre-filled multidose pen delivers
450&nbsp;IU (equivalent to 33&nbsp;micrograms) in 0.75&nbsp;mL.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#99CCFF'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 900 IU PEN&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#99CCFF'><span lang=EN-GB
style='font-size:11.0pt;color:black'>Each pre-filled multidose pen delivers
900&nbsp;IU (equivalent to 66&nbsp;micrograms) in 1.5&nbsp;mL.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>* recombinant human follicle
stimulating hormone (r&#8209;hFSH) produced in Chinese Hamster Ovary (CHO)
cells by recombinant DNA technology</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>For the full list of excipients, see section&nbsp;6.1.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>3.       PHARMACEUTICAL
FORM</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>Solution for injection in pre-filled pen.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>Clear colourless solution.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>The pH of the solution is 6.7&#8209;7.3.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>4.       CLINICAL
PARTICULARS</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<h2 style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:28.35pt;
margin-bottom:.0001pt;text-indent:-28.35pt;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;text-transform:none'>4.1     Therapeutic
indications</span></h2>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB style='font-size:11.0pt'>In adult women</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Anovulation (including
polycystic ovarian syndrome) in women who have been unresponsive to treatment
with clomiphene citrate.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Stimulation of
multifollicular development in women undergoing superovulation for assisted
reproductive technologies (ART) such as <i>in&nbsp;vitro</i> fertilisation
(IVF), gamete intra-fallopian transfer and zygote intra-fallopian transfer.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>GONAL-f in association
with a luteinising hormone (LH) preparation is recommended for the stimulation
of follicular development in women with severe LH and FSH deficiency. In
clinical trials these patients were defined by an endogenous serum LH level
&lt;&nbsp;1.2&nbsp;IU/L.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><i><u><span lang=EN-GB
style='font-size:11.0pt'><span style='text-decoration:none'>&nbsp;</span></span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB style='font-size:11.0pt'>In adult men</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'><span style='text-decoration:none'>&nbsp;</span></span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>GONAL-f is indicated
for the stimulation of spermatogenesis in men who have congenital or acquired
hypogonadotrophic hypogonadism with concomitant human Chorionic Gonadotropin
(hCG) therapy.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<h2 style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:28.35pt;
margin-bottom:.0001pt;text-indent:-28.35pt;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;text-transform:none'>4.2     Posology and
method of administration</span></h2>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Treatment with GONAL-f should
be initiated under the supervision of a physician experienced in the treatment
of fertility disorders.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>Patients must be provided with the correct number of pens for their
treatment course and educated to use the proper injection techniques.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><u><span lang=EN-GB style='font-size:11.0pt'><span style='text-decoration:
 none'>&nbsp;</span></span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB style='font-size:11.0pt'>Posology</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>The dose recommendations given for GONAL-f are those in use for
urinary FSH. Clinical assessment of GONAL-f indicates that its daily doses,
regimens of administration, and treatment monitoring procedures should not be
different from those currently used for urinary FSH-containing medicinal
products. It is advised to adhere to the recommended starting doses indicated
below.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Comparative clinical studies
have shown that on average patients require a lower cumulative dose and shorter
treatment duration with GONAL-f compared with urinary FSH. Therefore, it is
considered appropriate to give a lower total dose of GONAL-f than generally
used for urinary FSH, not only in order to optimise follicular development but
also to minimise the risk of unwanted ovarian hyperstimulation. See section&nbsp;5.1.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Bioequivalence has been
demonstrated between equivalent doses of the monodose presentation and the
multidose presentation of GONAL-f.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>Women with anovulation (including polycystic
ovarian syndrome)</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>GONAL&#8209;f may be given as
a course of daily injections. In menstruating women treatment should commence
within the first 7&nbsp;days of the menstrual cycle.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>A commonly used regimen
commences at 75&#8209;150&nbsp;IU FSH daily and is increased preferably by 37.5
or 75&nbsp;IU at 7 or preferably 14&nbsp;day intervals if necessary, to obtain
an adequate, but not excessive, response. Treatment should be tailored to the
individual patients response as assessed by measuring follicle size by
ultrasound and/or oestrogen secretion. The maximal daily dose is usually not
higher than 225&nbsp;IU FSH. If a patient fails to respond adequately after
4&nbsp;weeks of treatment, that cycle should be abandoned and the patient
should undergo further evaluation after which she may recommence treatment at a
higher starting dose than in the abandoned cycle.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>When an optimal response is
obtained, a single injection of 250&nbsp;micrograms recombinant human
choriogonadotropin alfa (r&#8209;hCG) or 5,000&nbsp;IU, up to 10,000&nbsp;IU
hCG should be administered 24&#8209;48&nbsp;hours after the last GONAL-f
injection. The patient is recommended to have coitus on the day of, and the day
following, hCG administration. Alternatively, intrauterine insemination (IUI)
may be performed.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>If an excessive response is
obtained, treatment should be stopped and hCG withheld (see section&nbsp;4.4).
Treatment should recommence in the next cycle at a dose lower than that of the
previous cycle.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><u><span lang=EN-GB style='font-size:11.0pt'><span style='text-decoration:
 none'>&nbsp;</span></span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><i><u><span lang=EN-GB style='font-size:11.0pt'>Women
undergoing ovarian stimulation for multiple follicular development prior to in&nbsp;vitro
fertilisation or other assisted reproductive technologies</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>A
commonly used regimen for superovulation involves the administration of 150&#8209;225&nbsp;IU
of GONAL&#8209;f daily, commencing on days&nbsp;2 or 3 of the cycle. Treatment
is continued until adequate follicular development has been achieved (as
assessed by monitoring of serum oestrogen concentrations and/or ultrasound
examination), with the dose adjusted according to the patients response, to
usually not higher than 450&nbsp;IU daily. In general, adequate follicular
development is achieved on average by the tenth day of treatment (range 5 to
20&nbsp;days).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>A single injection of
250&nbsp;micrograms r&#8209;hCG or 5,000&nbsp;IU up to 10,000&nbsp;IU hCG is
administered 24&#8209;48&nbsp;hours after the last GONAL&#8209;f injection to
induce final follicular maturation.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Down-regulation with a gonadotropin-releasing
hormone (GnRH) agonist or antagonist is now commonly used in order to suppress
the endogenous LH surge and to control tonic levels of LH. In a commonly used
protocol, GONAL&#8209;f is started approximately 2&nbsp;weeks after the start
of agonist treatment, both being continued until adequate follicular
development is achieved. For example, following two weeks of treatment with an
agonist, 150&#8209;225&nbsp;IU GONAL&#8209;f are administered for the first
7&nbsp;days. The dose is then adjusted according to the ovarian response.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Overall experience with IVF
indicates that in general the treatment success rate remains stable during the
first four attempts and gradually declines thereafter.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><i><u><span lang=EN-GB style='font-size:11.0pt'>Women
with anovulation resulting from severe LH and FSH deficiency</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>In LH
and FSH deficient women (hypogonadotrophic hypogonadism), the objective of
GONAL&#8209;f therapy in association with lutropin alfa is to develop a single
mature Graafian follicle from which the oocyte will be liberated after the
administration of human chorionic gonadotropin (hCG). GONAL&#8209;f should be
given as a course of daily injections simultaneously with lutropin alfa. Since
these patients are amenorrhoeic and have low endogenous oestrogen secretion,
treatment can commence at any time.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>A recommended regimen
commences at 75&nbsp;IU of lutropin alfa daily with 75&#8209;150&nbsp;IU FSH.
Treatment should be tailored to the individual patients response as assessed
by measuring follicle size by ultrasound and oestrogen response.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>If an FSH dose increase is
deemed appropriate, dose adaptation should preferably be after 7&#8209;14&nbsp;day
intervals and preferably by 37.5&#8209;75&nbsp;IU increments. It may be
acceptable to extend the duration of stimulation in any one cycle to up to
5&nbsp;weeks.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>When an optimal response is obtained, a single injection of
250&nbsp;micrograms r-hCG or 5,000&nbsp;IU up to 10,000&nbsp;IU hCG should be
administered 24&#8209;48&nbsp;hours after the last GONAL&#8209;f and lutropin
alfa injections. The patient is recommended to have coitus on the day of, and
on the day following, hCG administration. Alternatively, IUI may be performed.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Luteal phase support may be
considered since lack of substances with luteotrophic activity (LH/hCG) after
ovulation may lead to premature failure of the corpus luteum.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>If an excessive response is
obtained, treatment should be stopped and hCG withheld. Treatment should
recommence in the next cycle at a dose of FSH lower than that of the previous
cycle.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><i><u><span lang=EN-GB style='font-size:11.0pt'>Men
with hypogonadotrophic hypogonadism</span></u></i></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>GONAL&#8209;f should be given at a dose of 150&nbsp;IU three times a
week, concomitantly with hCG, for a minimum of 4&nbsp;months. If after this
period, the patient has not responded, the combination treatment may be
continued; current clinical experience indicates that treatment for at least
18&nbsp;months may be necessary to achieve spermatogenesis.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'>Special
populations</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><i><u><span lang=EN-GB style='font-size:11.0pt'><span
 style='text-decoration:none'>&nbsp;</span></span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>Elderly</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>There is no relevant use of
GONAL&#8209;f in the elderly population. Safety and effectiveness of GONAL&#8209;f
in elderly patients have not been established.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><i><u><span lang=EN-GB style='font-size:11.0pt'>Renal
or hepatic impairment</span></u></i></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>Safety, efficacy and pharmacokinetics of GONAL&#8209;f in patients
with renal or hepatic impairment have not been established.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><i><u><span lang=EN-GB>Paediatric population</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>There is no relevant use of
GONAL&#8209;f in the paediatric population.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'>Method
of administration</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>GONAL&#8209;f is intended for
subcutaneous use. The injection should be given at the same time each day.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>The first injection of GONAL&#8209;f
should be performed under direct medical supervision. Self-administration of
GONAL&#8209;f should only be performed by patients who are well motivated,
adequately trained and have access to expert advice.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>As GONAL&#8209;f pre-filled
pen with multidose cartridge is intended for several injections, clear
instructions should be provided to the patients to avoid misuse of the
multidose presentation.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>For instructions on the
administration with the pre-filled pen, see section&nbsp;6.6 and the
Instructions for use.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<h2 style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:28.35pt;
margin-bottom:.0001pt;text-indent:-28.35pt;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;text-transform:none'>4.3     Contraindications</span></h2>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>hypersensitivity to the
active substance or to any of the excipients listed in section&nbsp;6.1</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>tumours of the
hypothalamus or pituitary gland</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>ovarian enlargement or
ovarian cyst not due to polycystic ovarian syndrome</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>gynaecological
haemorrhages of unknown aetiology</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>ovarian, uterine or
mammary carcinoma</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>GONAL-f must not be used when an effective
response cannot be obtained, such as:</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>primary ovarian failure</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>malformations of sexual
organs incompatible with pregnancy</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>fibroid tumours of the
uterus incompatible with pregnancy</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>primary testicular
insufficiency</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<h2 style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:28.35pt;
margin-bottom:.0001pt;text-indent:-28.35pt;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;text-transform:none'>4.4     Special
warnings and precautions for use</span></h2>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal;page-break-after:
avoid'><u><span lang=EN-GB style='font-size:11.0pt'>Traceability</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>In order to improve the
traceability of biological medicinal products, the name and the batch number of
the administered product should be clearly recorded.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'>General
recommendations</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>GONAL&#8209;f is a potent
gonadotrophic substance capable of causing mild to severe adverse reactions and
should only be used by physicians who are thoroughly familiar with infertility
problems and their management.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Gonadotropin therapy requires
a certain time commitment by physicians and supportive health professionals, as
well as the availability of appropriate monitoring facilities. In women, safe
and effective use of GONAL&#8209;f calls for monitoring of ovarian response
with ultrasound, alone or preferably in combination with measurement of serum
oestradiol levels, on a regular basis. There may be a degree of inter&#8209;patient
variability in response to FSH administration, with a poor response to FSH in
some patients and exaggerated response in others. The lowest effective dose in
relation to the treatment objective should be used in both men and women.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB style='font-size:11.0pt'>Porphyria</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Patients with porphyria or a
family history of porphyria should be closely monitored during treatment with
GONAL&#8209;f. Deterioration or a first appearance of this condition may
require cessation of treatment.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB style='font-size:11.0pt'>Treatment in women</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Before starting treatment,
the couples infertility should be assessed as appropriate and putative
contraindications for pregnancy evaluated. In particular, patients should be
evaluated for hypothyroidism, adrenocortical deficiency, hyperprolactinemia and
appropriate specific treatment given.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Patients undergoing
stimulation of follicular growth, whether as treatment for anovulatory
infertility or ART procedures, may experience ovarian enlargement or develop
hyperstimulation. Adherence to recommended GONAL&#8209;f dose and regimen of administration
and careful monitoring of therapy will minimise the incidence of such events.
For accurate interpretation of the indices of follicle development and
maturation, the physician should be experienced in the interpretation of the
relevant tests.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>In clinical trials, an
increase of the ovarian sensitivity to GONAL&#8209;f was shown when
administered with lutropin alfa. If an FSH dose increase is deemed appropriate,
dose adaptation should preferably be at 7&#8209;14&nbsp;day intervals and
preferably with 37.5-75&nbsp;IU increments.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>No direct comparison of GONAL&#8209;f/LH
versus human menopausal gonadotropin (hMG) has been performed. Comparison with
historical data suggests that the ovulation rate obtained with GONAL&#8209;f/LH
is similar to that obtained with hMG.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<h3 style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:28.35pt;
margin-bottom:.0001pt;text-indent:-28.35pt;line-height:normal'><i><u><span
lang=EN-GB style='font-size:11.0pt;font-weight:normal'>Ovarian Hyperstimulation
Syndrome (OHSS)</span></u></i></h3>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>A certain degree of ovarian
enlargement is an expected effect of controlled ovarian stimulation. It is more
commonly seen in women with polycystic ovarian syndrome and usually regresses
without treatment.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>In distinction to uncomplicated ovarian enlargement, OHSS is a
condition that can manifest itself with increasing degrees of severity. It
comprises marked ovarian enlargement, high serum sex steroids, and an increase
in vascular permeability which can result in an accumulation of fluid in the
peritoneal, pleural and, rarely, in the pericardial cavities.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>The following symptomatology
may be observed in severe cases of OHSS: abdominal pain, abdominal distension,
severe ovarian enlargement, weight gain, dyspnoea, oliguria and
gastrointestinal symptoms including nausea, vomiting and diarrhoea. Clinical
evaluation may reveal hypovolaemia, haemoconcentration, electrolyte imbalances,
ascites, haemoperitoneum, pleural effusions, hydrothorax, or acute pulmonary
distress. Very rarely, severe OHSS may be complicated by ovarian torsion or
thromboembolic events such as pulmonary embolism, ischaemic stroke or
myocardial infarction.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Independent risk factors for
developing OHSS include polycystic ovarian syndrome high absolute or rapidly
rising serum oestradiol levels (e.g. &gt;&nbsp;900&nbsp;pg/mL or
&gt;&nbsp;3,300&nbsp;pmol/L in anovulation; &gt;&nbsp;3,000&nbsp;pg/mL or
&gt;&nbsp;11,000&nbsp;pmol/L in ART) and large number of developing ovarian
follicles (e.g. &gt;&nbsp;3&nbsp;follicles of &#8805;&nbsp;14&nbsp;mm in
diameter in anovulation; &#8805;&nbsp;20 follicles of &#8805;&nbsp;12 mm in
diameter in ART).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Adherence to recommended
GONAL&#8209;f dose and regimen of administration can minimise the risk of
ovarian hyperstimulation (see sections&nbsp;4.2 and 4.8). Monitoring of
stimulation cycles by ultrasound scans as well as oestradiol measurements are
recommended to early identify risk factors.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>There is evidence to suggest that hCG plays a key role in triggering
OHSS and that the syndrome may be more severe and more protracted if pregnancy
occurs. Therefore, if signs of ovarian hyperstimulation occur such as serum
oestradiol level &gt;&nbsp;5,500&nbsp;pg/mL or &gt;&nbsp;20,200&nbsp;pmol/L
and/or &#8805;&nbsp;40&nbsp;follicles in total, it is recommended that hCG be
withheld and the patient be advised to refrain from coitus or to use barrier
contraceptive methods for at least 4&nbsp;days. OHSS may progress rapidly
(within 24&nbsp;hours) or over several days to become a serious medical event.
It most often occurs after hormonal treatment has been discontinued and reaches
its maximum at about seven to ten days following treatment. Therefore, patients
should be followed for at least two weeks after hCG administration.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>In ART, aspiration of all follicles prior to ovulation may reduce
the occurrence of hyperstimulation.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Mild or moderate OHSS usually
resolves spontaneously. If severe OHSS occurs, it is recommended that
gonadotropin treatment be stopped if still ongoing, and that the patient be
hospitalised and appropriate therapy be started.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>Multiple pregnancy</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>In patients undergoing
ovulation induction, the incidence of multiple pregnancy is increased compared
with natural conception. The majority of multiple conceptions are twins.
Multiple pregnancy, especially of high order, carries an increased risk of
adverse maternal and perinatal outcomes.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>To minimise the risk of
multiple pregnancy, careful monitoring of ovarian response is recommended.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>In patients undergoing ART
procedures the risk of multiple pregnancy is related mainly to the number of
embryos replaced, their quality and the patient age.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>The patients should be
advised of the potential risk of multiple births before starting treatment.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>Pregnancy loss</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>The incidence of pregnancy loss
by miscarriage or abortion is higher in patients undergoing stimulation of
follicular growth for ovulation induction or ART than following natural conception.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>Ectopic pregnancy</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Women with a history of tubal
disease are at risk of ectopic pregnancy, whether the pregnancy is obtained by
spontaneous conception or with fertility treatments. The prevalence of ectopic
pregnancy after ART, was reported to be higher than in the general population.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>Reproductive system neoplasms</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>There have been reports of
ovarian and other reproductive system neoplasms, both benign and malignant, in
women who have undergone multiple treatment regimens for infertility treatment.
It is not yet established whether or not treatment with gonadotropins increases
the risk of these tumours in infertile women.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>Congenital malformation</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>The prevalence of congenital
malformations after ART may be slightly higher than after spontaneous conceptions.
This is thought to be due to differences in parental characteristics (e.g.
maternal age, sperm characteristics) and multiple pregnancies.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>Thromboembolic events</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>In women with recent or
ongoing thromboembolic disease or women with generally recognised risk factors
for thromboembolic events, such as personal or family history, treatment with
gonadotropins may further increase the risk for aggravation or occurrence of
such events. In these women, the benefits of gonadotropin administration need
to be weighed against the risks. It should be noted however that pregnancy
itself as well as OHSS also carry an increased risk of thromboembolic events.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB style='font-size:11.0pt'>Treatment in men</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Elevated endogenous FSH
levels are indicative of primary testicular failure. Such patients are
unresponsive to GONAL&#8209;f/hCG therapy. GONAL-f should not be used when an
effective response cannot be obtained.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Semen analysis is recommended
4 to 6&nbsp;months after the beginning of treatment as part of the assessment
of the response.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'>Sodium
content</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>GONAL&#8209;f contains less
than 1&nbsp;mmol sodium (23&nbsp;mg) per dose, i.e. it is essentially sodium-free.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<h2 style='margin:0in;margin-bottom:.0001pt;text-indent:0in;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;text-transform:none'>4.5     Interaction
with other medicinal products and other forms of interaction</span></h2>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Concomitant use of GONAL-f
with other medicinal products used to stimulate ovulation (e.g. hCG, clomiphene
citrate) may potentiate the follicular response, whereas concurrent use of a
GnRH agonist or antagonist to induce pituitary desensitisation may increase the
dose of GONAL-f needed to elicit an adequate ovarian response. No other
clinically significant medicinal product interaction has been reported during
GONAL-f therapy.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<h2 style='margin:0in;margin-bottom:.0001pt;text-indent:0in;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;text-transform:none'>4.6     Fertility,
pregnancy and lactation</span></h2>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'>Pregnancy</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>There is no indication for
use of GONAL-f during pregnancy. Data on a limited number of exposed
pregnancies (less than 300&nbsp;pregnancy outcomes) indicate no malformative or
feto/neonatal toxicity of follitropin alfa.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>No teratogenic effect has
been observed in animal studies (see section&nbsp;5.3).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>In case of exposure during
pregnancy, clinical data are not sufficient to exclude a teratogenic effect of
GONAL&#8209;f.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'>Breast&#8209;feeding</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>GONAL&#8209;f is not
indicated during breast&#8209;feeding.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'>Fertility</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoPlainText align=left style='margin-top:0in;text-align:left;
line-height:normal'><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>GONAL-f
is indicated for use in infertility (see section&nbsp;4.1).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><u><span lang=EN-GB style='font-size:11.0pt'><span style='text-decoration:
 none'>&nbsp;</span></span></u></p>

<h2 style='margin:0in;margin-bottom:.0001pt;text-indent:0in;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;text-transform:none'>4.7     Effects on
ability to drive and use machines</span></h2>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>GONAL&#8209;f is expected to
have no or negligible influence on the ability to drive and use machines.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<h2 style='margin:0in;margin-bottom:.0001pt;text-indent:0in;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;text-transform:none'>4.8     Undesirable
effects</span></h2>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal;page-break-after:
avoid'><u><span lang=EN-GB style='font-size:11.0pt'>Summary of the safety
profile</span></u></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal;page-break-after:
avoid'><u><span lang=EN-GB style='font-size:11.0pt'><span style='text-decoration:
 none'>&nbsp;</span></span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>The most commonly reported
adverse reactions are headache, ovarian cysts and local injection site
reactions (e.g. pain, erythema, haematoma, swelling and/or irritation at the
site of injection).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Mild or moderate ovarian
hyperstimulation syndrome (OHSS) has been commonly reported and should be
considered as an intrinsic risk of the stimulation procedure. Severe OHSS is
uncommon (see section&nbsp;4.4).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Thromboembolism may occur
very rarely (see section&nbsp;4.4).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal;page-break-after:
avoid'><u><span lang=EN-GB style='font-size:11.0pt'>List of adverse reactions</span></u></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal;page-break-after:
avoid'><u><span lang=EN-GB style='font-size:11.0pt'><span style='text-decoration:
 none'>&nbsp;</span></span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>The following definitions
apply to the frequency terminology used hereafter: very common (&#8805;&nbsp;1/10),
common (&#8805;&nbsp;1/100 to &lt;&nbsp;1/10), uncommon (&#8805;&nbsp;1/1,000
to &lt; 1/100), rare (&#8805;&nbsp;1/10,000 to &lt;&nbsp;1/1,000), very rare
(&lt;&nbsp;1/10,000).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'>Treatment
in women</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:78.0pt;margin-bottom:.0001pt;text-align:left;
text-indent:-78.0pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>Immune system disorders</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:78.0pt;margin-bottom:.0001pt;text-align:left;
text-indent:-78.0pt;line-height:normal'><span lang=EN-GB style='font-size:11.0pt'>Very
rare:           Mild to severe hypersensitivity reactions including
anaphylactic reactions and shock</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:78.0pt;margin-bottom:.0001pt;text-align:left;
text-indent:-78.0pt;line-height:normal'><u><span lang=EN-GB style='font-size:
11.0pt'><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:78.0pt;margin-bottom:.0001pt;text-align:left;
text-indent:-78.0pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>Nervous system disorders</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:78.0pt;margin-bottom:.0001pt;text-align:left;
text-indent:-78.0pt;line-height:normal'><span lang=EN-GB style='font-size:11.0pt'>Very
common:    Headache</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:78.0pt;margin-bottom:.0001pt;text-align:left;
text-indent:-78.0pt;line-height:normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:78.0pt;margin-bottom:.0001pt;text-align:left;
text-indent:-78.0pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>Vascular disorders</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:78.0pt;margin-bottom:.0001pt;text-align:left;
text-indent:-78.0pt;line-height:normal'><span lang=EN-GB style='font-size:11.0pt'>Very
rare:           Thromboembolism (both in association with and separate from
OHSS)</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:78.0pt;margin-bottom:.0001pt;text-align:left;
text-indent:-78.0pt;line-height:normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:78.0pt;margin-bottom:.0001pt;text-align:left;
text-indent:-78.0pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>Respiratory, thoracic and mediastinal
disorders</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:78.0pt;margin-bottom:.0001pt;text-align:left;
text-indent:-78.0pt;line-height:normal'><span lang=EN-GB style='font-size:11.0pt'>Very
rare:           Exacerbation or aggravation of asthma</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:78.0pt;margin-bottom:.0001pt;text-align:left;
text-indent:-78.0pt;line-height:normal'><u><span lang=EN-GB style='font-size:
11.0pt'><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:78.0pt;margin-bottom:.0001pt;text-align:left;
text-indent:-78.0pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>Gastrointestinal disorders</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:78.0pt;margin-bottom:.0001pt;text-align:left;
text-indent:-78.0pt;line-height:normal'><span lang=EN-GB style='font-size:11.0pt'>Common:           Abdominal
pain, abdominal distension, abdominal discomfort, nausea, vomiting, diarrhoea</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:78.0pt;margin-bottom:.0001pt;text-align:left;
text-indent:-78.0pt;line-height:normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:78.0pt;margin-bottom:.0001pt;text-align:left;
text-indent:-78.0pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>Reproductive system and breast disorders</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:78.0pt;margin-bottom:.0001pt;text-align:left;
text-indent:-78.0pt;line-height:normal'><span lang=EN-GB style='font-size:11.0pt'>Very
common:    Ovarian cysts</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:77.95pt;margin-bottom:.0001pt;text-align:left;
text-indent:-77.95pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>Common:           Mild or moderate OHSS (including associated
symptomatology)</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:78.0pt;margin-bottom:.0001pt;text-align:left;
text-indent:-78.0pt;line-height:normal'><span lang=EN-GB style='font-size:11.0pt'>Uncommon:        Severe
OHSS (including associated symptomatology) (see section&nbsp;4.4)</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:77.95pt;margin-bottom:.0001pt;text-align:left;
text-indent:-77.95pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>Rare:                  Complication of severe OHSS</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:78.0pt;margin-bottom:.0001pt;text-align:left;
text-indent:-78.0pt;line-height:normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:78.0pt;margin-bottom:.0001pt;text-align:left;
text-indent:-78.0pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>General disorders and administration site
conditions</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:78.0pt;margin-bottom:.0001pt;text-align:left;
text-indent:-78.0pt;line-height:normal'><span lang=EN-GB style='font-size:11.0pt'>Very
common:    Injection site reactions (e.g. pain, erythema, haematoma, swelling
and/or irritation at the site of injection)</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:78.0pt;margin-bottom:.0001pt;text-align:left;
text-indent:-78.0pt;line-height:normal'><i><u><span lang=EN-GB
style='font-size:11.0pt'><span style='text-decoration:none'>&nbsp;</span></span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:78.0pt;margin-bottom:.0001pt;text-align:left;
text-indent:-78.0pt;line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB style='font-size:11.0pt'>Treatment in men</span></u></p>

<p class=Formatvorlage1 style='margin-left:78.0pt;text-indent:-78.0pt;
line-height:normal;page-break-after:avoid'><span lang=EN-GB style='font-family:
"Times New Roman",serif'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:78.0pt;margin-bottom:.0001pt;text-align:left;
text-indent:-78.0pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>Immune system disorders</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:78.0pt;margin-bottom:.0001pt;text-align:left;
text-indent:-78.0pt;line-height:normal'><span lang=EN-GB style='font-size:11.0pt'>Very
rare:           Mild to severe hypersensitivity reactions including
anaphylactic reactions and shock</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:78.0pt;margin-bottom:.0001pt;text-align:left;
text-indent:-78.0pt;line-height:normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:78.0pt;margin-bottom:.0001pt;text-align:left;
text-indent:-78.0pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>Respiratory, thoracic and mediastinal
disorders</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:78.0pt;margin-bottom:.0001pt;text-align:left;
text-indent:-78.0pt;line-height:normal'><span lang=EN-GB style='font-size:11.0pt'>Very
rare:           Exacerbation or aggravation of asthma</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:78.0pt;margin-bottom:.0001pt;text-align:left;
text-indent:-78.0pt;line-height:normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:78.0pt;margin-bottom:.0001pt;text-align:left;
text-indent:-78.0pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>Skin and subcutaneous tissue disorders</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:78.0pt;margin-bottom:.0001pt;text-align:left;
text-indent:-78.0pt;line-height:normal'><span lang=EN-GB style='font-size:11.0pt'>Common:           Acne</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:78.0pt;margin-bottom:.0001pt;text-align:left;
text-indent:-78.0pt;line-height:normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:78.0pt;margin-bottom:.0001pt;text-align:left;
text-indent:-78.0pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>Reproductive system and breast disorders</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:78.0pt;margin-bottom:.0001pt;text-align:left;
text-indent:-78.0pt;line-height:normal'><span lang=EN-GB style='font-size:11.0pt'>Common:           Gynaecomastia,
varicocele</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:78.0pt;margin-bottom:.0001pt;text-align:left;
text-indent:-78.0pt;line-height:normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:78.0pt;margin-bottom:.0001pt;text-align:left;
text-indent:-78.0pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>General disorders and administration site
conditions</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:78.0pt;margin-bottom:.0001pt;text-align:left;
text-indent:-78.0pt;line-height:normal'><span lang=EN-GB style='font-size:11.0pt'>Very
common:    Injection site reactions (e.g. pain, erythema, haematoma, swelling
and/or irritation at the site of injection)</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:78.0pt;margin-bottom:.0001pt;text-align:left;
text-indent:-78.0pt;line-height:normal'><u><span lang=EN-GB style='font-size:
11.0pt'><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:78.0pt;margin-bottom:.0001pt;text-align:left;
text-indent:-78.0pt;line-height:normal;page-break-after:avoid'><i><u><span
lang=EN-GB style='font-size:11.0pt'>Investigations</span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:78.0pt;margin-bottom:.0001pt;text-align:left;
text-indent:-78.0pt;line-height:normal'><span lang=EN-GB style='font-size:11.0pt'>Common:           Weight
gain</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;text-autospace:none'><u><span lang=EN-GB
style='font-size:11.0pt'>Reporting of suspected adverse reactions</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;text-autospace:none'><span lang=EN-GB style='font-size:11.0pt'>Reporting
suspected adverse reactions after authorisation of the medicinal product is
important. It allows continued monitoring of the benefit/risk balance of the
medicinal product. Healthcare professionals are asked to report any suspected
adverse reactions via the <span style='color:black;background:#D9D9D9'>national
reporting system listed in </span></span><span lang=EN-GB><a
href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc"><span
style='font-size:11.0pt;background:#D9D9D9'>Appendix&nbsp;V</span></a></span><span
lang=EN-GB style='font-size:11.0pt'>.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<h2 style='margin:0in;margin-bottom:.0001pt;text-indent:0in;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;text-transform:none'>4.9     Overdose</span></h2>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>The effects of an overdose of
GONAL-f are unknown, nevertheless, there is a possibility that OHSS may occur
(see section&nbsp;4.4).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>5.       PHARMACOLOGICAL
PROPERTIES</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<h2 style='margin:0in;margin-bottom:.0001pt;text-indent:0in;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;text-transform:none'>5.1     Pharmacodynamic
properties</span></h2>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Pharmacotherapeutic group:
Sex hormones and modulators of the genital systems, gonadotropins, ATC code:
G03GA05.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><i><u><span lang=EN-GB style='font-size:11.0pt'><span style='text-decoration:
 none'>&nbsp;</span></span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;text-autospace:none'><span lang=EN-GB style='font-size:11.0pt'>In women,
the most important effect resulting from parenteral administration of FSH is
the development of mature Graafian follicles.</span><span lang=EN-GB
style='font-size:11.0pt'> In women with anovulation, the object of GONAL-f
therapy is to develop a single mature Graafian follicle from which the ovum
will be liberated after the administration of hCG.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'>Clinical
efficacy and safety in women</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>In clinical trials, patients
with severe FSH and LH deficiency were defined by an endogenous serum LH level
&lt;&nbsp;1.2&nbsp;IU/L as measured in a central laboratory. However, it should
be taken into account that there are variations between LH measurements
performed in different laboratories.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>In clinical studies comparing
r&#8209;hFSH (follitropin alfa) and urinary FSH in ART (see table below) and in
ovulation induction, GONAL&#8209;f was more potent than urinary FSH in terms of
a lower total dose and a shorter treatment period needed to trigger follicular
maturation.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>In ART, GONAL-f at a lower
total dose and shorter treatment period than urinary FSH, resulted in a higher
number of oocytes retrieved when compared to urinary FSH.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>Table:
Results of study GF&nbsp;8407 (randomised parallel group study comparing
efficacy and safety of GONAL&#8209;f with urinary FSH in assisted reproduction
technologies)</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='margin-left:26.7pt;border-collapse:collapse;border:none'>
 <tr style='page-break-inside:avoid'>
  <td width=243 valign=top style='width:182.6pt;border:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=Titlefortables style='margin:0in;text-indent:0in;line-height:normal'><span
  lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=142 valign=top style='width:106.3pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=Titlefortables style='margin:0in;text-indent:0in;line-height:normal'><span
  lang=EN-GB style='font-size:11.0pt'>GONAL-f<br>
  (n = 130)</span></p>
  </td>
  <td width=142 valign=top style='width:106.35pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=Titlefortables style='margin:0in;text-indent:0in;line-height:normal'><span
  lang=EN-GB style='font-size:11.0pt'>urinary FSH</span><span lang=EN-GB
  style='font-size:11.0pt'> <br>
  (n = 116)</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width=243 valign=top style='width:182.6pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=left style='margin-top:0in;text-align:left;
  line-height:normal;page-break-after:avoid'><span lang=EN-GB style='font-size:
  11.0pt'>Number of oocytes retrieved</span></p>
  </td>
  <td width=142 valign=top style='width:106.3pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=left style='margin-top:0in;text-align:left;
  line-height:normal;page-break-after:avoid'><span lang=EN-GB style='font-size:
  11.0pt'>11.0 ± 5.9</span></p>
  </td>
  <td width=142 valign=top style='width:106.35pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=left style='margin-top:0in;text-align:left;
  line-height:normal;page-break-after:avoid'><span lang=EN-GB style='font-size:
  11.0pt'>8.8 ± 4.8</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width=243 valign=top style='width:182.6pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=left style='margin-top:0in;text-align:left;
  line-height:normal;page-break-after:avoid'><span lang=EN-GB style='font-size:
  11.0pt'>Days of FSH stimulation required</span></p>
  </td>
  <td width=142 valign=top style='width:106.3pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=left style='margin-top:0in;text-align:left;
  line-height:normal;page-break-after:avoid'><span lang=EN-GB style='font-size:
  11.0pt'>11.7 ± 1.9</span></p>
  </td>
  <td width=142 valign=top style='width:106.35pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=left style='margin-top:0in;text-align:left;
  line-height:normal;page-break-after:avoid'><span lang=EN-GB style='font-size:
  11.0pt'>14.5 ± 3.3</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width=243 valign=top style='width:182.6pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=left style='margin-top:0in;text-align:left;
  line-height:normal;page-break-after:avoid'><span lang=EN-GB style='font-size:
  11.0pt'>Total dose of FSH required (number of FSH 75&nbsp;IU ampoules) </span></p>
  </td>
  <td width=142 valign=top style='width:106.3pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=left style='margin-top:0in;text-align:left;
  line-height:normal;page-break-after:avoid'><span lang=EN-GB style='font-size:
  11.0pt'>27.6 ± 10.2</span></p>
  </td>
  <td width=142 valign=top style='width:106.35pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=left style='margin-top:0in;text-align:left;
  line-height:normal;page-break-after:avoid'><span lang=EN-GB style='font-size:
  11.0pt'>40.7 ± 13.6</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width=243 valign=top style='width:182.6pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=left style='margin-top:0in;text-align:left;
  line-height:normal'><span lang=EN-GB style='font-size:11.0pt'>Need to
  increase the dose (%)</span></p>
  </td>
  <td width=142 valign=top style='width:106.3pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=left style='margin-top:0in;text-align:left;
  line-height:normal'><span lang=EN-GB style='font-size:11.0pt'>56.2</span></p>
  </td>
  <td width=142 valign=top style='width:106.35pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=left style='margin-top:0in;text-align:left;
  line-height:normal'><span lang=EN-GB style='font-size:11.0pt'>85.3</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Differences between the 2&nbsp;groups
were statistically significant (p&lt;&nbsp;0.05) for all criteria listed.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><i><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'>Clinical
efficacy and safety in men</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><i><u><span lang=EN-GB style='font-size:11.0pt'><span
 style='text-decoration:none'>&nbsp;</span></span></u></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>In men deficient in FSH,
GONAL&#8209;f administered concomitantly with hCG for at least 4&nbsp;months
induces spermatogenesis.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<h2 style='margin:0in;margin-bottom:.0001pt;text-indent:0in;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;text-transform:none'>5.2     Pharmacokinetic
properties</span></h2>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Following intravenous
administration, follitropin alfa is distributed to the extracellular fluid
space with an initial half-life of around 2&nbsp;hours and eliminated from the
body with a terminal half-life of about one day. The steady state volume of
distribution and total clearance are 10&nbsp;L and 0.6&nbsp;L/h, respectively.
One&#8209;eighth of the follitropin alfa dose is excreted in the urine.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Following subcutaneous
administration, the absolute bioavailability is about 70%. Following repeated
administration, follitropin alfa accumulates 3&#8209;fold achieving a steady&#8209;state
within 3&#8209;4&nbsp;days. In women whose endogenous gonadotropin secretion is
suppressed, follitropin alfa has nevertheless been shown to effectively
stimulate follicular development and steroidogenesis, despite unmeasurable LH
levels.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<h2 style='margin:0in;margin-bottom:.0001pt;text-indent:0in;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;text-transform:none'>5.3     Preclinical
safety data</span></h2>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Non-clinical data reveal no
special hazard for humans based on conventional studies of single and repeated
dose toxicity and genotoxicity additional to that already stated in other
sections of this SmPC.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Impaired fertility has been
reported in rats exposed to pharmacological doses of follitropin alfa
(&#8805;&nbsp;40&nbsp;IU/kg/day) for extended periods, through reduced
fecundity.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Given in high doses
(&#8805;&nbsp;5&nbsp;IU/kg/day) follitropin alfa caused a decrease in the
number of viable foetuses without being a teratogen, and dystocia similar to
that observed with urinary Menopausal Gonadotropin (hMG). However, since
GONAL-f is not indicated in pregnancy, these data are of limited clinical
relevance.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>6.       PHARMACEUTICAL
PARTICULARS</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<h2 style='margin:0in;margin-bottom:.0001pt;text-indent:0in;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;text-transform:none'>6.1     List of
excipients</span></h2>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Poloxamer 188</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Sucrose</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Methionine</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Sodium dihydrogen phosphate
monohydrate</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Disodium phosphate dihydrate</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>m-Cresol</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Phosphoric acid, concentrated</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Sodium hydroxide</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Water for injections</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<h2 style='margin:0in;margin-bottom:.0001pt;text-indent:0in;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;text-transform:none'>6.2     Incompatibilities</span></h2>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Not applicable.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<h2 style='margin:0in;margin-bottom:.0001pt;text-indent:0in;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;text-transform:none'>6.3     Shelf life</span></h2>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>2&nbsp;years.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Once opened, the medicinal
product may be stored for a maximum of 28&nbsp;days at or below 25°C. The
patient should write on the GONAL-f pre-filled pen the day of the first use.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<h2 style='margin:0in;margin-bottom:.0001pt;text-indent:0in;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;text-transform:none'>6.4     Special
precautions for storage</span></h2>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Store in a refrigerator (2°C&#8209;8°C).
Do not freeze.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Before opening and within its
shelf life, the medicinal product may be removed from the refrigerator, without
being refrigerated again, for up to 3&nbsp;months at or below 25°C. The product
must be discarded if it has not been used after 3&nbsp;months.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Store in the original
package, in order to protect from light.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>For in-use storage
conditions, see section&nbsp;6.3.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<h2 style='margin:0in;margin-bottom:.0001pt;text-indent:0in;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;text-transform:none'>6.5     Nature and
contents of container</span></h2>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#D5DCE4'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f <span
style='background:yellow'>150</span> IU PEN&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#D5DCE4'><span lang=EN-GB
style='font-size:11.0pt;color:black;background:yellow'>0.25</span><span
lang=EN-GB style='font-size:11.0pt;color:black'>&nbsp;mL of solution for
injection in 3&nbsp;mL cartridge (Type&nbsp;I glass), with a plunger stopper
(halobutyl rubber) and an aluminium crimp cap with a black rubber inlay.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#D5DCE4'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#D5DCE4'><span lang=EN-GB
style='font-size:11.0pt;color:black'>Pack of one pre-filled pen and <span
style='background:yellow'>4&nbsp;needles</span> to be used with the pen for
administration.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#CCFFFF'><i><span lang=EN-GB
style='font-size:11.0pt;color:black'>&lt;GONAL-f 300 IU  PEN&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#CCFFFF'><span lang=EN-GB style='font-size:11.0pt;color:black'>0.5&nbsp;mL
of solution for injection in 3&nbsp;mL cartridge (Type&nbsp;I glass), with a
plunger stopper (halobutyl rubber) and an aluminium crimp cap with a black
rubber inlay.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#CCFFFF'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#CCFFFF'><span lang=EN-GB style='font-size:11.0pt;color:black'>Pack
of one pre-filled pen and 8&nbsp;needles to be used with the pen for
administration.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#CCECFF'><i><span lang=EN-GB
style='font-size:11.0pt;color:black;background:#CCECFF'>&lt;GONAL-f 450 IU
PEN&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#CCECFF'><span lang=EN-GB style='font-size:11.0pt;color:black'>0.75&nbsp;mL
of solution for injection in 3&nbsp;mL cartridge (Type&nbsp;I glass), with a
plunger stopper (halobutyl rubber) and an aluminium crimp cap with a black
rubber inlay.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#CCECFF'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#CCECFF'><span lang=EN-GB style='font-size:11.0pt;color:black'>Pack
of one pre-filled pen and 12&nbsp;needles to be used with the pen for
administration.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#99CCFF'><i><span lang=EN-GB
style='font-size:11.0pt;color:black'>&lt;GONAL-f 900 IU PEN&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#99CCFF'><span lang=EN-GB style='font-size:11.0pt;color:black'>1.5&nbsp;mL
of solution for injection in 3&nbsp;mL cartridge (Type&nbsp;I glass), with a
plunger stopper (halobutyl rubber) and an aluminium crimp cap with a black
rubber inlay.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#99CCFF'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#99CCFF'><span lang=EN-GB style='font-size:11.0pt;color:black'>Pack
of one pre-filled pen and 20&nbsp;needles to be used with the pen for
administration.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><i><span lang=EN-GB style='font-size:11.0pt;background:#99CCFF'>&nbsp;</span></i></p>

<h2 style='margin:0in;margin-bottom:.0001pt;text-indent:0in;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;text-transform:none'>6.6     Special
precautions for disposal and other handling</span></h2>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>See the Instructions for use.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>The solution should not be
administered if it contains particles or is not clear.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Any unused solution must be
discarded not later than 28&nbsp;days after first opening.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#D5DCE4'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f <span
style='background:yellow'>150</span> IU PEN&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#D5DCE4'><span lang=EN-GB style='font-size:11.0pt;color:black'>GONAL-f
<span style='background:yellow'>150&nbsp;IU/0.25</span>&nbsp;mL solution for
injection in pre-filled pen is not designed to allow the cartridge to be
removed.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#CCFFFF'><i><span lang=EN-GB
style='font-size:11.0pt;color:black'>&lt;GONAL-f 300 IU PEN&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#CCFFFF'><span lang=EN-GB style='font-size:11.0pt;color:black'>GONAL-f
300&nbsp;IU/0.5&nbsp;mL solution for injection in pre-filled pen is not
designed to allow the cartridge to be removed.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#CCECFF'><i><span lang=EN-GB
style='font-size:11.0pt;color:black;background:#CCECFF'>&lt;GONAL-f 450 IU
PEN&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#CCECFF'><span lang=EN-GB style='font-size:11.0pt;color:black'>GONAL-f
450&nbsp;IU/0.75&nbsp;mL solution for injection in pre-filled pen is not
designed to allow the cartridge to be removed.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#99CCFF'><i><span lang=EN-GB
style='font-size:11.0pt;color:black'>&lt;GONAL-f 900 IU PEN&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#99CCFF'><span lang=EN-GB style='font-size:11.0pt;color:black'>GONAL-f
900&nbsp;IU/1.5&nbsp;mL solution for injection in pre-filled pen is not
designed to allow the cartridge to be removed.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Discard used needles
immediately after injection.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Any unused medicinal product
or waste material should be disposed of in accordance with local requirements.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>7.       MARKETING
AUTHORISATION HOLDER</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoListParagraph style='margin:0in;margin-bottom:.0001pt;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>Merck
Europe B.V.</span></p>

<p class=MsoListParagraph style='margin:0in;margin-bottom:.0001pt;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>Gustav
Mahlerplein&nbsp;102</span></p>

<p class=MsoListParagraph style='margin:0in;margin-bottom:.0001pt;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>1082
MA Amsterdam</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>The Netherlands</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>8.       MARKETING
AUTHORISATION NUMBER</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#D5DCE4'><i><span
lang=FR style='font-size:11.0pt;color:black'>&lt;GONAL-f <span
style='background:yellow'>150</span> IU PEN&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#D5DCE4'><span lang=FR style='font-size:11.0pt;color:black'>EU/1/95/001/<span
style='background:yellow'>000</span></span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=FR style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#CCFFFF'><i><span lang=FR
style='font-size:11.0pt;color:black'>&lt;GONAL-f 300 IU PEN&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#CCFFFF'><span lang=FR style='font-size:11.0pt;color:black'>EU/1/95/001/033</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=FR style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#CCECFF'><i><span lang=FR
style='font-size:11.0pt;color:black;background:#CCECFF'>&lt;GONAL-f 450 IU
PEN&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#CCECFF'><span lang=FR style='font-size:11.0pt;color:black'>EU/1/95/001/034</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=FR style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#99CCFF'><i><span lang=FR
style='font-size:11.0pt;color:black'>&lt;GONAL-f 900 IU PEN&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#99CCFF'><span lang=EN-GB style='font-size:11.0pt;color:black'>EU/1/95/001/035</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>9.       DATE
OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Date of first authorisation:
20&nbsp;October 1995.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Date of latest renewal: 20&nbsp;October
2010.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>10.     DATE
OF REVISION OF THE TEXT</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Detailed information on this
medicinal product is available on the website of the European Medicines Agency </span><span
lang=EN-GB><a href="http://www.ema.europa.eu/"><span style='font-size:11.0pt'>http://www.ema.europa.eu</span></a></span><span
lang=EN-GB style='font-size:11.0pt'>.</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>ANNEX II</span></b></p>

<p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:70.8pt;
margin-bottom:0in;margin-left:85.05pt;margin-bottom:.0001pt;text-align:left;
text-indent:-35.4pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>A.        MANUFACTURERS OF THE BIOLOGICAL ACTIVE SUBSTANCE AND </span></b><b><span
lang=EN-GB style='font-size:11.0pt'>MANUFACTURER RESPONSIBLE FOR BATCH RELEASE</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-35.4pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:70.8pt;
margin-bottom:0in;margin-left:85.05pt;margin-bottom:.0001pt;text-align:left;
text-indent:-35.4pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>B.        CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:28.35pt;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-35.4pt;line-height:normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:28.35pt;
margin-bottom:0in;margin-left:85.05pt;margin-bottom:.0001pt;text-align:left;
text-indent:-35.4pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>C.        OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING
AUTHORISATION</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:28.35pt;
margin-bottom:0in;margin-left:85.05pt;margin-bottom:.0001pt;text-align:left;
text-indent:-35.4pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:28.35pt;
margin-bottom:0in;margin-left:85.05pt;margin-bottom:.0001pt;text-align:left;
text-indent:-35.4pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>D.        CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND
EFFECTIVE USE OF THE MEDICINAL PRODUCT</span></b></p>

<p class=MsoNormalIndent align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<b><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span></b>

<h1 align=left style='text-align:left;page-break-after:avoid'><span lang=EN-GB>A.      MANUFACTURERS
OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURER RESPONSIBLE FOR BATCH
RELEASE</span></h1>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'>Name
and address of the manufacturer of the biological active substance</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoBodyTextIndent2 align=left style='margin-left:0in;text-align:left;
text-indent:0in;line-height:normal;page-break-after:avoid'><span lang=IT>Merck
Serono S.A.</span></p>

<p class=MsoBodyTextIndent2 align=left style='margin-left:0in;text-align:left;
text-indent:0in;line-height:normal;page-break-after:avoid'><span lang=IT>Succursale
dAubonne</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=FR style='font-size:11.0pt'>Zone
Industrielle de lOuriettaz</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=FR style='font-size:11.0pt'>1170
Aubonne</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=FR style='font-size:11.0pt'>Switzerland</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=FR style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>or</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;text-autospace:none'><span lang=EN-GB
style='font-size:11.0pt'>Merck S.L.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>C/
Batanes&nbsp;1</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>28760
Tres Cantos (Madrid)</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Spain</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'>Name
and address of the manufacturer responsible for batch release</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><a name="_Hlk521430198"><span lang=IT
style='font-size:11.0pt'>Merck Serono S.p.A.</span></a></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=IT style='font-size:11.0pt'>Via delle
Magnolie&nbsp;15 (loc. frazione Zona Industriale)</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>70026
Modugno (BA)</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Italy</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<h1 align=left style='text-align:left;page-break-after:avoid'><span lang=EN-GB>B.      CONDITIONS
OR RESTRICTIONS REGARDING SUPPLY AND USE</span></h1>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='margin-left:0in;text-align:left;
text-indent:0in;line-height:normal'><span lang=EN-GB>Medicinal product subject
to restricted medical prescription (see Annex&nbsp;I: Summary of Product Characteristics,
section&nbsp;4.2).</span></p>

<p class=MsoBodyTextIndent align=left style='margin-left:0in;text-align:left;
text-indent:0in;line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='margin-left:0in;text-align:left;
text-indent:0in;line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<h1 align=left style='text-align:left;page-break-after:avoid'><span lang=EN-GB>C.      OTHER
CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION</span></h1>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><a
name="_Hlk15460205"><span lang=EN-GB style='font-size:11.0pt;font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB style='font-size:11.0pt'>Periodic safety
update reports (PSURs)</span></b></a></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>The requirements for
submission of PSURs for this medicinal product are set out in the list of Union
reference dates (EURD list) </span><span lang=EN-GB style='font-size:11.0pt'>provided
for under Article 107c(7) of Directive 2001/83/EC and any subsequent updates
published on the European medicines web-portal.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<h1 align=left style='text-align:left;page-break-after:avoid'><span lang=EN-GB>D.      CONDITIONS
OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL
PRODUCT</span></h1>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB style='font-size:11.0pt'>Risk management plan
(RMP)</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>The marketing authorisation
holder (MAH) shall perform the required pharmacovigilance activities and
interventions detailed in the agreed RMP presented in Module&nbsp;1.8.2 of the
marketing authorisation and any agreed subsequent updates of the RMP.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>An
updated RMP should be submitted:</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>At the request of the
European Medicines Agency;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Whenever the risk
management system is modified, especially as the result of new information
being received that may lead to a significant change to the benefit/risk
profile or as the result of an important (pharmacovigilance or risk
minimisation) milestone being reached.</span></p>

<b><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span></b>

<p class=Heading1left><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>ANNEX III</span></b></p>

<p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>LABELLING AND PACKAGE LEAFLET</span></b></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<h1><span lang=EN-GB>A. LABELLING</span></h1>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black;background:#CCCCCC'><br clear=all style='page-break-before:always'>
</span>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB style='font-size:11.0pt;
text-transform:uppercase'>PARTICULARS TO APPEAR ON THE OUTER PACKAGING</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB style='font-size:11.0pt;
text-transform:uppercase'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB style='font-size:11.0pt;
text-transform:uppercase'>GONAL-</span></b><b><span lang=EN-GB
style='font-size:11.0pt'>f<span style='text-transform:uppercase'> 75&nbsp;IU, BOX
OF 1, 5, 10 VIALS AND 1, 5, 10 PRE-FILLED SYRINGES</span></span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>1.       NAME OF THE MEDICINAL PRODUCT</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>GONAL-f
75&nbsp;IU powder and solvent for solution for injection</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>follitropin alfa</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>2.       STATEMENT
OF ACTIVE SUBSTANCE(S)</span></b></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>Each vial contains 5.5&nbsp;micrograms follitropin alfa equivalent
to 75&nbsp;IU. Each mL of the reconstituted solution contains 75&nbsp;IU.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>3.       LIST
OF EXCIPIENTS</span></b></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><b><span
lang=EN-GB style='text-transform:uppercase'>&nbsp;</span></b></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Excipients: sucrose, sodium dihydrogen phosphate monohydrate,
disodium phosphate dihydrate, methionine, polysorbate&nbsp;20, concentrated
phosphoric acid and sodium hydroxide.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Solvent for solution for
injection: water for injections.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>4.       PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>1&nbsp;vial of powder for
solution for injection.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>1&nbsp;pre-filled syringe of
1&nbsp;mL solvent.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt;color:black;background:#BFBFBF'>5&nbsp;vials
of powder for solution for injection.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt;color:black;background:#BFBFBF'>5&nbsp;pre-filled
syringes of 1&nbsp;mL solvent.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt;color:black;background:#BFBFBF'>10&nbsp;vials
of powder for solution for injection.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt;color:black;background:#BFBFBF'>10&nbsp;pre-filled
syringes of 1&nbsp;mL solvent.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>5.       METHOD
AND ROUTE(S) OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Read the package leaflet before use.</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Subcutaneous use.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>6.       SPECIAL
WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF
CHILDREN</span></b></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>Keep out of the sight and reach of children.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>7.       OTHER SPECIAL WARNING(S), IF NECESSARY</span></b></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal;page-break-after:
avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>8.       EXPIRY DATE</span></b></p>

</div>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>EXP</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>9.       SPECIAL STORAGE CONDITIONS</span></b></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal;page-break-after:
avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>Do not store above 25°C. Store in the original package in order to
protect from light.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>10.     SPECIAL
PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS
DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>Discard any unused solution.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>11.     NAME
AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoListParagraph style='margin:0in;margin-bottom:.0001pt;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>Merck
Europe B.V.</span></p>

<p class=MsoListParagraph style='margin:0in;margin-bottom:.0001pt;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>Gustav
Mahlerplein&nbsp;102</span></p>

<p class=MsoListParagraph style='margin:0in;margin-bottom:.0001pt;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>1082
MA Amsterdam</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>The Netherlands</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>12.     MARKETING
AUTHORISATION NUMBER(S)</span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>EU/1/95/001/025   <span style='color:black;background:#D9D9D9'>1&nbsp;vial
of powder for solution for injection</span></span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:85.05pt;margin-bottom:.0001pt;text-align:left;
text-indent:-85.05pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>                            <span style='color:black;background:#D9D9D9'>1&nbsp;pre-filled
syringe of solvent</span></span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:85.05pt;margin-bottom:.0001pt;text-align:left;
text-indent:-85.05pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;color:black;background:#D9D9D9'>EU/1/95/001/026   5&nbsp;vials of powder
for solution for injection</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:85.05pt;margin-bottom:.0001pt;text-align:left;
text-indent:-85.05pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>                            <span style='color:black;background:#D9D9D9'>5&nbsp;pre-filled
syringes of solvent</span></span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:85.05pt;margin-bottom:.0001pt;text-align:left;
text-indent:-85.05pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;color:black;background:#D9D9D9'>EU/1/95/001/027   10&nbsp;vials of
powder for solution for injection</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:85.05pt;margin-bottom:.0001pt;text-align:left;
text-indent:-85.05pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>                            <span style='color:black;background:#D9D9D9'>10&nbsp;pre-filled
syringes of solvent</span></span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:85.05pt;margin-bottom:.0001pt;text-align:left;
text-indent:-85.05pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>13.     BATCH
NUMBER</span></b></p>

</div>

<p class=MsoBodyText align=left style='margin-left:28.35pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='margin-left:28.35pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB>Batch</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>Solvent Batch</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>14.     GENERAL
CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText align=left style='margin-left:28.35pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>15.     INSTRUCTIONS ON USE</span></b></p>

</div>

<p class=MsoBodyText align=left style='margin-left:28.35pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='margin-left:28.35pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='page-break-after:avoid'><span lang=EN-GB>16.     INFORMATION
IN BRAILLE</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText align=left style='margin-left:28.35pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB>gonal-f 75&nbsp;iu</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='page-break-after:avoid'><span lang=EN-GB>17.     UNIQUE
IDENTIFIER  2D BARCODE</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt;color:black;background:#D9D9D9'>2D barcode carrying the
unique identifier included.</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='page-break-after:avoid'><span lang=EN-GB>18.     UNIQUE
IDENTIFIER - HUMAN READABLE DATA</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>PC </span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal;page-break-after:
avoid'><span lang=EN-GB style='font-size:11.0pt'>SN </span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt'>NN </span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black;background:#CCCCCC'><br clear=all style='page-break-before:always'>
</span>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB style='font-size:11.0pt;text-transform:uppercase'>minimum
particulars to appear on small immediate packaging units</span></b></p>

<h2 style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:28.35pt;
margin-bottom:.0001pt;text-indent:-28.35pt;line-height:normal;page-break-after:
auto;border:none;padding:0in'><span lang=EN-GB style='font-size:11.0pt;
text-transform:none'>&nbsp;</span></h2>

<h2 style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:28.35pt;
margin-bottom:.0001pt;text-indent:-28.35pt;line-height:normal;page-break-after:
auto;border:none;padding:0in'><span lang=EN-GB style='font-size:11.0pt;
text-transform:none'>GONAL-f 75 IU, VIAL LABEL</span></h2>

</div>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>1.       name of the medicinal product and
route(s) of administration</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>GONAL-f 75&nbsp;IU powder for solution for
injection</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>follitropin
alfa</span></p>

<p class=MsoBodyText align=left style='margin-left:28.35pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB>S.C.</span></p>

<p class=MsoBodyText align=left style='margin-left:28.35pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='margin-left:28.35pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>2.       METHOD OF ADMINISTRATION</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText align=left style='margin-left:28.35pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>3.       EXPIRY DATE</span></p>

</div>

<p class=MsoBodyText align=left style='margin-left:28.35pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='margin-left:28.35pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB>EXP</span></p>

<p class=MsoBodyText align=left style='margin-left:28.35pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='margin-left:28.35pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>4.       BATCH NUMBER</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>Batch</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>5.       CONTENTS BY WEIGHT, BY VOLUME OR BY
UNIT</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB style='color:black;background:#D9D9D9'>75&nbsp;UI</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>6.       OTHER</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<b><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
text-transform:uppercase'><br clear=all style='page-break-before:always'>
</span></b>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>minimum particulars to appear on small
immediate packaging units<br>
<br>
</span></p>

<p class=Label style='page-break-after:avoid'><span lang=EN-GB>Gonal-</span><span
lang=EN-GB style='text-transform:none'>f</span><span lang=EN-GB> 75&nbsp;IU,
SOLVENT PRE-FILLED SYRINGE LABEL</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>1.       name of the medicinal product and
route(s) of administration</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Solvent for powder for
solution for injection for GONAL-f</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>water for injections</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>2.       METHOD OF ADMINISTRATION</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>3.       EXPIRY DATE</span></p>

</div>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>EXP</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>4.       BATCH NUMBER</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>Batch</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>5.       CONTENTS BY WEIGHT, BY VOLUME OR BY
UNIT</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>1&nbsp;mL/pre-filled syringe</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>6.       OTHER</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black;background:#CCCCCC'><br clear=all style='page-break-before:always'>
</span>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB style='font-size:11.0pt;
text-transform:uppercase'>PARTICULARS TO APPEAR ON THE OUTER PACKAGING</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB style='font-size:11.0pt;
text-transform:uppercase'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>GONAL-f
1050&nbsp;IU/1.75&nbsp;ML,<span style='text-transform:uppercase'> BOX OF 1 VIAL
AND 1 PRE-FILLED SYRINGE</span></span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>1.       name of the medicinal product</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>GONAL-f
1050&nbsp;IU/1.75&nbsp;mL powder and solvent for solution for injection</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>follitropin alfa</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>2.       statement of active substance(s)</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>Each multidose vial contains 87&nbsp;micrograms follitropin alfa
equivalent to 1200&nbsp;IU. Each mL of the reconstituted solution contains
600&nbsp;IU.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>3.       list of excipients</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><b><span
lang=EN-GB style='text-transform:uppercase'>&nbsp;</span></b></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Excipients: sucrose, sodium dihydrogen phosphate monohydrate,
disodium phosphate dihydrate, concentrated phosphoric acid and sodium
hydroxide.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Solvent for solution for
injection: water for injections, benzyl alcohol 0.9%.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>4.       pharmaceutical form and contents</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>1&nbsp;vial of powder for solution for injection.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>1&nbsp;pre-filled syringe of 2&nbsp;mL solvent.</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>15&nbsp;disposable syringes for administration graduated in FSH
units.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>5.       method and route(s) of administration</span></p>

</div>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>For multiple injections only.</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Read the package leaflet before use.</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Subcutaneous use.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>6.       special warning that the medicinal product must be stored
out of the Sightand reach of children</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>Keep out of the sight and reach of children.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='page-break-after:avoid'><span lang=EN-GB>7.       other
special warning(S), IF NECESSARY</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal;page-break-after:
avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>The solvent pre-filled syringe provided should be used for
reconstitution only.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>The reconstituted vial should be for single patient use only.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='page-break-after:avoid'><span lang=EN-GB>8.       expiry
date</span></p>

</div>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>EXP</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='page-break-after:avoid'><span lang=EN-GB>9.       special
storage conditions</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal;page-break-after:
avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>Prior to reconstitution, do not store above 25°C. Store in the
original package in order to protect from light.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>After reconstitution, do not store above 25°C. Do not freeze. Store
in the original container.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>10.     special precautions for disposal of unused medicinal
products or waste materials derived from such medicinal products, if
appropriate</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>Discard any unused solution after 28&nbsp;days.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>11.     name and address of the marketing
authorisation holder</span></p>

</div>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoListParagraph style='margin:0in;margin-bottom:.0001pt;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>Merck
Europe B.V.</span></p>

<p class=MsoListParagraph style='margin:0in;margin-bottom:.0001pt;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>Gustav
Mahlerplein&nbsp;102</span></p>

<p class=MsoListParagraph style='margin:0in;margin-bottom:.0001pt;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>1082
MA Amsterdam</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>The Netherlands</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>12.     MARKETING AUTHORISATION number(s)</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:92.15pt;margin-bottom:.0001pt;text-indent:-92.15pt;line-height:
normal'><span lang=EN-GB>EU/1/95/001/021     <span style='color:black;
background:#D9D9D9'>1&nbsp;vial of powder for solution for injection<br>
1&nbsp;pre-filled syringe of solvent<br>
15&nbsp;disposable syringes</span></span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>13.     batch number</span></p>

</div>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Batch</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Solvent Batch</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>14.     general classification for supply</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>15.     instructions on use</span></p>

</div>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='page-break-after:avoid'><span lang=EN-GB>16.     information
in braille</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>gonal-f 1050&nbsp;iu</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='page-break-after:avoid'><span lang=EN-GB>17.     UNIQUE
IDENTIFIER  2D BARCODE</span></p>

</div>

<p class=MsoNormal style='margin-top:0in;line-height:normal;page-break-after:
avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt;color:black;background:#D9D9D9'>2D barcode carrying the
unique identifier included.</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='page-break-after:avoid'><span lang=EN-GB>18.     UNIQUE
IDENTIFIER - HUMAN READABLE DATA</span></p>

</div>

<p class=MsoNormal style='margin-top:0in;line-height:normal;page-break-after:
avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal;page-break-after:
avoid'><span lang=EN-GB style='font-size:11.0pt'>PC </span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal;page-break-after:
avoid'><span lang=EN-GB style='font-size:11.0pt'>SN </span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt'>NN </span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black;background:#CCCCCC'><br clear=all style='page-break-before:always'>
</span>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB style='font-size:11.0pt;
text-transform:uppercase'>minimum particulars to appear on small immediate
packaging units<br>
<br>
</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>GONAL-f 1050 IU/1.75 ML, VIAL LABEL</span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>1.       name of the medicinal product and
route(s) of administration</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>GONAL-f
1050&nbsp;IU/1.75&nbsp;mL powder for solution for injection</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>follitropin
alfa</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>S.C.</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>2.       METHOD OF ADMINISTRATION</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>3.       EXPIRY DATE</span></p>

</div>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>EXP</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>4.       Date of reconstitution</span></p>

</div>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Date:</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>5.       BATCH NUMBER</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>Batch</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>6.       CONTENTS BY WEIGHT, BY VOLUME OR BY
UNIT</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>1200&nbsp;IU/vial</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>7.       other</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB style='font-size:11.0pt;
text-transform:uppercase'>minimum particulars to appear on small immediate
packaging units<br>
<br>
</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>GONAL-f 1050&nbsp;IU/1.75&nbsp;ML, SOLVENT PRE-FILLED
SYRINGE LABEL</span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>1.       name of the medicinal product and
route(s) of administration</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Solvent for use with GONAL-f 1050&nbsp;IU/1.75&nbsp;mL</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>water for injections, benzyl alcohol 0.9%</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>2.       METHOD OF ADMINISTRATION</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>3.       EXPIRY DATE</span></p>

</div>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>EXP</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>4.       BATCH NUMBER</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>Batch</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>5.       CONTENTS BY WEIGHT, BY VOLUME OR BY
UNIT</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>2&nbsp;mL/pre-filled syringe</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>6.       other</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black;background:#CCCCCC'><br clear=all style='page-break-before:always'>
</span>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB style='font-size:11.0pt;
text-transform:uppercase'>PARTICULARS TO APPEAR ON THE OUTER PACKAGING</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB style='font-size:11.0pt;
text-transform:uppercase'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>GONAL-f 450&nbsp;IU/0.75&nbsp;ML,<span
style='text-transform:uppercase'> BOX OF 1 VIAL AND 1 PRE-FILLED SYRINGE</span></span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>1.       name of the medicinal product</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>GONAL-f
450&nbsp;IU/0.75&nbsp;mL powder and solvent for solution for injection</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>follitropin alfa</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>2.       statement of active substance(s)</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>Each multidose vial contains 44&nbsp;micrograms follitropin alfa
equivalent to 600&nbsp;IU. Each mL of the reconstituted solution contains
600&nbsp;IU.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>3.       list of excipients</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><b><span
lang=EN-GB style='text-transform:uppercase'>&nbsp;</span></b></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><span lang=EN-GB>Excipients: sucrose, sodium dihydrogen
phosphate monohydrate, disodium phosphate dihydrate, concentrated phosphoric
acid and sodium hydroxide.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Solvent for solution for
injection: water for injections, benzyl alcohol 0.9%.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>4.       pharmaceutical form and contents</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>1&nbsp;vial of powder for solution for injection.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>1&nbsp;pre-filled syringe of 1&nbsp;mL solvent.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>6&nbsp;disposable syringes
for administration graduated in FSH units.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>5.       method and route(s) of administration</span></p>

</div>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>For multiple injections only.</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><span lang=EN-GB>Read the package leaflet before use.</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Subcutaneous use.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>6.       special warning that the medicinal product must be stored
out of the Sight and reach of children</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>Keep out of the sight and reach of children.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='page-break-after:avoid'><span lang=EN-GB>7.       other
special warning(S), IF NECESSARY</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal;page-break-after:
avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>The solvent pre-filled syringe provided should be used for
reconstitution only.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>The reconstituted vial should be for single patient use only.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='page-break-after:avoid'><span lang=EN-GB>8.       expiry
date</span></p>

</div>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>EXP</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='page-break-after:avoid'><span lang=EN-GB>9.       special
storage conditions</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal;page-break-after:
avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>Prior to reconstitution, do not store above 25°C. Store in the
original package in order to protect from light.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>After reconstitution, do not store above 25°C. Do not freeze. Store
in the original container.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>10.     special precautions for disposal of unused medicinal
products or waste materials derived from such medicinal products, if appropriate</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>Discard any unused solution after 28&nbsp;days.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>11.     name and address of the marketing
authorisation holder</span></p>

</div>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoListParagraph style='margin:0in;margin-bottom:.0001pt;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>Merck
Europe B.V.</span></p>

<p class=MsoListParagraph style='margin:0in;margin-bottom:.0001pt;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>Gustav
Mahlerplein&nbsp;102</span></p>

<p class=MsoListParagraph style='margin:0in;margin-bottom:.0001pt;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>1082
MA Amsterdam</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>The Netherlands</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>12.     MARKETING AUTHORISATION number(s)</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:92.15pt;margin-bottom:.0001pt;text-indent:-92.15pt;line-height:
normal'><span lang=EN-GB>EU/1/95/001/031     <span style='color:black;
background:#D9D9D9'>1&nbsp;vial of powder for solution for injection<br>
1&nbsp;pre-filled syringe of solvent<br>
6&nbsp;disposable syringes</span></span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>13.     batch number</span></p>

</div>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Batch</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Solvent Batch</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>14.     general classification for supply</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>15.     instructions on use</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='page-break-after:avoid'><span lang=EN-GB>16.     information
in braille</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>gonal-f 450&nbsp;iu</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='page-break-after:avoid'><span lang=EN-GB>17.     UNIQUE
IDENTIFIER  2D BARCODE</span></p>

</div>

<p class=MsoNormal style='margin-top:0in;line-height:normal;page-break-after:
avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt;color:black;background:#D9D9D9'>2D barcode carrying the
unique identifier included.</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='page-break-after:avoid'><span lang=EN-GB>18.     UNIQUE
IDENTIFIER - HUMAN READABLE DATA</span></p>

</div>

<p class=MsoNormal style='margin-top:0in;line-height:normal;page-break-after:
avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal;page-break-after:
avoid'><span lang=EN-GB style='font-size:11.0pt'>PC </span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal;page-break-after:
avoid'><span lang=EN-GB style='font-size:11.0pt'>SN </span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt'>NN </span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black;background:#CCCCCC'><br clear=all style='page-break-before:always'>
</span>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB style='font-size:11.0pt;
text-transform:uppercase'>minimum particulars to appear on small immediate
packaging units<br>
<br>
</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>GONAL-f 450&nbsp;IU/0.75&nbsp;ML, VIAL LABEL</span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>1.       name of the medicinal product and
route(s) of administration</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>GONAL-f
450&nbsp;IU/0.75&nbsp;mL powder for solution for injection</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>follitropin
alfa</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>S.C.</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>2.       METHOD OF ADMINISTRATION</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>3.       EXPIRY DATE</span></p>

</div>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>EXP</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>4.       Date of reconstitution</span></p>

</div>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Date:</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>5.       BATCH NUMBER</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>Batch</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>6.       CONTENTS BY WEIGHT, BY VOLUME OR BY
UNIT</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>600&nbsp;IU/vial</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>7.       other</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB style='font-size:11.0pt;
text-transform:uppercase'>minimum particulars to appear on small immediate
packaging units<br>
<br>
</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>GONAL-f 450&nbsp;IU/0.75&nbsp;ML, SOLVENT PRE-FILLED
SYRINGE LABEL</span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>1.       name of the medicinal product and
route(s) of administration</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Solvent for use with GONAL-f 450&nbsp;IU/0.75&nbsp;mL</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>water for injections, benzyl
alcohol 0.9%</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>2.       METHOD OF ADMINISTRATION</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>3.       EXPIRY DATE</span></p>

</div>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>EXP</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>4.       BATCH NUMBER</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>Batch</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>5.       CONTENTS BY WEIGHT, BY VOLUME OR BY
UNIT</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>1&nbsp;mL/pre-filled syringe</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>6.       other</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<b><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span></b>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt;text-transform:uppercase'>PARTICULARS TO APPEAR ON THE
OUTER PACKAGING</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt;text-transform:uppercase'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt;text-transform:uppercase'>GONAL-</span></b><b><span
lang=EN-GB style='font-size:11.0pt'>f<span style='text-transform:uppercase'>
150&nbsp;IU/0.25&nbsp;ML PEN, BOX OF 1 PRE-FILLED PEN</span></span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt;text-transform:uppercase'>1.       name of the
medicinal product</span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>GONAL-f
150&nbsp;IU/0.25&nbsp;mL solution for injection in pre-filled pen</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>follitropin alfa</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt;text-transform:uppercase'>2.       statement of active
substance(s)</span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>Each
pre-filled multidose pen delivers 150&nbsp;IU follitropin alfa, equivalent to
11&nbsp;micrograms, per 0.25&nbsp;mL.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Follitropin alfa,
600&nbsp;IU/mL (equivalent to 44&nbsp;micrograms/mL).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt;text-transform:uppercase'>3.       list of excipients</span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt;
text-transform:uppercase'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Excipients:
Poloxamer&nbsp;188, sucrose, methionine, sodium dihydrogen phosphate
monohydrate, disodium phosphate dihydrate, m-cresol, concentrated phosphoric
acid, sodium hydroxide and water for injections.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt;text-transform:uppercase'>4.       pharmaceutical form
and contents</span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>Solution
for injection in a pre-filled pen.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>1&nbsp;multidose
pre-filled pen</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>4&nbsp;injection needles</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt;text-transform:uppercase'>5.       method and route(s)
of administration</span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>Read
the package leaflet before use.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Subcutaneous use.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt;text-transform:uppercase'>6.       special
warning that the medicinal product must be stored out of the Sight and reach of
children</span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Keep out of the sight and
reach of children.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt;text-transform:uppercase'>7.       other special
warning(S), IF NECESSARY</span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt;text-transform:uppercase'>8.       expiry date</span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>EXP</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt;text-transform:uppercase'>9.       special storage
conditions</span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>Store
in a refrigerator. Do not freeze.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>Store
in the original package in order to protect from light.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>Within
its shelf-life, the medicine may be stored at or below 25°C for up to
3&nbsp;months without being refrigerated and must be discarded afterwards.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Once opened, the medicine may
be stored for a maximum of 28&nbsp;days at or below 25°C.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt;text-transform:uppercase'>10.     special
precautions for disposal of unused medicinal products or waste materials
derived from such medicinal products, if appropriate</span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Any unused medicine or waste
material should be disposed in accordance with local requirements.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt;text-transform:uppercase'>11.     name and address of
the marketing authorisation holder</span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal;page-break-after:
avoid'><span lang=EN-GB style='font-size:11.0pt'>Merck Europe B.V.</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal;page-break-after:
avoid'><span lang=EN-GB style='font-size:11.0pt'>Gustav Mahlerplein&nbsp;102</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal;page-break-after:
avoid'><span lang=EN-GB style='font-size:11.0pt'>1082 MA Amsterdam</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>The Netherlands</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt;text-transform:uppercase'>12.     MARKETING
AUTHORISATION number(s)</span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>EU/1/95/001/000     <span
style='color:black;background:#D9D9D9'>solution for injection in pre-filled pen<br>
</span>                               <span style='color:black;background:#D9D9D9'>4
needles</span></span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt;text-transform:uppercase'>13.     batch number</span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Batch</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt;text-transform:uppercase'>14.     general
classification for supply</span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt;text-transform:uppercase'>15.     </span></b><b><span
lang=EN-GB style='font-size:11.0pt'>INSTRUCTIONS ON USE</span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt;text-transform:uppercase'>16.     information in
braille</span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>gonal-f
150&nbsp;iu/0.25&nbsp;ml</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt;text-transform:uppercase'>17.     UNIQUE IDENTIFIER 
2D BARCODE</span></b></p>

</div>

<p class=MsoNormal style='margin-top:0in;line-height:normal;page-break-after:
avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt;color:black;background:#D9D9D9'>2D barcode carrying the
unique identifier included.</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt;text-transform:uppercase'>18.     UNIQUE IDENTIFIER -
HUMAN READABLE DATA</span></b></p>

</div>

<p class=MsoNormal style='margin-top:0in;line-height:normal;page-break-after:
avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal;page-break-after:
avoid'><span lang=EN-GB style='font-size:11.0pt'>PC</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt'>SN</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt'>NN</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black;background:#CCCCCC'><br clear=all style='page-break-before:always'>
</span>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 1.0pt 1.0pt 1.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt;text-transform:uppercase'>PARTICULARS TO APPEAR ON THE
PEN</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>GONAL-f 150&nbsp;IU/0.25&nbsp;ML PEN, STICKER</span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><i><span lang=EN-GB style='font-size:11.0pt;
color:black;background:#BFBFBF'>A sticker will be added to allow the patient to
write the day of first use.</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><i><span lang=EN-GB style='font-size:11.0pt;
background:#BFBFBF'>&nbsp;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB><img border=0 width=203 height=170
src="file:///c:/Users/makum/Desktop/Learning/p-ie/EMA%20EPI%20PoC/function_code/work/H/CAP/gonal-f/en/2021-06-04T08-55-59Z/gonal-f_clean_files/image001.png"></span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black;background:#CCCCCC'><br clear=all style='page-break-before:always'>
</span>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt;text-transform:uppercase'>minimum particulars to appear
on small immediate packaging units<br>
<br>
</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>GONAL-f 150 IU/0.25 ML PEN, PEN LABEL</span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt;text-transform:uppercase'>1.       name of the
medicinal product and route(s) of administration</span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>GONAL-f
150&nbsp;IU/0.25&nbsp;mL solution for injection in pre-filled pen</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>follitropin
alfa</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Subcutaneous use</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt;text-transform:uppercase'>2.       METHOD OF
ADMINISTRATION</span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt;text-transform:uppercase'>3.       EXPIRY DATE</span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>EXP</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Shelf-life after first use:
28&nbsp;days</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt;text-transform:uppercase'>4.       BATCH NUMBER</span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Batch</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt;text-transform:uppercase'>5.       CONTENTS BY WEIGHT,
BY VOLUME OR BY UNIT</span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt;color:black;background:#BFBFBF'>150&nbsp;IU/0.25&nbsp;mL</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt;text-transform:uppercase'>6.       other</span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<b><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span></b>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB style='font-size:11.0pt;
text-transform:uppercase'>PARTICULARS TO APPEAR ON THE OUTER PACKAGING</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB style='font-size:11.0pt;
text-transform:uppercase'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt;text-transform:uppercase'>Gonal-</span></b><b><span
lang=EN-GB style='font-size:11.0pt'>f<span style='text-transform:uppercase'>
300&nbsp;IU/0.5&nbsp;ML PEN, BOX OF 1 PRE-FILLED PEN</span></span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>1.       name of the medicinal product</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>GONAL-f
300&nbsp;IU/0.5&nbsp;mL solution for injection in pre-filled pen</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>follitropin alfa</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>2.       statement of active substance(s)</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>Each pre-filled multidose pen delivers 300&nbsp;IU follitropin alfa,
equivalent to 22&nbsp;micrograms, per 0.5&nbsp;mL.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>Follitropin alfa, 600&nbsp;IU/mL (equivalent to
44&nbsp;micrograms/mL).</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>3.       list of excipients</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><b><span
lang=EN-GB style='text-transform:uppercase'>&nbsp;</span></b></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Excipients: Poloxamer&nbsp;188, sucrose, methionine, sodium
dihydrogen phosphate monohydrate, disodium phosphate dihydrate, m-cresol,
concentrated phosphoric acid, sodium hydroxide and water for injections.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>4.       pharmaceutical form and contents</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>Solution for injection in a pre-filled pen.</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>1&nbsp;multidose pre-filled pen</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>8&nbsp;injection needles</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>5.       method and route(s) of administration</span></p>

</div>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Read the package leaflet before use.</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Subcutaneous use.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>6.       special warning that the medicinal product must be stored
out of the Sight and reach of children</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>Keep out of the sight and reach of children.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='page-break-after:avoid'><span lang=EN-GB>7.       other
special warning(S), IF NECESSARY</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal;page-break-after:
avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='page-break-after:avoid'><span lang=EN-GB>8.       expiry
date</span></p>

</div>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>EXP</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='page-break-after:avoid'><span lang=EN-GB>9.       special
storage conditions</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal;page-break-after:
avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormalIndent style='margin:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Store in a refrigerator. Do
not freeze.</span></p>

<p class=MsoNormalIndent style='margin:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Store in the original package
in order to protect from light.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Within its shelf-life, the medicine
may be stored at or below 25°C for up to 3&nbsp;months without being
refrigerated and must be discarded afterwards.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Once opened, the medicine may
be stored for a maximum of 28&nbsp;days at or below 25°C.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>10.     special precautions for disposal of unused medicinal
products or waste materials derived from such medicinal products, if
appropriate</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>Any unused medicine or waste material should be disposed in
accordance with local requirements.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>11.     name and address of the marketing
authorisation holder</span></p>

</div>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoListParagraph style='margin:0in;margin-bottom:.0001pt;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>Merck
Europe B.V.</span></p>

<p class=MsoListParagraph style='margin:0in;margin-bottom:.0001pt;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>Gustav
Mahlerplein&nbsp;102</span></p>

<p class=MsoListParagraph style='margin:0in;margin-bottom:.0001pt;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>1082
MA Amsterdam</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>The Netherlands</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>12.     MARKETING AUTHORISATION number(s)</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:92.15pt;margin-bottom:.0001pt;text-indent:-92.15pt;line-height:
normal'><span lang=EN-GB>EU/1/95/001/033     <span style='color:black;
background:#D9D9D9'>solution for injection in pre-filled pen<a
name="OLEII-109_Company_Response_to_LoQLINK2"></a><br>
8 needles</span></span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>13.     batch number</span></p>

</div>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Batch</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>14.     general classification for supply</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>15.     instructions on use</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='page-break-after:avoid'><span lang=EN-GB>16.     information
in braille</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>gonal-f 300&nbsp;iu/0.5&nbsp;ml</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='page-break-after:avoid'><span lang=EN-GB>17.     UNIQUE
IDENTIFIER  2D BARCODE</span></p>

</div>

<p class=MsoNormal style='margin-top:0in;line-height:normal;page-break-after:
avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt;color:black;background:#D9D9D9'>2D barcode carrying the
unique identifier included.</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='page-break-after:avoid'><span lang=EN-GB>18.     UNIQUE
IDENTIFIER - HUMAN READABLE DATA</span></p>

</div>

<p class=MsoNormal style='margin-top:0in;line-height:normal;page-break-after:
avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal;page-break-after:
avoid'><span lang=EN-GB style='font-size:11.0pt'>PC </span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal;page-break-after:
avoid'><span lang=EN-GB style='font-size:11.0pt'>SN </span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt'>NN </span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black;background:#CCCCCC'><br clear=all style='page-break-before:always'>
</span>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 1.0pt 1.0pt 1.0pt'>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal;
page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='text-transform:uppercase'>PARTICULARS TO APPEAR ON THE PEN</span></b></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal;
page-break-after:avoid;border:none;padding:0in'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal;
page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>GONAL-f
300&nbsp;IU/0.5&nbsp;ML PEN, STICKER</span></b></p>

</div>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><i><span
lang=EN-GB style='background:#BFBFBF'>&nbsp;</span></i></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><i><span
lang=EN-GB style='color:black;background:#BFBFBF'>A sticker will be added to
allow the patient to write the day of first use.</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt;
background:#CCCCCC'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB><img border=0 width=203
height=170
src="file:///c:/Users/makum/Desktop/Learning/p-ie/EMA%20EPI%20PoC/function_code/work/H/CAP/gonal-f/en/2021-06-04T08-55-59Z/gonal-f_clean_files/image001.png"></span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black;background:#CCCCCC'><br clear=all style='page-break-before:always'>
</span>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB style='font-size:11.0pt;
text-transform:uppercase'>minimum particulars to appear on small immediate
packaging units<br>
<br>
</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>GONAL-f 300&nbsp;IU/0.5&nbsp;ML PEN, PEN LABEL</span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>1.       name of the medicinal product and
route(s) of administration</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>GONAL-f
300&nbsp;IU/0.5&nbsp;mL solution for injection in pre-filled pen</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><span lang=EN-GB>follitropin alfa</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Subcutaneous use</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>2.       METHOD OF ADMINISTRATION</span></p>

</div>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>3.       EXPIRY DATE</span></p>

</div>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>EXP</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Shelf-life after first use: 28&nbsp;days</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>4.       BATCH NUMBER</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>Batch</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>5.       CONTENTS BY WEIGHT, BY VOLUME OR BY
UNIT</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB style='color:black;background:#BFBFBF'>300&nbsp;IU/0.5&nbsp;mL</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>6.       other</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal;border:none;
padding:0in'><b><span lang=EN-GB>PARTICULARS TO APPEAR ON THE OUTER PACKAGING</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB style='font-size:11.0pt;
text-transform:uppercase'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt;text-transform:uppercase'>Gonal-</span></b><b><span
lang=EN-GB style='font-size:11.0pt'>f<span style='text-transform:uppercase'>
450&nbsp;IU/0.75&nbsp;ML, BOX OF 1 pre-filled PEN</span></span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>1.       name of the medicinal product</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>GONAL-f
450&nbsp;IU/0.75&nbsp;mL solution for injection in pre-filled pen</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>follitropin alfa</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>2.       statement of active substance(s)</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>Each pre-filled multidose pen delivers 450&nbsp;IU follitropin alfa,
equivalent to 33&nbsp;micrograms, per 0.75&nbsp;mL.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>Follitropin alfa, 600&nbsp;IU/mL (equivalent to 44&nbsp;micrograms/mL).</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>3.       list of excipients</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><b><span
lang=EN-GB style='text-transform:uppercase'>&nbsp;</span></b></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Excipients: Poloxamer&nbsp;188, sucrose, methionine, sodium
dihydrogen phosphate monohydrate, disodium phosphate dihydrate, m-cresol,
concentrated phosphoric acid, sodium hydroxide and water for injections.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>4.       pharmaceutical form and contents</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>Solution for injection in a pre-filled pen.</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>1&nbsp;multidose pre-filled pen</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>12&nbsp;injection needles </span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>5.       method and route(s) of administration</span></p>

</div>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Read the package leaflet before use.</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Subcutaneous use.</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='margin-left:28.35pt;text-indent:-28.35pt;page-break-after:
avoid'><span lang=EN-GB>6.       special warning that the medicinal product
must be stored out of the Sight and reach of children</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>Keep out of the sight and reach of children.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='page-break-after:avoid'><span lang=EN-GB>7.       other
special warning(S), IF NECESSARY</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal;page-break-after:
avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='page-break-after:avoid'><span lang=EN-GB>8.       expiry
date</span></p>

</div>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>EXP</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='page-break-after:avoid'><span lang=EN-GB>9.       special
storage conditions</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal;page-break-after:
avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormalIndent style='margin:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Store in a refrigerator. Do
not freeze.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>Store in the original package in order to protect from light.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Within its shelf-life, the
medicine may be stored at or below 25°C for up to 3 months without being
refrigerated and must be discarded afterwards.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Once opened, the medicine may
be stored for a maximum of 28 days at or below 25°C.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='margin-left:28.35pt;text-indent:-28.35pt;page-break-after:
avoid'><span lang=EN-GB>10.     special precautions for disposal of unused
medicinal products or waste materials derived from such medicinal products, if
appropriate</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>Any unused medicine or waste material should be disposed in
accordance with local requirements.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>11.     name and address of the marketing
authorisation holder</span></p>

</div>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoListParagraph style='margin:0in;margin-bottom:.0001pt;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>Merck
Europe B.V.</span></p>

<p class=MsoListParagraph style='margin:0in;margin-bottom:.0001pt;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>Gustav
Mahlerplein&nbsp;102</span></p>

<p class=MsoListParagraph style='margin:0in;margin-bottom:.0001pt;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>1082
MA Amsterdam</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>The Netherlands</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>12.     MARKETING AUTHORISATION number(s)</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:92.15pt;margin-bottom:.0001pt;text-indent:-92.15pt;line-height:
normal'><span lang=EN-GB>EU/1/95/001/034     <span style='color:black;
background:#D9D9D9'>solution for injection in pre-filled pen<br>
12&nbsp;needles</span></span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>13.     batch number</span></p>

</div>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Batch</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>14.     general classification for supply</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>15.     instructions on use</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='page-break-after:avoid'><span lang=EN-GB>16.     Information
in braille</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>gonal-f 450&nbsp;iu/0.75&nbsp;ml</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='page-break-after:avoid'><span lang=EN-GB>17.     UNIQUE
IDENTIFIER  2D BARCODE</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt;color:black;background:#D9D9D9'>2D barcode carrying the
unique identifier included.</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='page-break-after:avoid'><span lang=EN-GB>18.     UNIQUE
IDENTIFIER - HUMAN READABLE DATA</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>PC </span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal;page-break-after:
avoid'><span lang=EN-GB style='font-size:11.0pt'>SN </span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt'>NN </span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black;background:#CCCCCC'><br clear=all style='page-break-before:always'>
</span>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 1.0pt 1.0pt 1.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt;text-transform:uppercase'>PARTICULARS TO APPEAR ON THE
PEN</span></b></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal;
page-break-after:avoid;border:none;padding:0in'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal;
page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>GONAL-f
450&nbsp;IU/0.75&nbsp;ML PEN, STICKER</span></b></p>

</div>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><i><span
lang=EN-GB style='color:black;background:#BFBFBF'>A sticker will be added to
allow the patient to write the day of first use.</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt;
background:#CCCCCC'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB><img border=0 width=203
height=170
src="file:///c:/Users/makum/Desktop/Learning/p-ie/EMA%20EPI%20PoC/function_code/work/H/CAP/gonal-f/en/2021-06-04T08-55-59Z/gonal-f_clean_files/image001.png"></span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black;background:#CCCCCC'><br clear=all style='page-break-before:always'>
</span>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB style='font-size:11.0pt;
text-transform:uppercase'>minimum particulars to appear on small immediate
packaging units<br>
<br>
</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>GONAL-f 450&nbsp;IU/0.75&nbsp;ML PEN, PEN LABEL</span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>1.       name of the medicinal product and
route(s) of administration</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><a name="_Hlk521334669"><span lang=EN-GB>GONAL-f
450&nbsp;IU/0.75&nbsp;mL solution for injection in pre-filled pen</span></a></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><span lang=EN-GB>follitropin alfa</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Subcutaneous use</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>2.       METHOD OF ADMINISTRATION</span></p>

</div>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>3.       EXPIRY DATE</span></p>

</div>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>EXP</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Shelf-life after first use: 28&nbsp;days</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>4.       BATCH NUMBER</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>Batch</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>5.       CONTENTS BY WEIGHT, BY VOLUME OR BY
UNIT</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB style='color:black;background:#BFBFBF'>450&nbsp;IU/0.75&nbsp;mL</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>6.       other</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB style='font-size:11.0pt;
text-transform:uppercase'>PARTICULARS TO APPEAR ON THE OUTER PACKAGING</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB style='font-size:11.0pt;
text-transform:uppercase'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>GONAL-f 900&nbsp;IU/1.5&nbsp;ML PEN<span
style='text-transform:uppercase'>, BOX OF 1 pre-filled PEN</span></span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>1.       name of the medicinal product</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>GONAL-f
900&nbsp;IU/1.5&nbsp;mL solution for injection in pre-filled pen</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>follitropin alfa</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>2.       statement of active substance(s)</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>Each pre-filled multidose pen delivers 900&nbsp;IU follitropin alfa,
equivalent to 66 micrograms, per 1.5&nbsp;mL.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>Follitropin alfa, 600&nbsp;IU/mL (equivalent to
44&nbsp;micrograms/mL).</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>3.       list of excipients</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><b><span
lang=EN-GB style='text-transform:uppercase'>&nbsp;</span></b></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Excipients: Poloxamer&nbsp;188, sucrose, methionine, sodium
dihydrogen phosphate monohydrate, disodium phosphate dihydrate, m-cresol,
concentrated phosphoric acid, sodium hydroxide and water for injections.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>4.       pharmaceutical form and contents</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>Solution for injection in a pre-filled pen.</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>1&nbsp;multidose pre-filled pen</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>20&nbsp;injection needles</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>5.       method and route(s) of administration</span></p>

</div>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Read the package leaflet before use.</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Subcutaneous use.</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>6.       special warning that the medicinal product must be stored
out of the Sight and reach of children</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>Keep out of the sight and reach of children.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='page-break-after:avoid'><span lang=EN-GB>7.       other
special warning(S), IF NECESSARY</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal;page-break-after:
avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='page-break-after:avoid'><span lang=EN-GB>8.       expiry
date</span></p>

</div>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>EXP</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='page-break-after:avoid'><span lang=EN-GB>9.       special
storage conditions</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal;page-break-after:
avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormalIndent style='margin:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Store in a refrigerator. Do
not freeze.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>Store in the original package in order to protect from light.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Within its shelf-life, the medicine
may be stored at or below 25°C for up to 3&nbsp;months without being
refrigerated and must be discarded afterwards.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Once opened, the medicine may
be stored for a maximum of 28&nbsp;days at or below 25°C.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>10.     special precautions for disposal of unused medicinal
products or waste materials derived from such medicinal products, if
appropriate</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>Any unused medicine or waste material should be disposed in
accordance with local requirements.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>11.     name and address of the marketing
authorisation holder</span></p>

</div>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoListParagraph style='margin:0in;margin-bottom:.0001pt;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>Merck
Europe B.V.</span></p>

<p class=MsoListParagraph style='margin:0in;margin-bottom:.0001pt;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>Gustav
Mahlerplein&nbsp;102</span></p>

<p class=MsoListParagraph style='margin:0in;margin-bottom:.0001pt;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>1082
MA Amsterdam</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>The Netherlands</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>12.     MARKETING AUTHORISATION number(s)</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-85.05pt;line-height:
normal'><span lang=EN-GB>EU/1/95/001/035   <span style='color:black;background:
#D9D9D9'>solution for injection in pre-filled pen<br>
20&nbsp;needles</span></span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>13.     batch number</span></p>

</div>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Batch</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>14.     general classification for supply</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>15.     instructions on use</span></p>

</div>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='page-break-after:avoid'><span lang=EN-GB>16.     information
in braille</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>gonal-f 900&nbsp;iu/1.5&nbsp;ml</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='page-break-after:avoid'><span lang=EN-GB>17.     UNIQUE
IDENTIFIER  2D BARCODE</span></p>

</div>

<p class=MsoNormal style='margin-top:0in;line-height:normal;page-break-after:
avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt;color:black;background:#D9D9D9'>2D barcode carrying the
unique identifier included.</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label style='page-break-after:avoid'><span lang=EN-GB>18.     UNIQUE
IDENTIFIER - HUMAN READABLE DATA</span></p>

</div>

<p class=MsoNormal style='margin-top:0in;line-height:normal;page-break-after:
avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal;page-break-after:
avoid'><span lang=EN-GB style='font-size:11.0pt'>PC </span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal;page-break-after:
avoid'><span lang=EN-GB style='font-size:11.0pt'>SN </span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt'>NN </span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black;background:#CCCCCC'><br clear=all style='page-break-before:always'>
</span>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt;text-transform:uppercase'>PARTICULARS TO APPEAR ON THE PEN</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt;text-transform:uppercase'>&nbsp;</span></b></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal;
page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>GONAL-f
900&nbsp;IU/1.5&nbsp;ML PEN, STICKER</span></b></p>

</div>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><i><span
lang=EN-GB style='color:black;background:#BFBFBF'>A sticker will be added to
allow the patient to write the day of first use.</span></i></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><i><span lang=EN-GB>&nbsp;</span></i></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB><img border=0 width=203 height=170
src="file:///c:/Users/makum/Desktop/Learning/p-ie/EMA%20EPI%20PoC/function_code/work/H/CAP/gonal-f/en/2021-06-04T08-55-59Z/gonal-f_clean_files/image001.png"></span></p>

<i><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span></i>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><i><span
lang=EN-GB>&nbsp;</span></i></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB style='font-size:11.0pt;
text-transform:uppercase'>minimum particulars to appear on small immediate
packaging units<br>
<br>
</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;border:none;padding:0in'><a name="_Hlk521334873"></a><a
name="_Hlk521334889"><b><span lang=EN-GB style='font-size:11.0pt'>GONAL-f 900&nbsp;IU/1.5&nbsp;ML
PEN, PEN LABEL</span></b></a></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>1.       name of the medicinal product and
route(s) of administration</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><span lang=EN-GB>GONAL-f 900&nbsp;IU/1.5&nbsp;mL
solution for injection in pre-filled pen</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><span lang=EN-GB>follitropin alfa</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Subcutaneous use</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>2.       METHOD OF ADMINISTRATION</span></p>

</div>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>3.       EXPIRY DATE</span></p>

</div>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>EXP</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Shelf-life after first use: 28&nbsp;days</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>4.       BATCH NUMBER</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>Batch</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>5.       CONTENTS BY WEIGHT, BY VOLUME OR BY
UNIT</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB style='color:black;background:#BFBFBF'>900&nbsp;IU/1.5&nbsp;mL</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=Label><span lang=EN-GB>6.       other</span></p>

</div>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<h1><span lang=EN-GB>B. PACKAGE LEAFLET</span></h1>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>Package leaflet: Information for the user</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=center style='margin-top:0in;text-align:center;
line-height:normal;background:#F3F3F3'><i><span lang=EN-GB style='font-size:
11.0pt;color:black'>&lt;GONAL-f</span></i><i><span lang=EN-GB style='font-size:
11.0pt;color:black'> 75 IU-pre-filled syringe&gt;</span></i></p>

<p class=MsoNormal align=center style='margin-top:0in;text-align:center;
line-height:normal;background:#F3F3F3'><b><span lang=EN-GB style='font-size:
11.0pt;color:black'>GONAL&#8209;f</span></b><span lang=EN-GB style='font-size:
11.0pt;color:black'> <b>75&nbsp;IU powder and solvent </b></span></p>

<p class=MsoNormal align=center style='margin-top:0in;text-align:center;
line-height:normal;background:#F3F3F3'><b><span lang=EN-GB style='font-size:
11.0pt;color:black'>for solution for injection</span></b></p>

<p class=MsoNormal align=center style='margin-top:0in;text-align:center;
line-height:normal;background:#F3F3F3'><span lang=EN-GB style='font-size:11.0pt;
color:black'>follitropin alfa</span></p>

<p class=MsoNormal align=center style='margin-top:0in;text-align:center;
line-height:normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-top:0in;text-align:center;
line-height:normal;background:#E6E6E6'><i><span lang=EN-GB style='font-size:
11.0pt;color:black'>&lt;GONAL-f 1050 IU&gt;</span></i></p>

<p class=MsoNormal align=center style='margin-top:0in;text-align:center;
line-height:normal;background:#E6E6E6'><b><span lang=EN-GB style='font-size:
11.0pt;color:black'>GONAL&#8209;f 1050&nbsp;IU/1.75&nbsp;mL powder and solvent </span></b></p>

<p class=MsoNormal align=center style='margin-top:0in;text-align:center;
line-height:normal;background:#E6E6E6'><b><span lang=EN-GB style='font-size:
11.0pt;color:black'>for solution for injection</span></b></p>

<p class=MsoNormal align=center style='margin-top:0in;text-align:center;
line-height:normal;background:#E6E6E6'><span lang=EN-GB style='font-size:11.0pt;
color:black'>follitropin alfa</span></p>

<p class=MsoNormal align=center style='margin-top:0in;text-align:center;
line-height:normal'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-top:0in;text-align:center;
line-height:normal;background:#CCCCCC'><i><span lang=EN-GB style='font-size:
11.0pt;color:black'>&lt;GONAL-f</span></i><i><span lang=EN-GB style='font-size:
11.0pt;color:black'> 450 IU &gt;</span></i></p>

<p class=MsoNormal align=center style='margin-top:0in;text-align:center;
line-height:normal;background:#CCCCCC'><b><span lang=EN-GB style='font-size:
11.0pt;color:black'>GONAL-f</span></b><span lang=EN-GB style='font-size:11.0pt;
color:black'> <b>450&nbsp;IU/0.75&nbsp;mL powder and solvent </b></span></p>

<p class=MsoNormal align=center style='margin-top:0in;text-align:center;
line-height:normal;background:#CCCCCC'><b><span lang=EN-GB style='font-size:
11.0pt;color:black'>for solution for injection</span></b></p>

<p class=MsoNormal align=center style='margin-top:0in;text-align:center;
line-height:normal;background:#CCCCCC'><span lang=EN-GB style='font-size:11.0pt;
color:black'>follitropin alfa</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><b><span
lang=EN-GB>Read all of this leaflet carefully before you start using this
medicine because it contains important information for you.</span></b></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Keep this leaflet. You may need to read it
again.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you have any further questions, ask your
doctor or pharmacist.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>This medicine has been prescribed for you only.
Do not pass it on to others. It may harm them, even if their signs of illness
are the same as yours.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you get any side effects, talk to your doctor
or pharmacist. This includes any possible side effects not listed in this
leaflet. See section&nbsp;4.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>What is in this leaflet</span></b></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>1.       What GONAL-f is and what it is used for</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>2.       What you need to know before you use GONAL-f</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>3.       How to use GONAL-f</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>4.       Possible side effects</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>5.       How to store GONAL-f</span></p>

<p class=Formatvorlage1 style='margin-left:28.35pt;text-indent:-28.35pt;
line-height:normal'><span lang=EN-GB style='font-family:"Times New Roman",serif'>6.       Contents
of the pack and other information </span></p>

<p class=Formatvorlage1 style='margin-left:28.35pt;text-indent:-28.35pt;
line-height:normal'><span lang=EN-GB style='font-family:"Times New Roman",serif'>          How
to prepare and use the GONAL-f powder and solvent</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>1.       What
GONAL-f is and what it is used for</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>What
GONAL-f is</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>GONAL&#8209;f contains a
medicine called follitropin alfa. Follitropin alfa is a type of Follicle
Stimulating Hormone (FSH) which belongs to the family of hormones called
gonadotropins. Gonadotropins are involved in reproduction and fertility.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>What
GONAL-f is used for</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>In
adult women, </span></b><span lang=EN-GB style='font-size:11.0pt'>GONAL-f is
used:</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>to help release an egg
from the ovary (ovulation) in women that cannot ovulate and that did not
respond to treatment with a medicine called clomiphene citrate.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>together with another
medicine called lutropin alfa (Luteinising Hormone or LH) to help release egg
from the ovary (ovulation) in women that are not ovulating because their body
is producing very little gonadotropins (FSH and LH).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>to help develop several
follicles (each containing an egg) in women undergoing assisted reproductive
technology procedures (procedures that may help you to become pregnant) such as
<i>in vitro</i> fertilisation, gamete intra-fallopian transfer or zygote
intra-fallopian transfer.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>In
adult men,</span></b><span lang=EN-GB style='font-size:11.0pt'> GONAL-f is
used:</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>together with another
medicine called human Chorionic Gonadotropin (hCG) to help produce sperm in
men that are infertile due to a low level of certain hormones.</span></p>

<p class=MsoBodyTextIndent align=left style='margin-left:28.35pt;text-align:
left;text-indent:-28.35pt;line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='margin-left:28.35pt;text-align:
left;text-indent:-28.35pt;line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>2.       What
you need to know before you use GONAL-f</span></b></p>

<p class=MsoNormalIndent style='margin:0in;margin-bottom:.0001pt;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoCommentText align=left style='margin-top:0in;text-align:left;
line-height:normal'><span lang=EN-GB style='font-size:11.0pt'>You and your
partners fertility should be evaluated before the treatment is started by a doctor
experienced in treating fertility disorders.</span></p>

<p class=MsoBodyText align=left style='margin-left:28.35pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>Do
not use GONAL-f</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>if you are allergic to
Follicle Stimulating Hormone or any of the other ingredients of this medicine
listed in section&nbsp;6.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>if you have a tumour in
your hypothalamus or pituitary gland (both are parts of the brain).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>if you are <b>a woman</b>:</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:56.7pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>with large ovaries or
sacs of fluids within the ovaries (ovarian cysts) of unknown origin.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:56.7pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>with unexplained
vaginal bleeding.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:56.7pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>with cancer in your
ovaries, womb or breasts.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:56.7pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>with a condition that
usually makes normal pregnancy impossible, such as ovarian failure (early
menopause), or malformed reproductive organs.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>if you are <b>a man</b>:</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:56.7pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>with damaged testicles
that cannot be healed.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Do not use GONAL-f if any of
the above applies to you. If you are not sure, talk to your doctor before using
this medicine.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>Warnings
and precautions</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'>Porphyria</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Tell your doctor before you
start treatment, if you or any member of your family have porphyria (an
inability to break down porphyrins that may be passed on from parents to
children).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>Tell
your doctor straight away if:</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>your skin becomes
fragile and easily blistered, especially skin that has been frequently in the
sun, and/or</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>you have stomach, arm
or leg pain.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>In case of the above events your doctor may recommend that you stop
treatment.</span></p>

<p class=MsoBodyText align=left style='margin-left:28.35pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=SV style='font-size:11.0pt'>Ovarian
Hyper-Stimulation Syndrome (OHSS)</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=SV style='font-size:11.0pt'><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>If you are a woman, this
medicine increases your risk of developing OHSS. This is when your follicles
develop too much and become large cysts. If you get lower abdominal pain, gain
any weight rapidly, feel sick or are vomiting or if you have difficulty in
breathing, talk to your doctor straight away who might ask you to stop using
this medicine (see section&nbsp;4).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>In case you are not
ovulating, and if the recommended dose and schedule of administration are
adhered to, the occurrence of OHSS is less likely. G<span style='text-transform:
uppercase'>onal</span>&#8209;f treatment seldom causes severe OHSS unless the
medicine that is used for final follicular maturation (containing human
Chorionic Gonadotropin, hCG) is administered. If you are developing OHSS your
doctor may not give you any hCG in this treatment cycle and you may be told not
to have sex or to use a barrier contraceptive method for at least four days.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'>Multiple
pregnancy</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;text-autospace:none'><span lang=EN-GB style='font-size:11.0pt'>When
using GONAL-f, you have a higher risk of being pregnant with more than one
child at the same time (multiple pregnancy, mostly twins), than if you
conceived naturally. Multiple pregnancy may lead to medical complications for
you and your babies. You can reduce the risk of multiple pregnancy by using the
right dose of GONAL-f at the right times. When undergoing assisted reproductive
technology, the risk of having a multiple pregnancy is related to your age, the
quality and the number of fertilised eggs or embryos placed inside you.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'>Miscarriage</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>When undergoing assisted
reproductive technology or stimulation of your ovaries to produce eggs, you are
more likely to have a miscarriage than the average woman.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'>Blood
clotting problems (thromboembolic events)</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>If you had in the past or
recently blood clots in the leg or in the lung, or a heart attack or stroke, or
if those happened in your family, then you might have a higher risk that these
problems occur or become worse with GONAL-f treatment.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'>Men
with too much FSH in their blood</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>If you are a man, having too
much FSH in your blood can be a sign of damaged testicles. GONAL&#8209;f
usually does not work if you have this problem.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>If your doctor decides to try
GONAL&#8209;f treatment, to monitor the treatment, they may ask you to provide
semen for analysis 4&nbsp;to 6&nbsp;months after starting treatment.</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'>Children</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>GONAL-f is not indicated for
use in children.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>Other medicines and GONAL-f</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><span lang=EN-GB>Tell your doctor if you are taking,
have recently taken or might take any other medicines.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>If you use GONAL-f with
other medicines which help ovulation (such as hCG or clomiphene citrate), this
may increase the response of your follicles.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>If you use GONAL-f at
the same time as a gonadotropin-releasing hormone (GnRH) agonist or
antagonist (these medicines reduce your sex hormone levels and stop you
ovulating) you may need a higher dose of GONAL&#8209;f to produce follicles.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>Pregnancy
and breast-feeding</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Do not use GONAL-f if you are
pregnant or breast-feeding.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>Driving
and using machines</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>It is not expected that this
medicine will affect your ability to drive and use machines.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F3F3F3'><i><span lang=EN-GB style='font-size:11.0pt;
color:black'>&lt;GONAL-f</span></i><i><span lang=EN-GB style='font-size:11.0pt;
color:black'> 75 IU-pre-filled syringe&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F2F2F2'><b><span lang=EN-GB style='font-size:11.0pt;
color:black'>GONAL-f contains sodium</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F2F2F2'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F2F2F2'><span lang=EN-GB style='font-size:11.0pt;color:black'>This
medicine contains less than 1&nbsp;mmol sodium (23&nbsp;mg) per dose, that is
to say essentially sodium&#8209;free.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#D9D9D9'><i><span lang=EN-GB style='font-size:11.0pt;
color:black;background:#CCCCCC'>&lt;GONAL-f 1050 IU &gt; + </span></i><i><span
lang=EN-GB style='font-size:11.0pt;color:black;background:#BFBFBF'>&lt;GONAL-f</span></i><i><span
lang=EN-GB style='font-size:11.0pt;color:black;background:#BFBFBF'> 450 IU</span></i><i><span
lang=EN-GB style='font-size:11.0pt;color:black;background:#CCCCCC'>&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#D9D9D9'><b><span lang=EN-GB
style='font-size:11.0pt;color:black'>GONAL-f contains sodium and benzyl alcohol</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#D9D9D9'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#D9D9D9'><span lang=EN-GB
style='font-size:11.0pt;color:black'>This medicine contains less than
1&nbsp;mmol sodium (23&nbsp;mg) per dose, that is to say essentially sodium&#8209;free.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#D9D9D9'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#D9D9D9'><span lang=EN-GB
style='font-size:11.0pt;color:black'>When prepared with the solvent provided,
this medicine contains 1.23&nbsp;mg benzyl alcohol in each 75&nbsp;IU dose
which is equivalent to 9.45&nbsp;mg/mL. Benzyl alcohol may cause allergic
reactions.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>3.       How
to use GONAL-f</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Always use this medicine<b> </b>exactly
as your doctor has told you. Check with your doctor or pharmacist if you are
not sure.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>Using
this medicine</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>GONAL-f is intended to
be given by injection just under the skin (subcutaneously). <i><span
style='color:black;background:#CCCCCC'>Additionally, &lt;GONAL-f 1050 IU &gt; +
</span><span style='color:black;background:#BFBFBF'>&lt;GONAL-f</span></i></span><i><span
lang=EN-GB style='font-size:11.0pt;color:black;background:#BFBFBF'> 450 IU &gt;</span></i><i><span
lang=EN-GB style='font-size:11.0pt;color:black;background:#CCCCCC'> </span></i><span
lang=EN-GB style='font-size:11.0pt;color:black;background:#CCCCCC'>The prepared
solution can be used for several injections.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>The first injection of
GONAL-f should be given under supervision of your doctor.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Your doctor or nurse
will show you how to inject GONAL-f before you can inject yourself.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>If you administer
GONAL-f to yourself, please carefully read and follow the instructions at the
end of this leaflet called How to prepare and use the GONAL-f powder and
solution.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>How
much to use</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F3F3F3'><i><span lang=EN-GB style='font-size:11.0pt;
color:black'>&lt;GONAL-f</span></i><i><span lang=EN-GB style='font-size:11.0pt;
color:black'> 75 IU-pre-filled syringe&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F2F2F2'><span lang=EN-GB style='font-size:11.0pt;color:black'>Your
doctor will decide how much medicine you will take and how often. The doses
described below are stated in International Units (IU).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#D9D9D9'><i><span lang=EN-GB style='font-size:11.0pt;
color:black;background:#CCCCCC'>&lt;GONAL-f 1050 IU &gt; + </span></i><i><span
lang=EN-GB style='font-size:11.0pt;color:black;background:#BFBFBF'>&lt;GONAL-f</span></i><i><span
lang=EN-GB style='font-size:11.0pt;color:black;background:#BFBFBF'> 450 IU &gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#D9D9D9'><span lang=EN-GB style='font-size:11.0pt;color:black'>Your
doctor will decide how much medicine you will take and how often. The doses
described below are stated in International Units (IU), which reflects the
grading of the administration syringes provided in the pack.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#D9D9D9'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#D9D9D9'><span lang=EN-GB
style='font-size:11.0pt;color:black'>If you use another syringe, which shows
millilitres (mL) instead of IUs, you can take the correct amount for injection
in mL from the following table:</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#D9D9D9'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<div align=center>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr style='page-break-inside:avoid'>
  <td width=189 valign=top style='width:141.75pt;border:solid windowtext 1.0pt;
  padding:1.4pt 5.4pt 1.4pt 5.4pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
  text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:
  #D9D9D9'><span lang=EN-GB style='font-size:11.0pt;color:black'>Dose to be
  injected (IU)</span></p>
  </td>
  <td width=203 valign=top style='width:152.4pt;border:solid windowtext 1.0pt;
  border-left:none;padding:1.4pt 5.4pt 1.4pt 5.4pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
  text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:
  #D9D9D9'><span lang=EN-GB style='font-size:11.0pt;color:black'>Volume to be
  injected (mL)</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width=189 valign=top style='width:141.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:1.4pt 5.4pt 1.4pt 5.4pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
  text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:
  #D9D9D9'><span lang=EN-GB style='font-size:11.0pt;color:black'>75</span></p>
  </td>
  <td width=203 valign=top style='width:152.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:1.4pt 5.4pt 1.4pt 5.4pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
  text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:
  #D9D9D9'><span lang=EN-GB style='font-size:11.0pt;color:black'>0.13</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width=189 valign=top style='width:141.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:1.4pt 5.4pt 1.4pt 5.4pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
  text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:
  #D9D9D9'><span lang=EN-GB style='font-size:11.0pt;color:black'>150</span></p>
  </td>
  <td width=203 valign=top style='width:152.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:1.4pt 5.4pt 1.4pt 5.4pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
  text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:
  #D9D9D9'><span lang=EN-GB style='font-size:11.0pt;color:black'>0.25</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width=189 valign=top style='width:141.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:1.4pt 5.4pt 1.4pt 5.4pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
  text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:
  #D9D9D9'><span lang=EN-GB style='font-size:11.0pt;color:black'>225</span></p>
  </td>
  <td width=203 valign=top style='width:152.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:1.4pt 5.4pt 1.4pt 5.4pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
  text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:
  #D9D9D9'><span lang=EN-GB style='font-size:11.0pt;color:black'>0.38</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width=189 valign=top style='width:141.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:1.4pt 5.4pt 1.4pt 5.4pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
  text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:
  #D9D9D9'><span lang=EN-GB style='font-size:11.0pt;color:black'>300</span></p>
  </td>
  <td width=203 valign=top style='width:152.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:1.4pt 5.4pt 1.4pt 5.4pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
  text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:
  #D9D9D9'><span lang=EN-GB style='font-size:11.0pt;color:black'>0.50</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width=189 valign=top style='width:141.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:1.4pt 5.4pt 1.4pt 5.4pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
  text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:
  #D9D9D9'><span lang=EN-GB style='font-size:11.0pt;color:black'>375</span></p>
  </td>
  <td width=203 valign=top style='width:152.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:1.4pt 5.4pt 1.4pt 5.4pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
  text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:
  #D9D9D9'><span lang=EN-GB style='font-size:11.0pt;color:black'>0.63</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width=189 valign=top style='width:141.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:1.4pt 5.4pt 1.4pt 5.4pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
  text-indent:-28.35pt;line-height:normal;background:#D9D9D9'><span lang=EN-GB
  style='font-size:11.0pt;color:black'>450</span></p>
  </td>
  <td width=203 valign=top style='width:152.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:1.4pt 5.4pt 1.4pt 5.4pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
  text-indent:-28.35pt;line-height:normal;background:#D9D9D9'><span lang=EN-GB
  style='font-size:11.0pt;color:black'>0.75</span></p>
  </td>
 </tr>
</table>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>Women</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>If
you are not ovulating and have irregular or no periods.</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>GONAL-f is usually
given every day.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>If you have irregular
periods, start using GONAL-f within the first 7&nbsp;days of your menstrual
cycle. If you do not have periods you can start using the medicine on any
convenient day.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>The usual starting dose
of GONAL-f is 75 to 150&nbsp;IU each day.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Your dose of GONAL-f
may be increased every 7 or every 14&nbsp;days by 37.5 to 75&nbsp;IU, until you
get the desired response.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>The maximum daily dose of
GONAL-f is usually not higher than 225&nbsp;IU.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>When you get the
desired response, you will be given a single injection of 250&nbsp;micrograms
of recombinant hCG (r-hCG, an hCG made in a laboratory by a special DNA
technique), or 5,000 to 10,000&nbsp;IU of hCG, 24 to 48&nbsp;hours after your
last GONAL&#8209;f injection. The best time</span><span lang=EN-GB
style='font-size:11.0pt'> to have sex is on the day of the hCG injection and
the day after.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>If your doctor cannot see a
desired response after 4&nbsp;weeks, that treatment cycle with GONAL-f should
be stopped. For the following treatment cycle, your doctor will give you a
higher starting dose of GONAL-f than before.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>If your body responds too
strongly, your treatment will be stopped and you will not be given any hCG (see
section&nbsp;2, OHSS). For the following cycle, your doctor will give you a
lower dose of GONAL&#8209;f than before.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>If
you are not ovulating, having no periods and have been diagnosed with very low
levels of FSH and LH hormones</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>The usual starting dose
of GONAL-f is 75 to 150&nbsp;IU together with 75&nbsp;IU of lutropin alfa.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>You will use these two
medicines each day for up to five weeks.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Your dose of GONAL-f
may be increased every 7 or every 14&nbsp;days by 37.5 to 75&nbsp;IU, until you
get the desired response.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>When you get the
desired response, you will be given a single injection of 250&nbsp;micrograms
of recombinant hCG (r-hCG, an hCG made in a laboratory by a special DNA
technique), or 5,000 to 10,000&nbsp;IU of hCG, 24 to 48&nbsp;hours after your
last injections of GONAL-f and lutropin alfa. The best time to have sex is on
the day of the hCG injection and the day after. Alternatively, intrauterine
insemination may be performed by placing the sperm into the womb cavity.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>If your doctor cannot see a
response after 5&nbsp;weeks, that treatment cycle with GONAL-f should be
stopped. For the following cycle, your doctor will give you a higher starting
dose of GONAL&#8209;f than before.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>If your body responds too
strongly, your treatment with GONAL-f will be stopped and you will not be given
any hCG (see section&nbsp;2, OHSS). For the following cycle, your doctor will give
you a lower dose of GONAL-f than before.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>If
you need to develop several eggs for collection prior to any assisted
reproductive technology</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>The usual starting dose
of GONAL&#8209;f is 150 to 225&nbsp;IU each day, from day&nbsp;2 or 3 of your
treatment cycle. </span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>GONAL-f dose may be
increased, depending on your response. The maximum daily dose is 450&nbsp;IU.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Treatment is continued
until your eggs have developed to a desired point. This usually takes about
10&nbsp;days but can take any time between 5 and 20&nbsp;days. Your doctor will
use blood tests and/or an ultrasound machine to check when this is.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>When your eggs are
ready, you will be given a single injection of 250&nbsp;micrograms recombinant
hCG (r-hCG, an hCG made in a laboratory by a special recombinant DNA
technique), or 5,000&nbsp;IU to 10,000&nbsp;IU of hCG, 24 to 48&nbsp;hours
after the last GONAL&#8209;f injection. This gets your eggs ready for
collection.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>In other cases, your doctor
may first stop you from ovulating by using a gonadotropin-releasing hormone
(GnRH) agonist or antagonist. Then GONAL-f is started approximately two weeks
after start of agonist treatment. The GONAL-f and GnRH agonist are then both
given until your follicles develop as desired. For example, after two weeks of
GnRH agonist treatment, 150 to 225&nbsp;IU GONAL&#8209;f is administered for
7&nbsp;days. The dose is then adjusted according to your ovarian response. </span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>Men</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>The usual dose of
GONAL-f is 150&nbsp;IU together with hCG.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>You will use these two
medicines three times a week for at least 4&nbsp;months.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>If you have not
responded to treatment after 4&nbsp;months, your doctor may suggest that you
continue using these two medicines for at least 18&nbsp;months.</span></p>

<p class=Formatvorlage1 style='margin-left:28.35pt;text-indent:-28.35pt;
line-height:normal'><span lang=EN-GB style='font-family:"Times New Roman",serif'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>If
you use more GONAL-f than you should</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>The effects of taking too
much GONAL-f are unknown. Nevertheless, one could expect Ovarian Hyper-Stimulation
Syndrome (OHSS) to occur, which is described in section&nbsp;4. However, the
OHSS will only occur if hCG is also administered (see section&nbsp;2, OHSS).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal;page-break-after:
avoid'><b><span lang=EN-GB>If you forget to use GONAL-f</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>If you forget to use GONAL-f,
do not take a double dose to make up for a forgotten dose. Please talk to your
doctor as soon as you notice that you forgot a dose.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>If you have any further
questions on the use of this medicine, ask your doctor or pharmacist.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>4.       Possible
side effects</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText align=left style='margin-left:28.35pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB>Like all medicines, this
medicine can cause side effects, although not everybody gets them.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>Serious
side effects in women</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Lower abdominal pain
together with nausea or vomiting may be the symptoms of Ovarian
Hyper-Stimulation Syndrome (OHSS). This may indicate that the ovaries
over-reacted to the treatment and that large ovarian cysts developed (see also
in section&nbsp;2. under Ovarian Hyper-Stimulation Syndrome). This side
effect is common (may affect up to 1 in 10&nbsp;people).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>The OHSS may become
severe with clearly enlarged ovaries, decreased urine production, weight gain,
difficulty in breathing and/or possible fluid accumulation in your stomach or
chest. This side effect is uncommon (may affect up to 1 in 100&nbsp;people).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Complications of OHSS
such as twisting of ovaries or blood clotting may occur rarely (may affect up
to 1 in 1,000&nbsp;people).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Serious blood clotting
complications (thromboembolic events) sometimes independent of OHSS may be
found very rarely (may affect up to 1 in 10,000&nbsp;people). This could cause
chest pain, breathlessness, stroke or heart attack (see also in section&nbsp;2.
under Blood clotting problems).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>Serious
side effects in men and women</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Allergic reactions such
as rash, red skin, hives, swelling of your face with difficulty breathing can
sometimes be serious. This side effect is very rare (may affect up to 1 in
10,000&nbsp;people).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>If you notice any of the
above-listed side effects, you should immediately contact your doctor who might
ask you to stop using GONAL-f.</span></b></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>Other
side effects in women</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'>Very
common (</span></u><span lang=EN-GB style='font-size:11.0pt'>may affect more
than 1 in 10&nbsp;people):</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Sacs of fluid within
the ovaries (ovarian cysts)</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Headache</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Local reactions at the
injection site, such as pain, redness, bruising, swelling and/or irritation</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'>Common
</span></u><span lang=EN-GB style='font-size:11.0pt'>(may affect up to 1 in
10&nbsp;people):</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal align=left style='margin:0in;margin-bottom:.0001pt;
text-align:left;text-indent:0in;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Abdominal pain</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Feeling sick, vomiting,
diarrhoea, abdominal cramps and bloating</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><u><span lang=EN-GB style='font-size:
11.0pt'><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'>Very
rare </span></u><span lang=EN-GB style='font-size:11.0pt'>(may affect up to 1
in 10,000&nbsp;people):</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Allergic reactions such
as rash, red skin, hives, swelling of your face with difficulty breathing may
occur. These reactions can sometimes be serious.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Your asthma may get
worse.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>Other side effects in men</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB style='font-size:11.0pt'>Very common</span></u><span lang=EN-GB
style='font-size:11.0pt'> (may affect more than 1 in 10 people):</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Local reactions at the
injection site, such as pain, redness, bruising, swelling and/or irritation</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><u><span lang=EN-GB style='font-size:
11.0pt'><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB style='font-size:11.0pt'>Common</span></u><span lang=EN-GB
style='font-size:11.0pt'> (may affect up to 1 in 10&nbsp;people):</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Swelling of the veins
above and behind the testicles (varicocele)</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Breast development,
acne or weight gain</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><u><span lang=EN-GB style='font-size:
11.0pt'><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB style='font-size:11.0pt'>Very rare</span></u><span lang=EN-GB
style='font-size:11.0pt'> (may affect up to 1 in 10,000&nbsp;people):</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Allergic reactions such
as rash, red skin, hives, swelling of your face with difficulty in breathing
may occur. These reactions can sometimes be serious.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Your asthma may get
worse.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal;page-break-after:
avoid'><b><span lang=EN-GB style='font-size:11.0pt'>Reporting of side effects</span></b></p>

<p class=BodytextAgency style='margin-bottom:0in;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>If you
get any side effects, talk to your doctor or pharmacist. This includes any
possible side effects not listed in this leaflet. You can also report side
effects directly via <span style='color:black;background:#D9D9D9'>the national
reporting system listed in </span></span><span lang=EN-GB><a
href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc"><span
style='font-size:11.0pt;font-family:"Times New Roman",serif;background:#D9D9D9'>Appendix&nbsp;V</span></a></span><span
lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>. By
reporting side effects you can help provide more information on the safety of
this medicine.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>5.       How
to store GONAL-f</span></b></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#F3F3F3'><i><span lang=EN-GB
style='font-size:11.0pt;color:black'>&lt;GONAL-f</span></i><i><span lang=EN-GB
style='font-size:11.0pt;color:black'> 75 IU - pre-filled syringe&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F3F3F3'><span lang=EN-GB style='font-size:11.0pt;color:black'>Keep
this medicine out of the sight and reach of children.</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal;
background:#F3F3F3'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F3F3F3'><span lang=EN-GB style='font-size:11.0pt;color:black'>Do
not use this medicine after the expiry date which is stated on the vial after
EXP. The expiry date refers to the last day of that month.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F3F3F3'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F3F3F3'><span lang=EN-GB style='font-size:11.0pt;color:black'>Do
not store above 25°C.</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal;
background:#F3F3F3'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F3F3F3'><span lang=EN-GB style='font-size:11.0pt;color:black'>Store
in the original package, in order to protect from light.</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal;
background:#F3F3F3'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal;
background:#F3F3F3'><span lang=EN-GB style='color:black'>Do not use GONAL-f if
you notice any visible signs of deterioration, if the liquid contains particles
or is not clear.</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal;
background:#F3F3F3'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F3F3F3'><span lang=EN-GB style='font-size:11.0pt;color:black'>The
medicine must be administered immediately after preparation.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F3F3F3'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F3F3F3'><span lang=EN-GB style='font-size:11.0pt;color:black'>Do
not throw away any medicines via wastewater. Ask your pharmacist how to throw
away medicines you no longer use. These measures will help to protect the
environment.</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal;
page-break-after:avoid;background:#D9D9D9'><i><span lang=EN-GB
style='color:black'>&lt;GONAL-f 1050 IU &gt;<span style='background:#CCCCCC'> +
</span><span style='background:#BFBFBF'>&lt;GONAL-f</span></span></i><i><span
lang=EN-GB style='color:black;background:#BFBFBF'> 450 IU &gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#D9D9D9'><span lang=EN-GB style='font-size:11.0pt;color:black'>Keep
this medicine out of the sight and reach of children.</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal;
background:#D9D9D9'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#D9D9D9'><span lang=EN-GB style='font-size:11.0pt;color:black'>Do
not use this medicine after the expiry date which is stated on the vial label
or carton after EXP. The expiry date refers to the last day of that month.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#D9D9D9'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#D9D9D9'><span lang=EN-GB style='font-size:11.0pt;color:black'>Prior
to reconstitution, do not store above 25°C.</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal;
background:#D9D9D9'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#D9D9D9'><span lang=EN-GB style='font-size:11.0pt;color:black'>Store
in the original package, in order to protect from light.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#D9D9D9'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#D9D9D9'><span lang=EN-GB style='font-size:11.0pt;color:black'>Do
not use GONAL-f if you notice any visible signs of deterioration, if the liquid
contains particles or is not clear.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;background:#D9D9D9'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#D9D9D9'><span
lang=EN-GB style='font-size:11.0pt;color:black'>Once the solution has been
prepared, it may be stored for a maximum of 28&nbsp;days.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#D9D9D9'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>Please
write on the GONAL-f vial the day you prepared the solution.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#D9D9D9'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>Do not
store above 25°C. Do not freeze.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#D9D9D9'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>Store in
the original container, in order to protect from light.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#D9D9D9'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>Do not use
any GONAL-f solution left in the vial after 28&nbsp;days.</span></p>

<p class=MsoBodyText align=left style='margin-left:28.35pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#D9D9D9'><span lang=EN-GB
style='color:black'>At the end of the treatment any unused solution must be
discarded.</span></p>

<p class=MsoBodyText align=left style='margin-left:28.35pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#D9D9D9'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal;
background:#D9D9D9'><span lang=EN-GB style='color:black'>Do not throw away any
medicines via wastewater. Ask your pharmacist how to throw away medicines you
no longer use. These measures will help to protect the environment.</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#F3F3F3'><i><span lang=EN-GB
style='font-size:11.0pt;color:black'>Additional in &lt;GONAL-f</span></i><i><span
lang=EN-GB style='font-size:11.0pt;color:black'> 75 IU- pre-filled syringe&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F3F3F3'><span lang=EN-GB style='font-size:11.0pt;color:black'>GONAL-f
should not be administered as a mixture with other medicines in the same
injection, except for lutropin alfa. Studies have shown that these two
medicines can be mixed and injected together, without either product being
adversely affected.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#E6E6E6'><i><span lang=EN-GB
style='font-size:11.0pt;color:black'>Additional in &lt;GONAL-f 1050 IU&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#E6E6E6'><span lang=EN-GB style='font-size:11.0pt;color:black'>GONAL-f
1050&nbsp;IU/1.75&nbsp;mL powder should not be mixed with other medicines in
the same injection.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#E6E6E6'><span lang=EN-GB style='font-size:11.0pt;color:black'>GONAL-f
1050&nbsp;IU/1.75&nbsp;mL powder is not to be mixed with other GONAL-f
containers within the same vial or syringe.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#CCCCCC'><i><span lang=EN-GB
style='font-size:11.0pt;color:black'>Additional in &lt;GONAL-f</span></i><i><span
lang=EN-GB style='font-size:11.0pt;color:black'> 450 IU&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#CCCCCC'><span lang=EN-GB
style='font-size:11.0pt;color:black'>GONAL-f 450&nbsp;IU/0.75&nbsp;mL powder
should not be mixed with other medicines in the same injection.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#CCCCCC'><span lang=EN-GB
style='font-size:11.0pt;color:black'>GONAL-f 450&nbsp;IU/0.75&nbsp;mL powder is
not to be mixed with other GONAL-f containers within the same vial or syringe.</span></p>

<p class=MsoBodyText align=left style='margin-left:28.35pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='margin-left:28.35pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='margin-left:28.35pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>6.       Contents of the pack and other information</span></b></p>

<p class=MsoBodyText align=left style='margin-left:28.35pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>What GONAL-f contains</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The active substance is follitropin alfa.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#F3F3F3'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f</span></i><i><span
lang=EN-GB style='font-size:11.0pt;color:black'> 75 IU pre-filled syringe&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>Each vial
contains 5.5&nbsp;micrograms of follitropin alfa.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>After
preparation of the final solution for injection, there are 75&nbsp;IU
(5.5&nbsp;micrograms) of follitropin alfa in each millilitre of solution.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>The other
ingredients are sucrose, sodium dihydrogen phosphate monohydrate, disodium
phosphate dihydrate, methionine, polysorbate&nbsp;20, concentrated phosphoric
acid and sodium hydroxide.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;background:#F3F3F3'><span lang=EN-GB style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='color:black'>The solvent is water for
injections.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText align=left style='margin-left:28.35pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E6E6E6'><i><span
lang=EN-GB style='color:black'>&lt;GONAL-f 1050 IU&gt; </span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>Each vial
contains 1,200&nbsp;IU of follitropin alfa.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>After
reconstitution, there are 1,050&nbsp;IU (77&nbsp;micrograms) of follitropin
alfa in 1.75&nbsp;mL solution, that means there are 600&nbsp;IU
(44&nbsp;micrograms) in each millilitre of solution.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>The other
ingredients are sucrose, sodium dihydrogen phosphate monohydrate, disodium
phosphate dihydrate, concentrated phosphoric acid and sodium hydroxide.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>The solvent
contains water for injections and benzyl alcohol.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText align=left style='margin-left:28.35pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#BFBFBF'><i><span
lang=EN-GB style='color:black'>&lt;GONAL-f</span></i><i><span lang=EN-GB
style='color:black'> 450 IU&gt; </span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#BFBFBF'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>Each vial
contains 600&nbsp;IU of follitropin alfa.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#BFBFBF'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>After
reconstitution, there are 450&nbsp;IU (33&nbsp;micrograms) of follitropin alfa
in 0.75&nbsp;mL solution, that means there are 600&nbsp;IU (44&nbsp;micrograms)
in each millilitre of solution.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#BFBFBF'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>The other
ingredients are sucrose, sodium dihydrogen phosphate monohydrate, disodium
phosphate dihydrate, concentrated phosphoric acid and sodium hydroxide.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#BFBFBF'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>The solvent
contains water for injections and benzyl alcohol.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>What GONAL-f looks like and contents of the
pack</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#F3F3F3'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f</span></i><i><span
lang=EN-GB style='font-size:11.0pt;color:black'> 75 IU -pre-filled syringe&gt; </span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>GONAL-f is
presented as a powder and solvent for solution which are used to prepare a
solution for injection.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>The powder
is a white pellet in a glass vial.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>The solvent
is a clear colourless liquid in a pre-filled syringe, each containing 1&nbsp;mL.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>GONAL-f is
supplied in packs of 1, 5, 10&nbsp;vials of powder with the corresponding
number of solvent in pre&#8209;filled syringes. Not all pack sizes may be
marketed.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='margin-left:28.35pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E6E6E6'><i><span
lang=EN-GB style='color:black'>&lt;GONAL-f 1050 IU&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>GONAL-f is
presented as a powder and solvent which are used to prepare a solution for
injection.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>The powder
is a white pellet in a multidose glass vial.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>The solvent
is a clear colourless liquid in a pre-filled syringe, each containing 2&nbsp;mL.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>GONAL-f is
supplied in packs of 1&nbsp;vial of powder with 1&nbsp;pre&#8209;filled syringe
of solvent and 15&nbsp;disposable syringes for administration graduated in International
Units (IU FSH).</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='margin-left:28.35pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#BFBFBF'><i><span
lang=EN-GB style='color:black'>&lt;GONAL-f</span></i><i><span lang=EN-GB
style='color:black'> 450 IU&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#BFBFBF'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>GONAL-f is
presented as a powder and solvent which are used to prepare a solution for
injection.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#BFBFBF'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>The powder
is a white pellet in a multidose glass vial.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#BFBFBF'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>The solvent
is a clear colourless liquid in a pre-filled syringe, each containing 1&nbsp;mL.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#BFBFBF'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>GONAL-f is
supplied in packs of 1&nbsp;vial of powder with 1&nbsp;pre&#8209;filled syringe
of solvent and 6&nbsp;disposable syringes for administration graduated in
International Units (IU FSH).</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>Marketing Authorisation Holder</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><u><span
lang=EN-GB style='font-size:11.0pt'><span style='text-decoration:none'>&nbsp;</span></span></u></b></p>

<p class=MsoListParagraph style='margin:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Merck Europe&nbsp;B.V.,
Gustav Mahlerplein&nbsp;102, 1082&nbsp;MA Amsterdam, The Netherlands</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>Manufacturer</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=IT>Merck Serono&nbsp;S.p.A., Via delle Magnolie&nbsp;15, 70026&nbsp;Modugno
(Bari), Italy</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=IT>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>This
leaflet was last revised in </span></b><span lang=EN-GB style='font-size:11.0pt'>{<b>MM/YYYY</b>}<b>.</b></span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Detailed information on this
medicine is available on the European Medicines Agency web site: </span><span
lang=EN-GB><span class=MsoHyperlink><span style='font-size:11.0pt'>http://www.ema.europa.eu</span></span></span><span
class=MsoHyperlink><span lang=EN-GB style='font-size:11.0pt'>.</span></span></p>

<i><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'><br clear=all style='page-break-before:always'>
</span></i>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#F3F3F3'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#F3F3F3'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f</span></i><i><span
lang=EN-GB style='font-size:11.0pt;color:black'> 75 IU (5.5
micrograms)-pre-filled syringe&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#F3F3F3'><i><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></i></p>

<p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#F3F3F3'><b><span
lang=EN-GB style='font-size:11.0pt;color:black'>HOW TO PREPARE AND USE THE
GONAL-f POWDER AND SOLVENT</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#F3F3F3'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>This section
tells you how to prepare and use your GONAL-f powder and solvent.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>Before
starting the preparation, please read these instructions the whole way through
first.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>Give
yourself the injection at the same time each day.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#F3F3F3'><b><span
lang=EN-GB style='font-size:11.0pt;color:black'>1.       Wash your hands and
find a clean area</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#F3F3F3'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>It is
important that your hands and the items you use be as clean as possible.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>A good
place is a clean table or kitchen surface.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><i><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><i><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#F3F3F3'><b><span
lang=EN-GB style='font-size:11.0pt;color:black'>2.       Get together
everything you need and lay them out:</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#F3F3F3'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>1&nbsp;pre-filled
syringe containing the solvent (the clear liquid)</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>1&nbsp;vial
containing GONAL-f (the white powder) </span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>1&nbsp;needle
for preparation </span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>1&nbsp;fine
bore needle for injection under the skin</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F3F3F3'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#F3F3F3'><span
lang=EN-GB style='font-size:11.0pt;color:black'>Not provided in the pack:</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>2&nbsp;alcohol
swabs</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>1&nbsp;sharps
container</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#F3F3F3'><b><span
lang=EN-GB style='font-size:11.0pt;color:black'>3.       Preparing the solution</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>Remove the
protective caps from the powder vial and from the pre-filled syringe.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>Attach the
needle for preparation to the pre-filled syringe, insert it into the powder
vial and slowly inject all the solvent. Swirl gently without removing the
syringe. Do not shake.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>Check that
the resulting solution is clear and does not contain any particles.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>Turn the
vial upside down and gently draw the solution back into the syringe by pulling
the plunger.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>Remove the
syringe from the vial and set it down carefully. Do not touch the needle and do
not allow the needle to touch any surface.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt;color:black'><img border=0 width=108 height=111
id="Bild 9"
src="file:///c:/Users/makum/Desktop/Learning/p-ie/EMA%20EPI%20PoC/function_code/work/H/CAP/gonal-f/en/2021-06-04T08-55-59Z/gonal-f_clean_files/image002.png"></span><span
lang=EN-GB style='font-size:11.0pt;color:black'> </span><span lang=EN-GB
style='font-size:11.0pt;color:black'><img border=0 width=108 height=111
id="Bild 10"
src="file:///c:/Users/makum/Desktop/Learning/p-ie/EMA%20EPI%20PoC/function_code/work/H/CAP/gonal-f/en/2021-06-04T08-55-59Z/gonal-f_clean_files/image003.png"></span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F3F3F3'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F3F3F3'><span lang=EN-GB style='font-size:11.0pt;color:black'>(If
you have been prescribed more than one vial of GONAL-f, slowly re&#8209;inject
the solution into another powder vial, until you have the prescribed number of
powder vials dissolved in the solution. If you have been prescribed lutropin
alfa in addition to GONAL-f, you may also mix the two medicines as an
alternative to injecting each product separately. After dissolving the lutropin
alfa powder, draw the solution back into the syringe and re-inject it into the
vial containing GONAL-f. Once the powder has dissolved, draw the solution back
into the syringe. Inspect for particles as before, and do not use if the
solution is not clear. Up to three containers of powder may be dissolved in
1&nbsp;mL of solvent.)</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#F3F3F3'><b><span
lang=EN-GB style='font-size:11.0pt;color:black'>4.       Getting ready the
syringe for injection</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>Change the
needle for the fine bore needle.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>Remove any
air bubbles: If you see air bubbles in the syringe, hold the syringe with the
needle pointing upwards and gently flick the syringe until all the air collects
at the top. Push the plunger until the air bubbles are gone.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt;color:black'><img border=0 width=120 height=124
id="Bild 11"
src="file:///c:/Users/makum/Desktop/Learning/p-ie/EMA%20EPI%20PoC/function_code/work/H/CAP/gonal-f/en/2021-06-04T08-55-59Z/gonal-f_clean_files/image004.png"></span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#F3F3F3'><b><span
lang=EN-GB style='font-size:11.0pt;color:black'>5.       Injecting the dose</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>Immediately
inject the solution: Your doctor or nurse will have already advised you where
to inject (e.g. tummy, front of thigh). To minimise skin irritation, select a
different injection site each day.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>Clean the
chosen skin area with an alcohol swab using a circular motion.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>Firmly
pinch the skin together and insert the needle at a 45° to 90° angle using a
dart-like motion.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>Inject
under the skin by pushing gently the plunger, as you were taught. Do not inject
directly into a vein. Take as much time as you need to inject all the solution.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>Immediately
withdraw the needle and clean the skin with an alcohol swab using a circular
motion. </span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt;color:black'><img border=0 width=184 height=129
id="Bild 12"
src="file:///c:/Users/makum/Desktop/Learning/p-ie/EMA%20EPI%20PoC/function_code/work/H/CAP/gonal-f/en/2021-06-04T08-55-59Z/gonal-f_clean_files/image005.png"></span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#F3F3F3'><b><span
lang=EN-GB style='font-size:11.0pt;color:black'>6.       After the injection</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#F3F3F3'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#F3F3F3'><span lang=EN-GB style='font-size:11.0pt;color:black'>Dispose
of all used items: Once you have finished your injection, immediately discard
all needles and empty glass containers safely preferably in the sharps container.
Any unused solution must be discarded.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<i><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'><br clear=all style='page-break-before:always'>
</span></i>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal;
page-break-after:avoid;background:#D9D9D9'><i><span lang=EN-GB
style='color:black'>&lt;GONAL-f 1050 IU &gt; +<span style='background:#CCCCCC'>
</span><span style='background:#BFBFBF'>&lt;GONAL-f</span></span></i><i><span
lang=EN-GB style='color:black;background:#BFBFBF'> 450 IU &gt;</span></i></p>

<p class=MsoBodyText align=left style='margin-left:28.35pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E6E6E6'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E6E6E6'><b><span
lang=EN-GB style='font-size:11.0pt;color:black'>HOW TO PREPARE AND USE THE
GONAL-f POWDER AND SOLVENT</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E6E6E6'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>This
section tells you how to prepare and use your GONAL-f powder and solvent.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>Before
starting the preparation, please read these instructions the whole way through
first.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>Give
yourself the injection at the same time each day.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#E6E6E6'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#E6E6E6'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E6E6E6'><b><span
lang=EN-GB style='font-size:11.0pt;color:black'>1.       Wash your hands and
find a clean area</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>It is
important that your hands and the items you use be as clean as possible.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>A good
place is a clean table or kitchen surface.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E6E6E6'><b><span
lang=EN-GB style='font-size:11.0pt;color:black'>2.       Get together
everything you need and lay them out:</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>2&nbsp;alcohol
swabs</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>The
pre-filled syringe containing the solvent (the clear liquid)</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>The vial
containing GONAL-f (the white powder)</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>An empty
syringe for injection (see illustration below) </span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt;color:black'><img border=0 width=321 height=134
id="Bild 13"
src="file:///c:/Users/makum/Desktop/Learning/p-ie/EMA%20EPI%20PoC/function_code/work/H/CAP/gonal-f/en/2021-06-04T08-55-59Z/gonal-f_clean_files/image006.png"></span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E6E6E6'><b><span
lang=EN-GB style='font-size:11.0pt;color:black'>3.</span></b><span lang=EN-GB
style='font-size:11.0pt;color:black'>       </span><b><span lang=EN-GB
style='font-size:11.0pt;color:black'>Preparing the solution</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E6E6E6'><b><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E6E6E6'><span
lang=EN-GB style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>Remove the
protective caps from the powder vial and from the pre-filled syringe.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>Take your
pre-filled syringe, insert the needle into the powder vial and slowly inject
all the solvent into the vial containing the powder.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>Remove the
syringe from the vial and throw it away (put the protective cap to avoid
injuries).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>This vial
contains several doses of GONAL-f. You will have to keep it several days and
only draw the prescribed dose every day. </span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt;color:black'><img border=0 width=115 height=117
id="Bild 14"
src="file:///c:/Users/makum/Desktop/Learning/p-ie/EMA%20EPI%20PoC/function_code/work/H/CAP/gonal-f/en/2021-06-04T08-55-59Z/gonal-f_clean_files/image007.png"></span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E6E6E6'><b><span
lang=EN-GB style='font-size:11.0pt;color:black'>4.       Getting ready the
syringe for injection </span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>Swirl
gently the vial of GONAL-f prepared in step&nbsp;3, do not shake. Check that
the solution is clear and does not contain any particles.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>Take the
syringe for injection and fill it with air by pulling the plunger to the
correct dose in International Units (IU FSH).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>Insert the
needle into the vial, turn the vial upside down and inject the air into the
vial.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>Draw the
prescribed dose of GONAL-f into the syringe for administration by pulling the
plunger until it reaches the correct dose in IU FSH.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><a
name="_Hlk480452169"><span lang=EN-GB style='font-size:11.0pt;color:black'><img
border=0 width=112 height=116 id="Bild 15"
src="file:///c:/Users/makum/Desktop/Learning/p-ie/EMA%20EPI%20PoC/function_code/work/H/CAP/gonal-f/en/2021-06-04T08-55-59Z/gonal-f_clean_files/image008.png"></span></a></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E6E6E6'><b><span
lang=EN-GB style='font-size:11.0pt;color:black'>5.       Removing air bubbles</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>If you see
air bubbles in the syringe, hold the syringe with the needle pointing upwards
and gently flick the syringe until all the air collects at the top. Push the
plunger until the air bubbles are gone.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt;color:black'><img border=0 width=120 height=124
id="Bild 16"
src="file:///c:/Users/makum/Desktop/Learning/p-ie/EMA%20EPI%20PoC/function_code/work/H/CAP/gonal-f/en/2021-06-04T08-55-59Z/gonal-f_clean_files/image009.png"></span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E6E6E6'><b><span
lang=EN-GB style='font-size:11.0pt;color:black'>6.       Injecting the dose</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>Immediately
inject the solution: Your doctor or nurse will have already advised you where
to inject (e.g. tummy, front of thigh). To minimise skin irritation, select a
different injection site each day.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>Clean the
chosen skin area with an alcohol swab using a circular motion.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>Firmly
pinch the skin together and insert the needle at a 45° to 90° angle using a
dart-like motion.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>Inject
under the skin by pushing gently the plunger, as you were taught. Do not inject
directly into a vein. Take as much time as you need to inject all the solution.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>Immediately
withdraw the needle and clean the skin with an alcohol swab using a circular
motion. </span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt;color:black'><img border=0 width=188 height=134
id="Bild 17"
src="file:///c:/Users/makum/Desktop/Learning/p-ie/EMA%20EPI%20PoC/function_code/work/H/CAP/gonal-f/en/2021-06-04T08-55-59Z/gonal-f_clean_files/image010.png"></span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E6E6E6'><b><span
lang=EN-GB style='font-size:11.0pt;color:black'>7.       After the injection</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E6E6E6'><b><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>Once you
have finished your injection, immediately discard the used syringes safely,
preferably in a sharps container.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>Store the
glass vial with the prepared solution in a safe place. You may need it again.
The prepared solution is for your use alone and must not be given to other
patients.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#E6E6E6'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>For further
injections with the prepared solution of GONAL-f, repeat steps&nbsp;4 to 7.</span></p>

<b><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span></b>

<p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>Package leaflet: Information for the user</span></b></p>

<p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=center style='margin-top:0in;text-align:center;
line-height:normal;background:#D5DCE4'><i><span lang=EN-GB style='font-size:
11.0pt;color:black'>&lt;GONAL-f <span style='background:yellow'>150</span> IU
PEN&gt;</span></i></p>

<p class=MsoNormal align=center style='margin-top:0in;text-align:center;
line-height:normal;background:#D5DCE4'><b><span lang=EN-GB style='font-size:
11.0pt;color:black'>GONAL-f <span style='background:yellow'>150&nbsp;IU/0.25</span>&nbsp;mL
solution for injection in pre-filled pen</span></b></p>

<p class=MsoNormal align=center style='margin-top:0in;text-align:center;
line-height:normal;background:#D5DCE4'><span lang=EN-GB style='font-size:11.0pt;
color:black'>follitropin alfa</span></p>

<p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
text-indent:-28.35pt;line-height:normal;background:#CCFFFF'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 300 IU PEN&gt;</span></i></p>

<p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
text-indent:-28.35pt;line-height:normal;background:#CCFFFF'><b><span
lang=EN-GB style='font-size:11.0pt;color:black'>GONAL-f 300&nbsp;IU/0.5&nbsp;mL
solution for injection in pre-filled pen</span></b></p>

<p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
text-indent:-28.35pt;line-height:normal;background:#CCFFFF'><span lang=EN-GB
style='font-size:11.0pt;color:black'>follitropin alfa</span></p>

<p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
text-indent:-28.35pt;line-height:normal;background:#CCECFF'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 450 IU PEN&gt;</span></i></p>

<p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
text-indent:-28.35pt;line-height:normal;background:#CCECFF'><b><span
lang=EN-GB style='font-size:11.0pt;color:black'>GONAL-f
450&nbsp;IU/0.75&nbsp;mL solution for injection in pre-filled pen</span></b></p>

<p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
text-indent:-28.35pt;line-height:normal;background:#CCECFF'><span lang=EN-GB
style='font-size:11.0pt;color:black'>follitropin alfa</span></p>

<p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
text-indent:-28.35pt;line-height:normal;background:#99CCFF'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 900 IU PEN&gt;</span></i></p>

<p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
text-indent:-28.35pt;line-height:normal;background:#99CCFF'><b><span
lang=EN-GB style='font-size:11.0pt;color:black'>GONAL-f 900&nbsp;IU/1.5&nbsp;mL
(solution for injection in pre-filled pen</span></b></p>

<p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
text-indent:-28.35pt;line-height:normal;background:#99CCFF'><span lang=EN-GB
style='font-size:11.0pt;color:black'>follitropin alfa</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><b><span
lang=EN-GB>Read all of this leaflet carefully before you start using this
medicine because it contains important information for you.</span></b></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Keep this leaflet. You may need to read it again.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you have any further questions, ask your
doctor or pharmacist.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>This medicine has been prescribed for you only.
Do not pass it on to others. It may harm them, even if their signs of illness
are the same as yours.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you get any side effects, talk to your doctor
or pharmacist. This includes any possible side effects not listed in this
leaflet. See section&nbsp;4.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>What is in this leaflet</span></b></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>1.       What GONAL-f is and what it is used for</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>2.       What you need to know before you use GONAL-f</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>3.       How to use GONAL-f</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>4.       Possible side effects</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>5.       How to store GONAL-f</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>6.       Contents of the pack and other information</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>          Instructions for use</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>1.       What GONAL-f is and
what it is used for</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>What
GONAL-f is</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>GONAL-f contains a medicine
called follitropin alfa. Follitropin alfa is a type of Follicle Stimulating
Hormone (FSH) which belongs to the family of hormones called gonadotropins.
Gonadotropins are involved in reproduction and fertility.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>What
GONAL-f is used for</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>In adult women, </span></b><span
lang=EN-GB style='font-size:11.0pt'>GONAL-f is used:</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>to help release an egg from
the ovary (ovulation) in women that cannot ovulate and that did not respond to
treatment with a medicine called clomiphene citrate.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>together with another
medicine called lutropin alfa (Luteinising Hormone or LH) to help release
egg from the ovary (ovulation) in women that are not ovulating because their
body is producing very little gonadotropins (FSH and LH).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>to help develop several
follicles (each containing an egg) in women undergoing assisted reproductive
technology procedures (procedures that may help you to become pregnant) such as
<i>in vitro</i> fertilisation, gamete intra-fallopian transfer or zygote
intra-fallopian transfer.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>In adult men,</span></b><span lang=EN-GB
style='font-size:11.0pt'> GONAL-f is used:</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>together with another
medicine called human Chorionic Gonadotropin (hCG) to help produce sperm in
men that are infertile due to a low level of certain hormones.</span></p>

<p class=MsoBodyTextIndent align=left style='margin-left:28.35pt;text-align:
left;text-indent:-28.35pt;line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='margin-left:28.35pt;text-align:
left;text-indent:-28.35pt;line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal;page-break-after:
avoid'><b><span lang=EN-GB>2.       What you need to know before you use GONAL-f</span></b></p>

<p class=MsoNormalIndent style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>You and your partners fertility should be evaluated before the
treatment is started by a doctor experienced in treating fertility disorders.</span></p>

<p class=MsoBodyText align=left style='margin-left:28.35pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>Do not use GONAL-f</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>if you are allergic to
Follicle Stimulating Hormone or any of the other ingredients of this medicine
listed in section&nbsp;6.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>if you have a tumour in
your hypothalamus or pituitary gland (both are parts of the brain).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>if you are <b>a woman</b>:</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:56.7pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>with large ovaries or
sacs of fluids within the ovaries (ovarian cysts) of unknown origin.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:56.7pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>with unexplained
vaginal bleeding.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:56.7pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>with cancer in your
ovaries, womb or breasts.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:56.7pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>with a condition that
usually makes normal pregnancy impossible, such as ovarian failure (early
menopause), or malformed reproductive organs.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>if you are <b>a man</b>:</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:56.7pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>with damaged testicles
that cannot be healed.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Do not use GONAL-f if any of
the above applies to you. If you are not sure, talk to your doctor before using
this medicine.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>Warnings and precautions</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB style='font-size:11.0pt'>Porphyria</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Tell your doctor before you
start treatment, if you or any member of your family have porphyria (an
inability to break down porphyrins that may be passed on from parents to children).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal;page-break-after:
avoid'><span lang=EN-GB>Tell your doctor straight away if:</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>your skin becomes
fragile and easily blistered, especially skin that has been frequently in the
sun, and/or</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>you have stomach, arm
or leg pain.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>In case of the above events your doctor may recommend that you stop
treatment.</span></p>

<p class=MsoBodyText align=left style='margin-left:28.35pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><u><span
lang=SV style='font-size:11.0pt'>Ovarian Hyper-Stimulation Syndrome (OHSS)</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><u><span
lang=SV style='font-size:11.0pt'><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>If you are a woman, this
medicine increases your risk of developing OHSS. This is when your follicles
develop too much and become large cysts. If you get lower abdominal pain, gain
any weight rapidly, feel sick or are vomiting or if you have difficulty in
breathing, talk to your doctor straight away who might ask you to stop using
this medicine (see section&nbsp;4).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>In case you are not
ovulating, and if the recommended dose and schedule of administration are
adhered to, the occurrence of OHSS is less likely. G<span style='text-transform:
uppercase'>onal</span>&#8209;f treatment seldom causes severe OHSS unless the
medicine that is used for final follicular maturation (containing human
Chorionic Gonadotropin, hCG) is administered. If you are developing OHSS your
doctor may not give you any hCG in this treatment cycle and you may be told not
to have sex or to use a barrier contraceptive method for at least four days.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'>Multiple
pregnancy</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;text-autospace:none'><span lang=EN-GB style='font-size:11.0pt'>When
using GONAL&#8209;f, you have a higher risk of being pregnant with more than
one child at the same time (multiple pregnancy, mostly twins), than if you
conceived naturally. Multiple pregnancy may lead to medical complications for
you and your babies. You can reduce the risk of multiple pregnancy by using the
right dose of GONAL&#8209;f at the right times. When undergoing assisted
reproductive technology, the risk of having a multiple pregnancy is related to your
age, the quality and the number of fertilised eggs or embryos placed inside
you.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'>Miscarriage</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>When undergoing assisted
reproductive technology or stimulation of your ovaries to produce eggs, you are
more likely to have a miscarriage than the average woman.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'>Blood
clotting problems (thromboembolic events)</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>If you had in the past or
recently blood clots in the leg or in the lung, or a heart attack or stroke, or
if those happened in your family, then you might have a higher risk that these
problems occur or become worse with GONAL&#8209;f treatment.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'>Men
with too much FSH in their blood</span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>If you are a man, having too
much FSH in your blood can be a sign of damaged testicles. GONAL&#8209;f
usually does not work if you have this problem.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>If your doctor decides to try
GONAL&#8209;f treatment, to monitor the treatment, they may ask you to provide
semen for analysis 4&nbsp;to 6&nbsp;months after starting treatment.</span></p>

<p class=MsoBodyText align=left style='margin-left:28.35pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB>Children</span></u></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoBodyText align=left style='margin-left:28.35pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB>GONAL&#8209;f is not
indicated for use in children.</span></p>

<p class=MsoBodyText align=left style='margin-left:28.35pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>Other
medicines and GONAL-f</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><span lang=EN-GB>Tell your doctor if you are taking,
have recently taken or might take any other medicines.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>If you use GONAL-f with
other medicines which help ovulation (such as hCG or clomiphene citrate), this
may increase the response of your follicles.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>If you use GONAL-f at
the same time as a gonadotropin-releasing hormone (GnRH) agonist or
antagonist (these medicines reduce your sex hormone levels and stop you
ovulating) you may need a higher dose of GONAL&#8209;f to produce follicles.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>Pregnancy
and breast-feeding</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Do not use GONAL-f if you are
pregnant or breast-feeding.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>Driving
and using machines</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>It is not expected that this medicine will affect your ability to drive
and use machines.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>GONAL-f
contains sodium</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>This medicine contains less
than 1&nbsp;mmol sodium (23&nbsp;mg) per dose, that is to say essentially
sodium&#8209;free.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal;page-break-after:
avoid'><b><span lang=EN-GB>3.       How to use GONAL-f</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Always use this medicine<b> </b>exactly
as your doctor has told you. Check with your doctor or pharmacist if you are
not sure.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>Using this medicine</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>GONAL-f is intended to
be given by injection just under the skin (subcutaneously). The pre-filled pen
can be used for several injections.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>The first injection of
GONAL-f should be given under supervision of your doctor.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Your doctor or nurse
will show you how to use the GONAL-f pre-filled pen to inject the medicine.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><a
name="OLEII-109_Company_Response_to_LoQLINK1"></a><a
name="OLEII-109_Company_Response_to_LoQLINK3"></a><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>If you administer
GONAL-f to yourself, please carefully read and follow the Instructions for use.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>How much to use</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Your doctor will decide how
much medicine you will take and how often. The doses described below are stated
in International Units (IU).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>Women</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>If you are not ovulating and have irregular
or no periods.</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>GONAL-f is usually
given every day.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>If you have irregular
periods, start using GONAL-f within the first 7&nbsp;days of your menstrual
cycle. If you do not have periods you can start using the medicine on any
convenient day.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>The usual starting dose
of GONAL-f is 75 to 150&nbsp;IU each day.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Your dose of GONAL-f
may be increased every 7 or every 14&nbsp;days by 37.5 to 75&nbsp;IU, until you
get the desired response.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>The maximum daily dose
of GONAL-f is usually not higher than 225&nbsp;IU.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>When you get the
desired response, you will be given a single injection of 250&nbsp;micrograms
of recombinant hCG (r-hCG, an hCG made in a laboratory by a special DNA
technique), or 5,000 to 10,000&nbsp;IU of hCG, 24 to 48&nbsp;hours after your
last GONAL&#8209;f injection. The best time</span><span lang=EN-GB
style='font-size:11.0pt'> to have sex is on the day of the hCG injection and
the day after.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>If your doctor cannot see a
desired response after 4&nbsp;weeks, that treatment cycle with GONAL-f should
be stopped. For the following treatment cycle, your doctor will give you a
higher starting dose of GONAL-f than before.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>If your body responds too
strongly, your treatment will be stopped and you will not be given any hCG (see
section&nbsp;2, OHSS). For the following cycle, your doctor will give you a
lower dose of GONAL&#8209;f than before.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>If
you are not ovulating, having no periods and have been diagnosed with very low
levels of FSH and LH hormones</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>The usual starting dose
of GONAL-f is 75 to 150&nbsp;IU together with 75&nbsp;IU of lutropin alfa.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>You will use these two
medicines each day for up to five weeks.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Your dose of GONAL-f may
be increased every 7 or every 14&nbsp;days by 37.5 to 75&nbsp;IU, until you get
the desired response.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>When you get the
desired response, you will be given a single injection of 250&nbsp;micrograms
of recombinant hCG (r-hCG, an hCG made in a laboratory by a special DNA
technique), or 5,000 to 10,000&nbsp;IU of hCG, 24 to 48&nbsp;hours after your
last injections of GONAL-f and lutropin alfa. The best time to have sex is on
the day of the hCG injection and the day after. Alternatively, intrauterine
insemination may be performed by placing the sperm into the womb cavity.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>If your doctor cannot see a
response after 5&nbsp;weeks, that treatment cycle with GONAL-f should be
stopped. For the following cycle, your doctor will give you a higher starting
dose of GONAL&#8209;f than before.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>If your body responds too
strongly, your treatment with GONAL-f will be stopped and you will not be given
any hCG (see section&nbsp;2, OHSS). For the following cycle, your doctor will
give you a lower dose of GONAL&#8209;f than before.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>If you need to develop several eggs for
collection prior to any assisted reproductive technology</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>The usual starting dose
of GONAL&#8209;f is 150 to 225&nbsp;IU each day, from day&nbsp;2 or 3 of your
treatment cycle. </span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>GONAL-f dose may be
increased, depending on your response. The maximum daily dose is 450&nbsp;IU.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Treatment is continued
until your eggs have developed to a desired point. This usually takes about
10&nbsp;days but can take any time between 5 and 20&nbsp;days. Your doctor will
use blood tests and/or an ultrasound machine to check when this is.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>When your eggs are
ready, you will be given a single injection of 250&nbsp;micrograms recombinant
hCG (r-hCG, an hCG made in a laboratory by a special recombinant DNA
technique), or 5,000&nbsp;IU to 10,000&nbsp;IU of hCG, 24 to 48&nbsp;hours
after the last GONAL&#8209;f injection. This gets your eggs ready for
collection.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>In other cases, your doctor
may first stop you from ovulating by using a gonadotropin-releasing hormone
(GnRH) agonist or antagonist. Then GONAL-f is started approximately two weeks
after start of agonist treatment. The GONAL-f and GnRH agonist are then both
given until your follicles develop as desired. For example, after two weeks of
GnRH agonist treatment, 150 to 225&nbsp;IU GONAL&#8209;f is administered for
7&nbsp;days. The dose is then adjusted according to your ovarian response.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>Men</span></b></p>

<p class=MsoNormalIndent style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>The usual dose of
GONAL-f is 150&nbsp;IU together with hCG.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>You will use these two
medicines three times a week for at least 4&nbsp;months.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>If you have not
responded to treatment after 4&nbsp;months, your doctor may suggest that you
continue using these two medicines for at least 18&nbsp;months.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>If you use more GONAL-f than you should</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>The effects of taking too
much GONAL-f are unknown. Nevertheless, one could expect Ovarian
Hyper-Stimulation Syndrome (OHSS) to occur, which is described in section&nbsp;4.
However, the OHSS will only occur if hCG is also administered (see section&nbsp;2,
OHSS).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>If you forget to use GONAL-f</span></b></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>If you forget to use GONAL-f, do not take a double dose to make up
for a forgotten dose. Please talk to your doctor as soon as you notice that you
forgot a dose.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>If you have any further
questions on the use of this medicine, ask your doctor or pharmacist.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal;page-break-after:
avoid'><b><span lang=EN-GB>4.       Possible side effects</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText align=left style='margin-left:28.35pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB>Like all medicines, this
medicine can cause side effects, although not everybody gets them.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>Serious side effects in women</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Lower abdominal pain
together with nausea or vomiting may be the symptoms of Ovarian Hyper-Stimulation
Syndrome (OHSS). This may indicate that the ovaries over-reacted to the
treatment and that large ovarian cysts developed (see also in section&nbsp;2.
under Ovarian Hyper-Stimulation Syndrome). This side effect is common (may
affect up to 1 in 10&nbsp;people).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>The OHSS may become
severe with clearly enlarged ovaries, decreased urine production, weight gain,
difficulty in breathing and/or possible fluid accumulation in your stomach or
chest. This side effect is uncommon (may affect up to 1 in 100&nbsp;people).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Complications of OHSS
such as twisting of ovaries or blood clotting may occur rarely (may affect up
to 1 in 1,000&nbsp;people).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Serious blood clotting
complications (thromboembolic events) sometimes independent of OHSS may be
found very rarely (may affect up to 1 in 10,000&nbsp;people). This could cause
chest pain, breathlessness, stroke or heart attack (see also in section&nbsp;2.
under Blood clotting problems).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>Serious side effects in men and women</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Allergic reactions such
as rash, red skin, hives, swelling of your face with difficulty breathing can
sometimes be serious. This side effect is very rare (may affect up to 1 in
10,000&nbsp;people).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>If you notice any of the
above-listed side effects, you should immediately contact your doctor who might
ask you to stop using GONAL-f.</span></b></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>Other side effects in women</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'>Very
common (</span></u><span lang=EN-GB style='font-size:11.0pt'>may affect more
than 1 in 10&nbsp;people):</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Sacs of fluid within
the ovaries (ovarian cysts)</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Headache</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Local reactions at the
injection site, such as pain, redness, bruising, swelling and/or irritation</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'>Common
</span></u><span lang=EN-GB style='font-size:11.0pt'>(may affect up to 1 in
10&nbsp;people):</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB style='font-size:11.0pt'><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Abdominal pain</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Feeling sick, vomiting,
diarrhoea, abdominal cramps and bloating</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB style='font-size:11.0pt'>Very
rare </span></u><span lang=EN-GB style='font-size:11.0pt'>(may affect up to 1
in 10,000&nbsp;people):</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Allergic reactions such
as rash, red skin, hives, swelling of your face with difficulty breathing may
occur. These reactions can sometimes be serious.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Your asthma may get
worse.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>Other side effects in men</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB style='font-size:11.0pt'>Very common (</span></u><span lang=EN-GB
style='font-size:11.0pt'>may affect more than 1 in 10&nbsp;people):</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Local reactions at the
injection site, such as pain, redness, bruising, swelling and/or irritation</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB style='font-size:11.0pt'>Common </span></u><span lang=EN-GB
style='font-size:11.0pt'>(may affect up to 1 in 10&nbsp;people):</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Swelling of the veins
above and behind the testicles (varicocele)</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Breast development,
acne or weight gain</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB style='font-size:11.0pt'>Very rare </span></u><span lang=EN-GB
style='font-size:11.0pt'>(may affect up to 1 in 10,000&nbsp;people):</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Allergic reactions such
as rash, red skin, hives, swelling of your face with difficulty in breathing
may occur. These reactions can sometimes be serious.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Your asthma may get
worse.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal;page-break-after:
avoid'><b><span lang=EN-GB style='font-size:11.0pt'>Reporting of side effects</span></b></p>

<p class=BodytextAgency style='margin-bottom:0in;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>If you
get any side effects, talk to your doctor or pharmacist. This includes any
possible side effects not listed in this leaflet. You can also report side
effects directly via <span style='color:black;background:#D9D9D9'>the national
reporting system listed in </span></span><span lang=EN-GB><a
href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc"><span
style='font-size:11.0pt;font-family:"Times New Roman",serif;background:#D9D9D9'>Appendix&nbsp;V</span></a></span><span
lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>. By
reporting side effects you can help provide more information on the safety of
this medicine.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal;page-break-after:
avoid'><b><span lang=EN-GB>5.       How to store GONAL-f</span></b></p>

<p class=MsoBodyText align=left style='margin-left:28.35pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Keep this medicine out of the
sight and reach of children.</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Do not use this medicine after the expiry date which is stated on
the cartridge label or carton after EXP. The expiry date refers to the last day
of that month.</span></p>

<p class=MsoNormalIndent style='margin:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormalIndent style='margin:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Store in a refrigerator (2°C &#8209;
8°C). Do not freeze.</span></p>

<p class=MsoNormalIndent style='margin:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Within its shelf life, the
product may be stored at or below 25°C for up to 3&nbsp;months without being
refrigerated again and must be discarded if it has not been used after 3&nbsp;months.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Store in the original package
in order to protect from light.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Do not use GONAL-f if you
notice any visible signs of deterioration, if the liquid contains particles or
is not clear.</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>Please
write on the GONAL-f pre-filled pen the day you first use it. For this purpose,
a sticker is provided with the Instructions for use.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Once opened, the pen
may be stored for a maximum of 28&nbsp;days outside of the fridge (at or below
25°C).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Do not use any medicine
left in your pre-filled pen after 28&nbsp;days.</span></p>

<p class=MsoBodyText align=left style='margin-left:28.35pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB>At the end of the
treatment any unused solution must be discarded.</span></p>

<p class=MsoBodyText align=left style='margin-left:28.35pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Do not throw away any medicines via wastewater. Ask your pharmacist
how to throw away medicines you no longer use. These measures will help to
protect the environment.</span></p>

<p class=MsoBodyText align=left style='margin-left:28.35pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='margin-left:28.35pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='margin-left:28.35pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>6.       Contents of the pack and other information</span></b></p>

<p class=MsoBodyText align=left style='margin-left:28.35pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>What GONAL-f contains</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The active substance is follitropin alfa.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E7E6E6'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f <span
style='background:yellow'>150</span> IU PEN&gt;</span></i></p>

<p class=MsoNormalIndent style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;background:#E7E6E6'><span lang=EN-GB style='font-size:11.0pt;font-family:
Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>There are
600&nbsp;IU (44&nbsp;micrograms) of follitropin alfa in each millilitre of
liquid. Each pre&#8209;filled pen with multidose cartridge delivers <span
style='background:yellow'>150</span>&nbsp;IU (<span style='background:yellow'>11</span>&nbsp;micrograms)
in <span style='background:yellow'>0.25</span>&nbsp;mL.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;background:#E7E6E6'><span lang=EN-GB style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='color:black'>The other ingredients are
poloxamer&nbsp;188, sucrose, methionine, sodium dihydrogen phosphate
monohydrate, disodium phosphate dihydrate, m-cresol, concentrated phosphoric
acid, sodium hydroxide and water for injections.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#CCFFFF'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 300 IU PEN&gt;</span></i></p>

<p class=MsoNormalIndent style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;background:#CCFFFF'><span lang=EN-GB style='font-size:11.0pt;font-family:
Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>There are
600&nbsp;IU (44&nbsp;micrograms) of follitropin alfa in each millilitre of
liquid. Each pre&#8209;filled pen with multidose cartridge delivers 300&nbsp;IU
(22&nbsp;micrograms) in 0.5&nbsp;mL.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;background:#CCFFFF'><span lang=EN-GB style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='color:black'>The other ingredients are
poloxamer&nbsp;188, sucrose, methionine, sodium dihydrogen phosphate
monohydrate, disodium phosphate dihydrate, m-cresol, concentrated phosphoric
acid, sodium hydroxide and water for injections.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#CCECFF'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 450 IU - PEN&gt;</span></i></p>

<p class=MsoNormalIndent style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;background:#CCECFF'><span lang=EN-GB style='font-size:11.0pt;font-family:
Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>There are
600&nbsp;IU (44&nbsp;micrograms) of follitropin alfa in each millilitre of
liquid. Each pre&#8209;filled pen with multidose cartridge delivers 450&nbsp;IU
(33&nbsp;micrograms) in 0.75&nbsp;mL.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;background:#CCECFF'><span lang=EN-GB style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='color:black'>The other ingredients are
poloxamer&nbsp;188, sucrose, methionine, sodium dihydrogen phosphate
monohydrate, disodium phosphate dihydrate, m-cresol, concentrated phosphoric
acid, sodium hydroxide and water for injections.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#99CCFF'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 900 IU - PEN&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#99CCFF'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>There are
600&nbsp;IU (44&nbsp;micrograms) of follitropin alfa in each millilitre of
liquid. Each pre&#8209;filled pen with multidose cartridge delivers 900&nbsp;IU
(66 micrograms) in 1.5&nbsp;mL.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#99CCFF'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>The other
ingredients are poloxamer&nbsp;188, sucrose, methionine, sodium dihydrogen
phosphate monohydrate, disodium phosphate dihydrate, m-cresol, concentrated
phosphoric acid, sodium hydroxide and water for injections.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>What GONAL-f looks like and contents of the
pack</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#E7E6E6'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f <span
style='background:yellow'>150</span> IU PEN&gt; </span></i></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;background:#E7E6E6'><span lang=EN-GB style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='color:black'>GONAL-f is presented as a
clear, colourless liquid for injection in a pre&#8209;filled pen.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;background:#E7E6E6'><span lang=EN-GB style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='color:black'>It is supplied in packs with
1&nbsp;pre-filled pen and <span style='background:yellow'>4&nbsp;disposable
needles</span>.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#CCFFFF'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 300 IU PEN&gt; </span></i></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;background:#CCFFFF'><span lang=EN-GB style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='color:black'>GONAL-f is presented as a
clear, colourless liquid for injection in a pre&#8209;filled pen.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;background:#CCFFFF'><span lang=EN-GB style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='color:black'>It is supplied in packs with
1&nbsp;pre-filled pen and 8&nbsp;disposable needles.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#CCECFF'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 450 IU - PEN&gt;</span></i></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;background:#CCECFF'><span lang=EN-GB style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='color:black'>GONAL-f is presented as a
clear, colourless liquid for injection in a pre&#8209;filled pen.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;background:#CCECFF'><span lang=EN-GB style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='color:black'>It is supplied in packs with
1&nbsp;pre-filled pen and <span class=MsoCommentReference>12&nbsp;d</span>isposable
needles.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#99CCFF'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 900 IU - PEN&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:.5in;margin-bottom:.0001pt;text-align:left;
text-indent:-.5in;line-height:normal;background:#99CCFF'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>GONAL-f is
presented as a clear, colourless liquid for injection in a pre&#8209;filled
pen.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:.5in;margin-bottom:.0001pt;text-align:left;
text-indent:-.5in;line-height:normal;background:#99CCFF'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>It is
supplied in packs with 1&nbsp;pre-filled pen and 20&nbsp;disposable needles.</span></p>

<p class=MsoBodyText2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>Marketing Authorisation Holder</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><u><span
lang=EN-GB style='font-size:11.0pt'><span style='text-decoration:none'>&nbsp;</span></span></u></b></p>

<p class=MsoListParagraph style='margin:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Merck Europe&nbsp;B.V.,
Gustav Mahlerplein&nbsp;102, 1082&nbsp;MA Amsterdam, The Netherlands</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>Manufacturer</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=IT>Merck Serono&nbsp;S.p.A., Via delle Magnolie&nbsp;15, 70026&nbsp;Modugno
(Bari), Italy</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=IT>&nbsp;</span></p>

<p class=MsoBodyText align=left style='margin-left:28.35pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=IT>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>This
leaflet was last revised in </span></b><span lang=EN-GB style='font-size:11.0pt'>{<b>MM/YYYY</b>}<b>.</b></span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Detailed information on this
medicine is available on the European Medicines Agency web site: </span><span
lang=EN-GB><span class=MsoHyperlink><span style='font-size:11.0pt'>http://www.ema.europa.eu</span></span></span><span
class=MsoHyperlink><span lang=EN-GB style='font-size:11.0pt'>.</span></span></p>

<b><i><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:#9B243E'><br clear=all style='page-break-before:always'>
</span></i></b>

<p class=Gonal-fTitle1 align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;text-align:center;text-indent:-28.35pt;
line-height:normal'><span lang=EN-GB style='color:windowtext'>Instructions for
use</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=center style='margin-top:0in;text-align:center;
line-height:normal;background:#E7E6E6'><i><span lang=EN-GB style='font-size:
11.0pt;color:black'>&lt;</span></i><i><span lang=EN-GB style='font-size:11.0pt;
color:black'>GONAL-f <span style='background:yellow'>150</span> IU PEN&gt;</span></i></p>

<p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
text-indent:-28.35pt;line-height:normal;background:#E7E6E6'><b><span
lang=EN-GB style='font-size:11.0pt;color:black'>GONAL-f PRE-FILLED PEN <span
style='background:yellow'>150&nbsp;IU/0.25&nbsp;mL</span></span></b></p>

<p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
text-indent:-28.35pt;line-height:normal;background:#E7E6E6'><i><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></i></p>

<p class=MsoNormal align=center style='margin-top:0in;text-align:center;
line-height:normal;background:#CCFFFF'><i><span lang=EN-GB style='font-size:
11.0pt;color:black'>&lt;</span></i><i><span lang=EN-GB style='font-size:11.0pt;
color:black'>GONAL-f 300 IU PEN&gt;</span></i></p>

<p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
text-indent:-28.35pt;line-height:normal;background:#CCFFFF'><b><span
lang=EN-GB style='font-size:11.0pt;color:black'>GONAL-f PRE-FILLED PEN 300&nbsp;IU/0.5&nbsp;mL</span></b></p>

<p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
text-indent:-28.35pt;line-height:normal;background:#CCFFFF'><i><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></i></p>

<p class=MsoNormal align=center style='margin-top:0in;text-align:center;
line-height:normal;background:#CCECFF'><i><span lang=EN-GB style='font-size:
11.0pt;color:black'>&lt;GONAL-f 450 IU- PEN &gt;</span></i></p>

<p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
text-indent:-28.35pt;line-height:normal;background:#CCECFF'><b><span
lang=EN-GB style='font-size:11.0pt;color:black'>GONAL-f PRE-FILLED PEN 450&nbsp;IU/0.75&nbsp;mL</span></b></p>

<p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
text-indent:-28.35pt;line-height:normal;background:#CCECFF'><i><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></i></p>

<p class=MsoNormal align=center style='margin-top:0in;text-align:center;
line-height:normal;background:#99CCFF'><i><span lang=EN-GB style='font-size:
11.0pt;color:black'>&lt;GONAL-f 900 IU - PEN&gt;</span></i></p>

<p class=MsoNormal align=center style='margin-top:0in;text-align:center;
line-height:normal;background:#99CCFF'><b><span lang=EN-GB style='font-size:
11.0pt;color:black'>GONAL-f PRE-FILLED PEN 900&nbsp;IU/1.5&nbsp;mL</span></b></p>

<p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>Solution for injection in pre-filled pen</span></p>

<p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>Follitropin alfa</span></p>

<p class=Gonal-fTitle1 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal'><span
lang=EN-GB style='color:windowtext'>&nbsp;</span></p>

<p class=Gonal-fTitle1 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal'><span
lang=EN-GB style='color:windowtext'>Contents</span></p>

<div style='border:none;border-top:solid windowtext 1.0pt;padding:1.0pt 0in 0in 0in'>

<p class=Gonal-fTitle1 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;page-break-after:
avoid;border:none;padding:0in'><span lang=EN-GB style='color:windowtext'>&nbsp;</span></p>

</div>

<p class=Gonal-fTitle1 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal'><span
lang=EN-GB style='color:windowtext'>1.       How to use the GONAL-f pre-filled
pen</span></p>

<p class=Gonal-fTitle1 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal'><span
lang=EN-GB style='color:windowtext'>2.       How to use your GONAL-f pre-filled
pen Treatment Diary</span></p>

<p class=Gonal-fTitle1 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal'><span
lang=EN-GB style='color:windowtext'>3.       Before you start using your GONAL-f
pre-filled pen</span></p>

<p class=Gonal-fTitle1 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal'><span
lang=EN-GB style='color:windowtext'>4.       Getting your GONAL-f pre-filled
pen ready for injection</span></p>

<p class=Gonal-fTitle1 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal'><span
lang=EN-GB style='color:windowtext'>5.       Setting the dose prescribed by
your doctor</span></p>

<p class=Gonal-fTitle1 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal'><span
lang=EN-GB style='color:windowtext'>6.       Injecting the dose</span></p>

<p class=Gonal-fTitle1 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal'><span
lang=EN-GB style='color:windowtext'>7.       After the injection</span></p>

<p class=Gonal-fTitle1 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal'><span
lang=EN-GB style='color:windowtext'>8.       GONAL-f pre-filled pen Treatment
Diary (see table at the end)</span></p>

<p class=Gonal-fTitle2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;border:none'><span
lang=EN-GB style='color:windowtext'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:49.65pt;margin-bottom:.0001pt;text-indent:-49.65pt;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>Warning: </span></b><span
lang=EN-GB style='font-size:11.0pt'>Please read these instructions for use
before using your </span><span lang=EN-GB style='font-size:11.0pt'>GONAL-f
pre-filled pen</span><span lang=EN-GB style='font-size:11.0pt'>. Follow the
procedure exactly, as it may differ from your past experience.</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 1.0pt 0in'>

<p class=Gonal-fTitle2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;page-break-after:
avoid;border:none;padding:0in'><span lang=EN-GB style='color:windowtext'>1.       How
to use the GONAL-f pre-filled pen</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Do not share the pen.
The pen is for subcutaneous injection only.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>The numbers on the <b>Dose
Feedback Window</b> are measured in International Units or IUs. Your doctor
will have told you how many IUs to inject each day.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>The numbers displayed
in the <b>Dose Feedback Window</b> help you to:</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:12.0pt'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB><img border=0 width=624 height=213
id="Picture 60"
src="file:///c:/Users/makum/Desktop/Learning/p-ie/EMA%20EPI%20PoC/function_code/work/H/CAP/gonal-f/en/2021-06-04T08-55-59Z/gonal-f_clean_files/image011.png"></span><span
lang=EN-GB style='font-size:11.0pt'>Give yourself the injection at the same
time each day. Example:         </span><span lang=EN-GB><img border=0 width=41
height=50 id="Picture 1"
src="file:///c:/Users/makum/Desktop/Learning/p-ie/EMA%20EPI%20PoC/function_code/work/H/CAP/gonal-f/en/2021-06-04T08-55-59Z/gonal-f_clean_files/image012.png"></span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Your doctor/pharmacist
will tell you how many pens you need to complete your treatment.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<div style='border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 1.0pt 0in'>

<p class=Gonal-fTitle2 style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;page-break-after:
avoid;border:none;padding:0in'><span lang=EN-GB style='color:windowtext'>2.       How
to use your GONAL-f pre-filled pen Treatment Diary</span></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;text-autospace:none'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;text-autospace:none'><span lang=EN-GB style='font-size:11.0pt'>A
treatment diary is included on the last page.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>Use the treatment diary to record the
amount of injected IUs you use each time.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:56.7pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Record the treatment
day number (1), date (2) and time (3) of your injection.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:56.7pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>In the first line of
the table the volume of your pen is already recorded for you (4).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:56.7pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Record your prescribed
dose in the Prescribed Dose section (5).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:56.7pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Verify you dialed the
right dose before injecting (6).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:56.7pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>After injection, read
the number shown in the <b>Dose Feedback Window</b>.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:56.7pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Confirm you received a
complete injection (7) or record the number shown in the <b>Dose Feedback
Window</b> if other than 0 (8).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:56.7pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>When needed, inject
yourself using a second pen, dialing your remaining dose written in the Amount
Displayed After Injection section (8).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:56.7pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Record this remaining
dose in the <b>Amount Set to Inject</b> section in the next row (6).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
line-height:normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:#FFCCCC;margin-left:28.35pt;margin-right:0in'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#FFCCCC;border:none;padding:0in'><span
lang=EN-GB style='font-size:11.0pt;color:black'>CAUTION:</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#FFCCCC;border:none;padding:0in'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>-----------------------------------------------------------------------------------------------------------------</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#FFCCCC;border:none;padding:0in'><i><span lang=EN-GB
style='font-size:11.0pt;color:black'>Using your treatment diary to record your
daily injection(s) allows you to verify every day that you received the full
prescribed dose.</span></i></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>An example of a treatment diary:</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=center style='margin-top:0in;text-align:center;
line-height:normal;background:#E7E6E6'><i><span lang=EN-GB style='font-size:
11.0pt;color:black'>&lt;</span></i><i><span lang=EN-GB style='font-size:11.0pt;
color:black'>GONAL-f <span style='background:yellow'>150 IU</span> PEN&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:12.0pt;page-break-after:avoid'><span
lang=EN-GB><img border=0 width=624 height=209 id="Picture 59"
src="file:///c:/Users/makum/Desktop/Learning/p-ie/EMA%20EPI%20PoC/function_code/work/H/CAP/gonal-f/en/2021-06-04T08-55-59Z/gonal-f_clean_files/image013.png"></span></p>

<p class=MsoNormal align=center style='margin-top:0in;text-align:center;
line-height:normal;background:#CCFFFF'><i><span lang=EN-GB style='font-size:
11.0pt;color:black'>&lt;</span></i><i><span lang=EN-GB style='font-size:11.0pt;
color:black'>GONAL-f 300 IU PEN&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
12.0pt;text-autospace:none'><span lang=EN-GB><img border=0 width=624
height=243 id="Picture 58"
src="file:///c:/Users/makum/Desktop/Learning/p-ie/EMA%20EPI%20PoC/function_code/work/H/CAP/gonal-f/en/2021-06-04T08-55-59Z/gonal-f_clean_files/image014.png"></span></p>

<p class=MsoNormal align=center style='margin-top:0in;text-align:center;
line-height:normal;page-break-after:avoid;background:#CCECFF'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 450 IU- PEN &gt;</span></i></p>

<p class=MsoNormal align=center style='margin-top:0in;text-align:center;
line-height:12.0pt'><span lang=EN-GB><img border=0 width=624 height=243
id="Picture 51"
src="file:///c:/Users/makum/Desktop/Learning/p-ie/EMA%20EPI%20PoC/function_code/work/H/CAP/gonal-f/en/2021-06-04T08-55-59Z/gonal-f_clean_files/image015.png"></span></p>

<p class=MsoNormal align=center style='margin-top:0in;text-align:center;
line-height:normal;background:#99CCFF'><i><span lang=EN-GB style='font-size:
11.0pt;color:black'>&lt;GONAL-f 900 IU - PEN&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
12.0pt;text-autospace:none'><span lang=EN-GB><img border=0 width=624
height=243 id="Picture 50"
src="file:///c:/Users/makum/Desktop/Learning/p-ie/EMA%20EPI%20PoC/function_code/work/H/CAP/gonal-f/en/2021-06-04T08-55-59Z/gonal-f_clean_files/image016.png"></span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;text-autospace:none'><b><span lang=EN-GB style='font-size:11.0pt'>Note: </span></b><span
lang=EN-GB style='font-size:11.0pt'>The 150&nbsp;IU pen maximum single-dose
setting is 150&nbsp;IU; the 300&nbsp;IU pen maximum single-dose setting is
300&nbsp;IU; the 450&nbsp;IU pen maximum single-dose setting is 450&nbsp;IU;
the 900&nbsp;IU pen maximum single-dose setting is 450&nbsp;IU.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<div style='border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 1.0pt 0in'>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>3.       Before you
start using your GONAL-f pre-filled pen</span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
style='position:relative;z-index:-1895830016'><span style='left:0px;position:
absolute;left:557px;top:-48983px;width:111px;height:1px'><img width=74
height=1
src="file:///c:/Users/makum/Desktop/Learning/p-ie/EMA%20EPI%20PoC/function_code/work/H/CAP/gonal-f/en/2021-06-04T08-55-59Z/gonal-f_clean_files/image017.png"></span></span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='position:relative;z-index:-1895828992'><span
style='left:0px;position:absolute;left:693px;top:-49000px;width:182px;
height:1px'><img width=121 height=1
src="file:///c:/Users/makum/Desktop/Learning/p-ie/EMA%20EPI%20PoC/function_code/work/H/CAP/gonal-f/en/2021-06-04T08-55-59Z/gonal-f_clean_files/image018.png"></span></span><span
lang=EN-GB style='font-size:11.0pt'>Wash your hands with soap and water.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Find a clean area and a<b>
flat surface.</b></span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Verify the<b>
expiration date</b> on the pen label.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Gather everything you
need and lay it out:</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><a
name="_Hlk15999597"><span lang=EN-GB><img border=0 width=507 height=277
id="Bild 46"
src="file:///c:/Users/makum/Desktop/Learning/p-ie/EMA%20EPI%20PoC/function_code/work/H/CAP/gonal-f/en/2021-06-04T08-55-59Z/gonal-f_clean_files/image019.jpg"></span></a></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal'><b><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='border-collapse:collapse'>
 <tr>
  <td width=187 valign=top style='width:140.1pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:14.2pt;margin-bottom:.0001pt;text-align:left;
  text-indent:-14.2pt;line-height:normal;page-break-after:avoid'><span
  lang=EN-GB style='font-size:11.0pt'>1.  Dose setting knob</span></p>
  </td>
  <td width=201 valign=top style='width:150.55pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:14.2pt;margin-bottom:.0001pt;text-align:left;
  text-indent:-14.2pt;line-height:normal;page-break-after:avoid'><span
  lang=EN-GB style='font-size:11.0pt'>5.  Threaded needle connector</span></p>
  </td>
  <td width=187 valign=top style='width:140.0pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:14.2pt;margin-bottom:.0001pt;text-align:left;
  text-indent:-14.2pt;line-height:normal;page-break-after:avoid'><span
  lang=EN-GB style='font-size:11.0pt'>9.  Inner needle shield</span></p>
  </td>
 </tr>
 <tr>
  <td width=187 valign=top style='width:140.1pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:14.2pt;margin-bottom:.0001pt;text-align:left;
  text-indent:-14.2pt;line-height:normal;page-break-after:avoid'><span
  lang=EN-GB style='font-size:11.0pt'>2.  <b>Dose Feedback Window</b></span></p>
  </td>
  <td width=201 valign=top style='width:150.55pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:14.2pt;margin-bottom:.0001pt;text-align:left;
  text-indent:-14.2pt;line-height:normal;page-break-after:avoid'><span
  lang=EN-GB style='font-size:11.0pt'>6.  Pen cap</span></p>
  </td>
  <td width=187 valign=top style='width:140.0pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:14.2pt;margin-bottom:.0001pt;text-align:left;
  text-indent:-14.2pt;line-height:normal;page-break-after:avoid'><span
  lang=EN-GB style='font-size:11.0pt'>10. Outer needle cap</span></p>
  </td>
 </tr>
 <tr>
  <td width=187 valign=top style='width:140.1pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:14.2pt;margin-bottom:.0001pt;text-align:left;
  text-indent:-14.2pt;line-height:normal;page-break-after:avoid'><span
  lang=EN-GB style='font-size:11.0pt'>3.  Plunger piston</span></p>
  </td>
  <td width=201 valign=top style='width:150.55pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:14.2pt;margin-bottom:.0001pt;text-align:left;
  text-indent:-14.2pt;line-height:normal;page-break-after:avoid'><span
  lang=EN-GB style='font-size:11.0pt'>7.  Peel-off seal tab</span></p>
  </td>
  <td width=187 valign=top style='width:140.0pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:14.2pt;margin-bottom:.0001pt;text-align:left;
  text-indent:-14.2pt;line-height:normal;page-break-after:avoid'><span
  lang=EN-GB style='font-size:11.0pt'>11. Alcohol swabs</span></p>
  </td>
 </tr>
 <tr>
  <td width=187 valign=top style='width:140.1pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:14.2pt;margin-bottom:.0001pt;text-align:left;
  text-indent:-14.2pt;line-height:normal'><span lang=EN-GB style='font-size:
  11.0pt'>4.  Reservoir holder</span></p>
  </td>
  <td width=201 valign=top style='width:150.55pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:14.2pt;margin-bottom:.0001pt;text-align:left;
  text-indent:-14.2pt;line-height:normal'><span lang=EN-GB style='font-size:
  11.0pt'>8.  Removable needle</span></p>
  </td>
  <td width=187 valign=top style='width:140.0pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:14.2pt;margin-bottom:.0001pt;text-align:left;
  text-indent:-14.2pt;line-height:normal'><span lang=EN-GB style='font-size:
  11.0pt'>12. Sharps disposal container</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<div style='border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 1.0pt 0in'>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>4.       Getting your
GONAL-f pre-filled pen</span><span lang=EN-GB> </span></b><b><span lang=EN-GB
style='font-size:11.0pt'>ready for injection</span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>4.1.    Take off the pen cap.</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>4.2.    Verify that the Dose Feedback
Window is set to0.</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB>                   </span><span lang=EN-GB><img border=0 width=249
height=142 id="Bild 47"
src="file:///c:/Users/makum/Desktop/Learning/p-ie/EMA%20EPI%20PoC/function_code/work/H/CAP/gonal-f/en/2021-06-04T08-55-59Z/gonal-f_clean_files/image020.png"><img
border=0 width=226 height=142 id="Bild 48"
src="file:///c:/Users/makum/Desktop/Learning/p-ie/EMA%20EPI%20PoC/function_code/work/H/CAP/gonal-f/en/2021-06-04T08-55-59Z/gonal-f_clean_files/image021.png"></span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><a
name="_Hlk521340370"><b><span lang=EN-GB style='font-size:11.0pt'>4.3.    Prepare
your needle for injection</span></b></a></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:12.0pt'><span lang=EN-GB><img border=0
width=624 height=221 id="Picture 49"
src="file:///c:/Users/makum/Desktop/Learning/p-ie/EMA%20EPI%20PoC/function_code/work/H/CAP/gonal-f/en/2021-06-04T08-55-59Z/gonal-f_clean_files/image022.png"></span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:#FFCCCC;margin-left:28.35pt;margin-right:0in'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#FFCCCC;border:none;padding:0in'><span
lang=EN-GB style='font-size:11.0pt;color:black'>CAUTION:</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#FFCCCC;border:none;padding:0in'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>-----------------------------------------------------------------------------------------------------------------</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#FFCCCC;border:none;padding:0in'><i><span lang=EN-GB
style='font-size:11.0pt;color:black'>If the peel-off seal is damaged or loose,
do not use the needle. Throw it away in a sharps disposal container. Get a new
needle.</span></i></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>4.4.    Attach the needle</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:56.7pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><a name="_Hlk521340525"><span
lang=EN-GB style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Screw the threaded tip
of the GONAL-f pre-filled pen into the outer needle cap until you feel a light
resistance.</span></a></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
line-height:normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-56.7pt;line-height:normal'><b><span
lang=EN-GB style='font-size:11.0pt'>Warning:    </span></b><span lang=EN-GB
style='font-size:11.0pt'>Do not attach the needle too tightly; the needle could
be difficult to remove after the injection.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-56.7pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
12.0pt'><span lang=EN-GB><img border=0 width=624 height=223 id="Picture 45"
src="file:///c:/Users/makum/Desktop/Learning/p-ie/EMA%20EPI%20PoC/function_code/work/H/CAP/gonal-f/en/2021-06-04T08-55-59Z/gonal-f_clean_files/image023.png"></span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>4.5.    Look closely at the tip of the
needle for tiny drop(s) of fluid</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:#FFCCCC;margin-left:28.35pt;margin-right:0in'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
12.0pt;page-break-after:avoid;background:#FFCCCC;border:none;padding:0in'><span
lang=EN-GB style='color:black'><img border=0 width=624 height=179
id="Picture 39"
src="file:///c:/Users/makum/Desktop/Learning/p-ie/EMA%20EPI%20PoC/function_code/work/H/CAP/gonal-f/en/2021-06-04T08-55-59Z/gonal-f_clean_files/image024.png"></span><span
lang=EN-GB style='font-size:11.0pt;color:black'>CAUTION:</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#FFCCCC;border:none;padding:0in'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>-----------------------------------------------------------------------------------------------------------------</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#FFCCCC;border:none;padding:0in'><i><span lang=EN-GB
style='font-size:11.0pt;color:black'>If you do not see a tiny drop(s) at or
near the needle tip <b>the first time</b> you use a new pen, you must perform
the steps on the next page.</span></i></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 1.0pt 0in'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>If you do not see a tiny drop(s) of fluid at or near
the tip the first time you use a new pen:</span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;text-indent:
28.35pt;line-height:normal'><span lang=EN-GB><img border=0 width=397
height=185
src="file:///c:/Users/makum/Desktop/Learning/p-ie/EMA%20EPI%20PoC/function_code/work/H/CAP/gonal-f/en/2021-06-04T08-55-59Z/gonal-f_clean_files/image025.png"></span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>1.       Gently turn the dose setting knob clockwise until it <b>reads
25</b> in the Dose Feedback Window. You can turn the dose knob backwards if you
turn it past 25.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
line-height:normal'><span lang=EN-GB><img border=0 width=469 height=173
src="file:///c:/Users/makum/Desktop/Learning/p-ie/EMA%20EPI%20PoC/function_code/work/H/CAP/gonal-f/en/2021-06-04T08-55-59Z/gonal-f_clean_files/image026.jpg"></span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>2.       Hold the pen with the needle pointing upward.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>3.       Tap the reservoir holder gently.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>4.       Press the dose setting knob <b>as far as it will go</b>. A
tiny drop of liquid will appear at the tip of the needle.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>5.       Verify that the Dose Feedback Window reads 0.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>6.       Proceed to <b>Section 5: Setting the dose prescribed by your
doctor</b>.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<div style='border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 1.0pt 0in'>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>5.       Setting the
dose prescribed by your doctor</span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=center style='margin-top:0in;text-align:center;
line-height:normal;page-break-after:avoid;background:#F2F2F2'><a
name="_Hlk16000373"><i><span lang=EN-GB style='font-size:11.0pt;color:black'>&lt;</span></i></a><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>GONAL-f <span style='background:
yellow'>150 IU</span> PEN&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#F2F2F2'><b><span
lang=EN-GB style='font-size:11.0pt;color:black'>5.1.    </span></b><span
lang=EN-GB style='font-size:11.0pt;color:black'>The pen contains <span
style='background:yellow'>150&nbsp;IU</span> follitropin alfa.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:56.7pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#F2F2F2'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>The <span
style='background:yellow'>150&nbsp;IU</span> pen <b>maximum single-dose setting
is <span style='background:yellow'>150&nbsp;IU</span>. </b>The smallest
single-dose setting is 12.5&nbsp;IU and the dose can be increased in increments
of 12.5&nbsp;IU.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=center style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:center;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#CCFFFF'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;</span></i><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>GONAL-f 300 IU PEN&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#CCFFFF'><b><span
lang=EN-GB style='font-size:11.0pt;color:black'>5.1.</span></b><span
lang=EN-GB style='font-size:11.0pt;color:black'>    The pen contains
300&nbsp;IU follitropin alfa.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:56.7pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#CCFFFF'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>The
300&nbsp;IU pen <b>maximum single-dose setting is 300&nbsp;IU. </b>The smallest
single-dose setting is 12.5&nbsp;IU and the dose can be increased in increments
of 12.5&nbsp;IU.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=center style='margin-top:0in;text-align:center;
line-height:normal;page-break-after:avoid;background:#CCECFF'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 450 IU- PEN &gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#CCECFF'><b><span
lang=EN-GB style='font-size:11.0pt;color:black'>5.1.</span></b><span
lang=EN-GB style='font-size:11.0pt;color:black'>    The pen contains
450&nbsp;IU follitropin alfa.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:56.7pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#CCECFF'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>The
450&nbsp;IU pen <b>maximum single-dose setting is 450&nbsp;IU. </b>The smallest
single-dose setting is 12.5&nbsp;IU and the dose can be increased in increments
of 12.5&nbsp;IU.</span></p>

<p class=MsoNormal align=center style='margin-top:0in;text-align:center;
line-height:normal'><i><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></i></p>

<p class=MsoNormal align=center style='margin-top:0in;text-align:center;
line-height:normal;page-break-after:avoid;background:#99CCFF'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 900 IU - PEN&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;background:#99CCFF'><b><span
lang=EN-GB style='font-size:11.0pt;color:black'>5.1.</span></b><span
lang=EN-GB style='font-size:11.0pt;color:black'>    The pen contains
900&nbsp;IU follitropin alfa.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:56.7pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;background:#99CCFF'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;color:black'>The
900&nbsp;IU pen <b>maximum single-dose setting is 450&nbsp;IU. </b>The smallest
single-dose setting is 12.5&nbsp;IU and the dose can be increased in increments
of 12.5&nbsp;IU.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;text-autospace:none'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>5.2.    Turn the dose setting knob until
your intended dose shows in the Dose Feedback Window</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:12.0pt'><span lang=EN-GB><img border=0
width=624 height=195 id="Picture 33"
src="file:///c:/Users/makum/Desktop/Learning/p-ie/EMA%20EPI%20PoC/function_code/work/H/CAP/gonal-f/en/2021-06-04T08-55-59Z/gonal-f_clean_files/image027.png"></span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>5.3.</span></b><span lang=EN-GB
style='font-size:11.0pt'>    </span><span lang=EN-GB style='font-size:11.0pt'>Set
the dose that was prescribed by your doctor (in the example shown in the
figure, it is 50&nbsp;IU).</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:56.7pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB><img border=0
width=383 height=136 id="Grafik 1"
src="file:///c:/Users/makum/Desktop/Learning/p-ie/EMA%20EPI%20PoC/function_code/work/H/CAP/gonal-f/en/2021-06-04T08-55-59Z/gonal-f_clean_files/image028.jpg"></span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:85.05pt;margin-bottom:.0001pt;text-align:left;
text-indent:-56.7pt;line-height:normal;text-autospace:none'><b><span
lang=EN-GB style='font-size:11.0pt'>Warning:    </span></b><span lang=EN-GB
style='font-size:11.0pt'>Check that the Dose Feedback Window displays your <b>complete
prescribed dose </b>before you move on to the next step.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<div style='border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 1.0pt 0in'>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>6.       Injecting
the dose</span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:21.3pt;margin-bottom:.0001pt;text-align:left;
text-indent:-21.3pt;line-height:normal;page-break-after:avoid;text-autospace:
none'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:12.0pt'><span lang=EN-GB><img border=0
width=624 height=552 id="Picture 27"
src="file:///c:/Users/makum/Desktop/Learning/p-ie/EMA%20EPI%20PoC/function_code/work/H/CAP/gonal-f/en/2021-06-04T08-55-59Z/gonal-f_clean_files/image029.png"></span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<div style='border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 1.0pt 0in'>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>7.       After the
injection</span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>7.1.    Verify you have given a complete
injection</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:56.7pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Check that the Dose
Feedback Window shows 0.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;text-indent:
28.35pt;line-height:normal'><span lang=EN-GB><img border=0 width=263 height=97
id="Bild 84"
src="file:///c:/Users/makum/Desktop/Learning/p-ie/EMA%20EPI%20PoC/function_code/work/H/CAP/gonal-f/en/2021-06-04T08-55-59Z/gonal-f_clean_files/image030.png"></span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;text-indent:
14.2pt;line-height:normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:85.05pt;margin-bottom:.0001pt;text-align:left;
text-indent:-56.7pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>Warning:</span></b><span lang=EN-GB style='font-size:11.0pt'>    If the
<b>Dose Feedback Window</b> shows a number higher than 0, the GONAL-f
pre-filled pen is empty and you have not received your full prescribed dose.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>7.2.    Complete a partial injection (only
when needed)</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:56.7pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>The <b>Dose Feedback
Window</b> will indicate the missing amount you need to inject <b>using a new
pen.</b></span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;text-indent:
28.35pt;line-height:normal'><span lang=EN-GB><img border=0 width=263 height=97
id="Bild 85"
src="file:///c:/Users/makum/Desktop/Learning/p-ie/EMA%20EPI%20PoC/function_code/work/H/CAP/gonal-f/en/2021-06-04T08-55-59Z/gonal-f_clean_files/image031.png"></span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:56.7pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Repeat Section&nbsp;3 <b>(Before
you start using your GONAL-f pre-filled pen) </b>through Section&nbsp;4 <b>(Getting
your GONAL-f pre-filled pen ready for injection)</b> with a second pen.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:56.7pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Set the dose to the
missing amount you recorded in the treatment diary or the number still
displayed in the Dose Feedback Window on your previous pen and inject.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB style='font-size:11.0pt'>7.3.    Removing the needle after each
injection</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
12.0pt'><span lang=EN-GB><img border=0 width=624 height=349 id="Picture 20"
src="file:///c:/Users/makum/Desktop/Learning/p-ie/EMA%20EPI%20PoC/function_code/work/H/CAP/gonal-f/en/2021-06-04T08-55-59Z/gonal-f_clean_files/image032.png"></span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB style='font-size:11.0pt'>7.4.    Storing
the GONAL-f pre-filled pen</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:#FFCCCC;margin-left:28.35pt;margin-right:0in'>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#FFCCCC;border:none;padding:0in'><span
lang=EN-GB style='font-size:11.0pt;color:black'>CAUTION:</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#FFCCCC;border:none;padding:0in'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>----------------------------------------------------------------------------------------------------------------</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid;background:#FFCCCC;border:none;padding:0in'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>Never store the pen with the
needle attached.</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;background:#FFCCCC;border:none;padding:0in'><b><i><span lang=EN-GB
style='font-size:11.0pt;color:black'>Always remove the needle from the </span></i></b><b><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>GONAL-f pre-filled pen before
replacing the pen cap.</span></i></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:56.7pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Store the pen in its
original packaging in a safe place.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:56.7pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><span lang=EN-GB style='font-size:
11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>When the pen is empty,
ask your pharmacist how to dispose of it.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:85.05pt;margin-bottom:.0001pt;text-align:left;
text-indent:-56.7pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>Warning:</span></b><span lang=EN-GB style='font-size:11.0pt'>    Do not
throw away any medicines via wastewater or household waste.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 1.0pt 0in'>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal;page-break-after:avoid;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>8.       GONAL-f
pre-filled pen Treatment Diary</span></b></p>

</div>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=center style='margin-top:0in;text-align:center;
line-height:normal;page-break-after:avoid;background:#E7E6E6'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;</span></i><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>GONAL-f <span style='background:
yellow'>150 IU</span> PEN&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
12.0pt;page-break-after:avoid'><span lang=EN-GB><img border=0 width=624
height=519 id="Picture 8"
src="file:///c:/Users/makum/Desktop/Learning/p-ie/EMA%20EPI%20PoC/function_code/work/H/CAP/gonal-f/en/2021-06-04T08-55-59Z/gonal-f_clean_files/image033.png"></span></p>

<p class=MsoNormal align=center style='margin-top:0in;text-align:center;
line-height:normal;page-break-after:avoid;background:#CCFFFF'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;</span></i><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>GONAL-f 300 IU PEN&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
12.0pt'><span lang=EN-GB><img border=0 width=624 height=519 id="Picture 7"
src="file:///c:/Users/makum/Desktop/Learning/p-ie/EMA%20EPI%20PoC/function_code/work/H/CAP/gonal-f/en/2021-06-04T08-55-59Z/gonal-f_clean_files/image034.png"></span></p>

<p class=MsoNormal align=center style='margin-top:0in;text-align:center;
line-height:normal;page-break-after:avoid;background:#CCECFF'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 450 IU- PEN &gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
12.0pt'><span lang=EN-GB><img border=0 width=624 height=519 id="Picture 6"
src="file:///c:/Users/makum/Desktop/Learning/p-ie/EMA%20EPI%20PoC/function_code/work/H/CAP/gonal-f/en/2021-06-04T08-55-59Z/gonal-f_clean_files/image035.png"></span></p>

<p class=MsoNormal align=center style='margin-top:0in;text-align:center;
line-height:normal;page-break-after:avoid;background:#99CCFF'><i><span
lang=EN-GB style='font-size:11.0pt;color:black'>&lt;GONAL-f 900 IU - PEN&gt;</span></i></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
12.0pt'><span lang=EN-GB><img border=0 width=624 height=519 id="Picture 5"
src="file:///c:/Users/makum/Desktop/Learning/p-ie/EMA%20EPI%20PoC/function_code/work/H/CAP/gonal-f/en/2021-06-04T08-55-59Z/gonal-f_clean_files/image036.png"></span></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><span lang=EN-GB style='font-size:11.0pt'>Note: The 150&nbsp;IU pen
maximum single-dose setting is 150&nbsp;IU; the 300&nbsp;IU pen maximum
single-dose setting is 300&nbsp;IU; the 450&nbsp;IU pen maximum single-dose
setting is 450&nbsp;IU; the 900&nbsp;IU pen maximum single-dose setting is 450&nbsp;IU.</span></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;
text-indent:-28.35pt;line-height:normal'><b><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=left style='margin-top:0in;text-align:left;line-height:
normal'><b><span lang=EN-GB style='font-size:11.0pt'>These instructions for use
were last revised in </span></b><span lang=EN-GB style='font-size:11.0pt'>{<b>MM/YYYY</b>}.</span></p>

<p class=MsoNormal style='margin-top:0in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

</div>

</body>

</html>
